class,text
3,A larger-scale trial is needed to replicate these findings and further understand the mechanisms of change .
3,A larger-scale trial is needed to replicate findings and further understand the mechanisms of change .
3,A larger-scale trial is needed to replicate these and further understand the mechanisms of change .
3,A larger-scale trial is to replicate these findings and further understand the mechanisms of change .
3,A trial is needed to replicate these findings and further understand the mechanisms of change .
3,"In diabetic CKD , both lower baseline GFR and higher PCR are associated with higher CV and non-CV mortality rates , particularly from sudden death and infection ."
3,"In diabetic CKD , both lower GFR and higher PCR are associated with higher and non-CV mortality rates , particularly from sudden death and infection ."
3,"In diabetic CKD , both lower baseline GFR and higher PCR are associated with higher CV and mortality rates , particularly sudden death and infection ."
3,"In diabetic CKD , both lower baseline GFR and higher PCR are associated with higher CV and non-CV mortality , particularly from sudden death infection ."
3,"In diabetic CKD , both lower baseline GFR and higher PCR with higher CV and non-CV mortality rates , particularly from sudden death and infection ."
4,These individual barriers might be addressed though patient navigation interventions .
4,These barriers might be addressed though patient navigation interventions .
4,These individual barriers might addressed though patient navigation interventions .
4,These individual barriers might be addressed though navigation interventions .
4,These individual barriers might be addressed though patient interventions .
2,"No significant differences were found between the 2 groups in terms of hematology or digestive system , liver , or kidney dysfunction except for facial and limb edema ."
2,"No differences were found between the 2 groups in terms of hematology or digestive system , liver , kidney dysfunction except for facial and limb edema ."
2,"No significant differences were between the 2 groups in terms of hematology or system , liver , or kidney dysfunction except for facial and limb edema ."
2,"No significant differences were found between 2 groups terms of hematology or digestive system , liver , or kidney dysfunction except for facial and limb edema ."
2,"No significant differences were found between the groups in terms of hematology or digestive , liver , or kidney dysfunction except for facial and limb edema ."
4,There are currently no agreed strategies for vitamin D replenishment after hip fracture surgery .
4,There are currently no agreed strategies for vitamin D replenishment after fracture surgery .
4,There are currently no agreed strategies for vitamin D replenishment hip fracture surgery .
4,There are no agreed strategies for vitamin D replenishment after hip fracture surgery .
4,There currently no agreed strategies for vitamin D replenishment after hip fracture surgery .
4,"The J-START was registered with the University Hospital Medical Information Network Clinical Trial Registration ( UMIN-CTR ) , Japan ( registration number : UMIN000000757 ) , on July 1 , 2007 ."
4,"The J-START was registered with the University Hospital Information Network Trial Registration ( UMIN-CTR ) , Japan ( registration number : UMIN000000757 ) , on July 1 , 2007 ."
4,"The J-START was registered with the University Hospital Medical Information Network Trial Registration ( ) , Japan ( registration number : UMIN000000757 ) , on July 1 , 2007 ."
4,"The J-START was registered with the University Hospital Medical Information Network Trial Registration ( UMIN-CTR ) , Japan ( number : UMIN000000757 ) , on July 1 , 2007 ."
4,"The J-START was registered with the University Medical Information Network Clinical Trial Registration ( UMIN-CTR ) , Japan ( registration number : UMIN000000757 ) , on July 1 , ."
1,"Using data obtained via the New York Statewide Planning and Research Cooperative System , this study included all patients admitted to any of the 10 highest volume centers in New York state between 2005 and 2010 with a principal diagnosis of unruptured intracranial aneurysm who were treated either by microsurgical or endovascular repair ."
1,"Using data obtained via the New York Statewide Planning and Research Cooperative System , this study included all patients admitted to any of the 10 highest volume in New York state between 2005 and 2010 with a principal diagnosis intracranial who were treated by microsurgical or endovascular repair ."
1,"Using data obtained via the New York and Research Cooperative System , this study included all patients admitted to of the highest volume centers in New York between 2005 and 2010 with a principal diagnosis of unruptured intracranial aneurysm who were treated either by microsurgical or endovascular repair ."
1,"Using data via the New York Statewide Planning and Research Cooperative System , this study included patients admitted to any of the 10 highest volume centers York state between 2005 2010 with a principal diagnosis of unruptured intracranial aneurysm who were treated either by microsurgical or endovascular repair ."
1,"Using obtained via the New York Statewide Planning and Research Cooperative System , this study included all patients admitted to any of the 10 highest volume centers in New York state 2005 2010 with a principal of unruptured intracranial aneurysm who were treated either by or endovascular repair ."
1,present with clinical evidence or high suspicion of multiple trauma ( predicted Injury Severity Score [ ISS ] 16 ) and 3 .
1,present with clinical evidence or high of multiple trauma ( predicted Injury Severity Score [ ISS ] 16 ) and 3 .
1,present with clinical evidence or high suspicion of multiple trauma ( predicted Injury Score [ ISS ] 16 ) and 3 .
1,present with clinical evidence or high suspicion of multiple trauma ( predicted Injury Severity Score [ ISS ] 16 ) 3 .
1,with clinical evidence or high suspicion of multiple trauma ( predicted Injury Severity Score [ ISS ] 16 ) and 3 .
1,Ten volunteers were each studied on 4 randomly assigned days .
1,Ten volunteers were each on 4 randomly assigned days .
1,Ten volunteers were each studied 4 randomly assigned days .
1,Ten volunteers were each studied on 4 randomly days .
1,Ten volunteers were studied on 4 randomly assigned days .
4,This discrepancy is known as Developmental Disregard ( DD ) .
4,This discrepancy is known as Developmental Disregard ( ) .
4,This discrepancy is known as Disregard ( DD ) .
4,This is known as Developmental Disregard ( DD ) .
4,discrepancy is known as Developmental Disregard ( DD ) .
1,We evaluated predictors of pregnancy and adherence to study medication among HIV-1-uninfected women enrolled in a randomized placebo-controlled trial of PrEP among African HIV-1-serodiscordant couples .
1,We evaluated predictors of pregnancy and adherence to medication among HIV-1-uninfected enrolled in a randomized placebo-controlled trial of PrEP among African HIV-1-serodiscordant couples .
1,We evaluated predictors of pregnancy and adherence to study medication among HIV-1-uninfected women enrolled in randomized placebo-controlled trial of PrEP African HIV-1-serodiscordant couples .
1,We evaluated predictors of pregnancy and adherence to study medication among women enrolled in a randomized placebo-controlled trial of PrEP among African HIV-1-serodiscordant .
1,We predictors of pregnancy and adherence to study medication among HIV-1-uninfected women enrolled in a randomized placebo-controlled of PrEP among African HIV-1-serodiscordant couples .
4,"Previous trials have shown less short-term recurrence with mesh , but adverse outcomes limit mesh use ."
4,"Previous have shown less short-term recurrence with mesh , but adverse outcomes limit mesh use ."
4,"Previous trials have less short-term recurrence with mesh , but adverse outcomes limit mesh use ."
4,"Previous trials have shown less recurrence with mesh , but adverse outcomes limit mesh use ."
4,"Previous trials have shown less short-term recurrence with mesh , but adverse outcomes limit use ."
3,Consequently physical activity behaviour outcomes in trials will not be biased by the season in which they are measured .
3,Consequently activity behaviour outcomes in trials will not be biased by the season in which they are measured .
3,Consequently physical activity behaviour outcomes in trials not be biased by the season in which they are measured .
3,Consequently physical activity behaviour outcomes in trials will not be biased by the season in they are measured .
3,Consequently physical activity outcomes in trials will not be biased by the season in which they are measured .
1,"Safety was established through serial serum potassium levels and measurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was established through serial serum levels and measurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was established through serial serum potassium and measurement of cystatin C , a non-creatinine measure of kidney function ."
1,"Safety was established through serial serum potassium levels and measurement of cystatin C , a non-creatinine measure of kidney ."
1,"Safety was established through serial serum potassium levels and of cystatin C , a non-creatinine measure of kidney function ."
2,"Regarding tryptophan metabolites , anthranilic acid ( AA ) levels were significantly higher at the end of the add-on phase compared with baseline ( p = 0.002 ) and correlated significantly with improvement of mood ( = -0.39 , p = 0.037 ) and seizure frequency reduction ( = -0.33 , p < 0.01 ) ."
2,"Regarding metabolites , anthranilic acid ( AA ) levels were significantly higher at the of the add-on phase compared with baseline ( p = 0.002 ) and correlated significantly with improvement of mood ( = -.39 , p = 0.037 ) and seizure frequency reduction ( = -0.33 , p <.01 ) ."
2,"Regarding tryptophan metabolites , acid ( AA ) levels were significantly at the end of the add-on phase compared with baseline ( p = 0.002 ) and correlated significantly with improvement of mood ( = -0.39 , p = 0.037 ) and reduction ( = -0.33 , p < 0.01 ) ."
2,"Regarding tryptophan metabolites , anthranilic ( AA ) levels were higher at the end of the add-on compared with baseline ( p = 0.002 ) and correlated significantly with improvement of mood ( = -0. , p = 0.037 ) and seizure frequency reduction ( = -0.33 , p < 0.01 ) ."
2,"Regarding tryptophan metabolites , anthranilic acid ( AA ) levels were significantly higher at end of the add-on compared with baseline ( p = 0.002 ) and correlated significantly with improvement of mood ( = -. , p = 0.037 ) and seizure frequency reduction ( = -0.33 , p < 0.01 ) ."
3,"Dietary EPA augments skin EPA : AA content , shifting eicosanoid synthesis towards less pro-inflammatory species , and promoting a regulatory milieu under basal conditions and in response to inflammatory insult ."
3,"Dietary EPA augments EPA : AA content , shifting eicosanoid synthesis towards less pro-inflammatory species , and promoting a regulatory milieu under basal conditions and in response to insult ."
3,"Dietary EPA augments skin EPA : AA content , shifting eicosanoid synthesis towards less pro-inflammatory species , and promoting a regulatory milieu under basal conditions in response to inflammatory ."
3,"Dietary EPA augments skin EPA : AA content , shifting eicosanoid synthesis towards pro-inflammatory species , and promoting a regulatory milieu under basal conditions and response to inflammatory insult ."
3,"EPA augments skin EPA : AA content , shifting eicosanoid synthesis towards less pro-inflammatory species , and promoting a regulatory milieu basal conditions and in response to inflammatory insult ."
4,Treatment aimed at slowing down the progression of DN is available but methods for early and definitive detection of DN progression are currently lacking .
4,Treatment aimed at slowing down the progression of DN is available but methods for early and detection of DN progression currently lacking .
4,Treatment aimed at slowing down the progression of DN is but methods for early and definitive detection of progression are currently lacking .
4,Treatment aimed slowing down the progression of DN is available but methods for early and detection of DN progression are currently lacking .
4,Treatment at slowing down the progression of DN is available but methods for early and definitive detection of DN progression are lacking .
1,"The GLYNDIET study is a 6-mo randomized , parallel , controlled clinical trial conducted in 122 overweight and obese adults ."
1,"The GLYNDIET study is 6-mo randomized , parallel , controlled clinical trial conducted in 122 overweight and obese adults ."
1,"The GLYNDIET study is a 6-mo , parallel , controlled clinical trial conducted in 122 overweight and obese adults ."
1,"The GLYNDIET study is a 6-mo randomized , parallel , controlled clinical conducted in 122 overweight and obese adults ."
1,"The study is a 6-mo randomized , parallel , controlled clinical trial conducted in 122 overweight and obese adults ."
4,Netherlands Trial Register NTR2199 .
4,Netherlands Register NTR2199 .
4,Netherlands Trial NTR2199 .
4,Netherlands Trial Register .
4,Trial Register NTR2199 .
3,N-acetylcysteine treatment during therapy facilitates long-term application of behavioral therapy techniques once patients are in the community after therapy has been completed .
3,N-acetylcysteine treatment during therapy facilitates long-term application of therapy techniques patients are in the community after therapy has been completed .
3,N-acetylcysteine treatment during therapy facilitates long-term of behavioral therapy techniques once are in the community after therapy has been completed .
3,N-acetylcysteine treatment during therapy long-term application of behavioral therapy techniques once patients are in the community after therapy has completed .
3,N-acetylcysteine treatment therapy facilitates long-term application of therapy techniques once patients are in the community after therapy has been completed .
3,This lack of benefit can probably be attributed to the rapid availability of fluids and emergency OR at this trauma center .
3,This lack of benefit can probably be attributed to availability of fluids and emergency OR at this trauma center .
3,This lack of benefit can probably be attributed to the rapid availability of fluids and at this trauma center .
3,This lack of benefit can probably be attributed to the rapid availability of fluids emergency at this trauma center .
3,This of can probably be attributed to the rapid availability of fluids and emergency OR at this trauma center .
2,Adverse reactions had nothing to do with CM treatment .
2,Adverse had nothing to do with CM treatment .
2,Adverse reactions had nothing to do with treatment .
2,Adverse reactions had nothing to with CM treatment .
2,reactions had nothing to do with CM treatment .
0,"To evaluate transient , large visual acuity ( VA ) decreases , termed sporadic vision loss , during anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration ( AMD ) ."
0,"To evaluate transient , large visual acuity ( VA ) decreases , sporadic vision loss , during anti-vascular endothelial growth factor treatment neovascular age-related macular degeneration ( AMD ) ."
0,"To evaluate transient , large visual acuity ( VA ) decreases , termed sporadic vision loss , during anti-vascular endothelial growth factor for age-related macular degeneration ( AMD ) ."
0,"To evaluate transient , large visual acuity ( VA ) decreases , termed vision loss , during anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration ( ) ."
0,"To transient , large visual acuity ( VA ) decreases , termed sporadic vision , during anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration ( AMD ) ."
3,"Bourdas DI , Tsakiris TS , Pavlakis KI , Triantafillou DV , Geladas ND ."
3,"Bourdas , Tsakiris TS , Pavlakis KI , Triantafillou DV , Geladas ND ."
3,"Bourdas DI , TS , Pavlakis KI , Triantafillou DV , Geladas ND ."
3,"Bourdas DI , Tsakiris TS , KI , Triantafillou DV , Geladas ND ."
3,"Bourdas DI , Tsakiris TS , Pavlakis KI , Triantafillou DV , Geladas ."
1,"In a split-mouth design , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
1,"In a design , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
1,"In a split-mouth design , teeth were assigned to experimental ( with ) and control ( without GO ) groups ."
1,"In a split-mouth design , teeth were assigned to experimental ( with GO ) control ( without GO ) groups ."
1,"a split-mouth design , teeth were assigned to experimental ( with GO ) and control ( without GO ) groups ."
3,"Calcitriol has apparent beneficial effect on acute cellular rejection of liver transplants , which may be associated with increases in the proportion of circulating Treg cells ."
3,"Calcitriol has apparent beneficial effect on acute cellular rejection of liver transplants , which associated with increases in the proportion of circulating Treg cells ."
3,"Calcitriol has apparent beneficial effect on acute cellular rejection of liver transplants , which be associated with in the proportion of circulating Treg cells ."
3,"Calcitriol has apparent beneficial effect on acute cellular rejection of liver transplants , which be associated with increases in the proportion circulating Treg cells ."
3,"Calcitriol has apparent beneficial effect on acute cellular rejection of liver transplants , which may be associated with increases in the proportion of Treg ."
3,"As afatinib is not a relevant modulator or substrate of cytochrome P450 enzymes , the drug-drug interaction potential is considered to be low ."
3,"As afatinib is not a relevant modulator or substrate of cytochrome enzymes , the drug-drug interaction potential considered to be low ."
3,"As afatinib is not relevant modulator or substrate of cytochrome P450 enzymes , the drug-drug interaction potential is considered to low ."
3,"As afatinib is not relevant modulator substrate of cytochrome P450 enzymes , the drug-drug interaction potential is considered to be low ."
3,"afatinib not a relevant modulator or substrate of cytochrome P450 enzymes , the drug-drug interaction potential is considered to be low ."
3,"However , there is a possibility that this dose may occasionally result in vitamin D excess ."
3,"However , there a possibility that this dose may occasionally result in vitamin D excess ."
3,"However , there is a possibility that dose may occasionally result in vitamin D excess ."
3,"However , there is a possibility that this dose may result in vitamin D excess ."
3,"However , there is a possibility that this dose occasionally result in vitamin D excess ."
0,"To propose a simple correction of body-mass index ( BMI ) based on self-reported weight and height ( reported BMI ) using gender , body shape perception and socioeconomic status in an adolescent population ."
0,"To propose a simple correction of body-mass ( BMI ) based on self-reported weight height ( reported BMI ) using gender , body shape perception and socioeconomic status in an adolescent population ."
0,"To propose a simple correction of body-mass index ( BMI ) based on self-reported and height ( reported BMI ) using gender , body shape perception and status in an adolescent population ."
0,"To propose a simple of body-mass index ( ) based on self-reported weight and height ( reported BMI ) using gender , body shape perception and socioeconomic status in an adolescent population ."
0,"propose a simple correction of body-mass index ( BMI ) based on self-reported weight and height ( reported BMI ) using gender , shape perception and socioeconomic status in an adolescent population ."
4,Several studies indicate that increasing the alimentary limb length in gastric bypass surgery produces only a minor improvement of excess BMI loss .
4,Several indicate that increasing the alimentary length in gastric bypass surgery produces only a minor improvement of excess BMI loss .
4,Several studies indicate increasing alimentary limb length in gastric bypass surgery produces only a minor improvement of excess BMI loss .
4,Several studies indicate that increasing the alimentary length gastric bypass surgery produces only a minor improvement of excess BMI loss .
4,Several studies indicate that increasing the alimentary limb length in gastric surgery produces only a minor improvement of excess loss .
1,We excluded patients who were taking vitamin D or calcium supplements .
1,We excluded patients who were taking D or calcium supplements .
1,We excluded patients who were taking vitamin D calcium supplements .
1,We excluded patients who were taking vitamin or calcium supplements .
1,We patients who were taking vitamin D or calcium supplements .
0,"Opioid pharmacotherapy is now the leading treatment for chronic pain , a problem that affects nearly one third of the U.S. population ."
0,"Opioid is now the leading treatment for chronic pain , problem that affects nearly one third of the U.S. population ."
0,"Opioid pharmacotherapy is now the leading treatment for chronic pain , a problem that nearly one of the U.S. population ."
0,"Opioid pharmacotherapy is now the treatment for chronic pain , a problem that affects nearly one third of the U.. population ."
0,"Opioid pharmacotherapy is the leading treatment for chronic pain , problem that affects nearly one third of the U.S. population ."
0,"Across the United States , tens of thousands of college students are mandated to receive an alcohol intervention following an alcohol policy violation ."
0,"Across the States , tens of thousands of college students are mandated to receive an alcohol intervention following an alcohol violation ."
0,"Across the United States , tens of thousands of college students are mandated to receive alcohol intervention following an alcohol violation ."
0,"Across the United States , tens of thousands of college students are mandated to receive an alcohol intervention following alcohol violation ."
0,"Across the United States , tens of thousands of students are mandated to receive an alcohol intervention an alcohol policy violation ."
2,"Final analysis included 21 acute right hemisphere stroke patients with neglect ( 23 enrolled , 2 lost to follow-up ) allocated either to the treatment ( 1 week hemifield eye patching and daily sessions of optokinetic stimulation , n = 11 ) or the control group ( no neglect-specific treatment , n = 10 ) ."
2,"Final analysis included 21 acute right hemisphere stroke patients neglect ( 23 enrolled , 2 lost to ) allocated either to the treatment ( 1 week hemifield eye patching and daily of optokinetic stimulation , n = 11 ) or the control group ( neglect-specific treatment , n = 10 ) ."
2,"Final analysis included 21 acute right hemisphere stroke patients with neglect ( 23 enrolled , 2 lost to follow-up ) allocated either to the treatment ( 1 eye and daily sessions of optokinetic stimulation , n = 11 ) or the group ( no neglect-specific treatment , n = 10 ) ."
2,"Final analysis included 21 acute stroke patients with neglect ( 23 enrolled , 2 lost to follow-up ) either to the treatment ( 1 week hemifield eye patching and daily sessions of optokinetic stimulation , n = 11 ) or the control group ( no neglect-specific treatment , = 10 ) ."
2,"Final analysis included acute right hemisphere stroke patients with neglect ( enrolled , 2 lost to follow-up ) allocated either to the treatment ( 1 week hemifield eye patching and daily sessions of optokinetic stimulation , = 11 ) or the control group ( neglect-specific treatment , n = 10 ) ."
4,The overuse of antimicrobials is recognized as the main selective pressure driving the emergence and spread of antimicrobial resistance in human bacterial pathogens .
4,The overuse of antimicrobials is as the main selective pressure driving the emergence spread of antimicrobial resistance in human bacterial pathogens .
4,The overuse of antimicrobials is recognized as the main pressure driving the emergence and spread antimicrobial resistance in human bacterial pathogens .
4,The overuse of antimicrobials is recognized the main selective pressure driving the emergence and spread of resistance in human bacterial pathogens .
4,overuse of antimicrobials is recognized as the main selective pressure driving the emergence and spread of antimicrobial resistance in human bacterial .
2,"No significant difference in visual , refractive , or topography outcomes was observed between the 2 groups at the last checkup ."
2,"No significant difference in , refractive , or topography outcomes was observed between the 2 groups at the last checkup ."
2,"No significant difference in visual , refractive , or topography outcomes observed between the 2 groups at the last checkup ."
2,"No significant difference in visual , refractive , or topography outcomes was between the 2 groups at the last checkup ."
2,"No significant difference in visual , refractive , or topography outcomes was observed between the 2 groups at the last ."
3,"Gender differences in the physiological response to spinning ( body temperature , mean blood pressure and heart rate ) can be explained in part by the distinct physical characteristics of each individual ."
3,"Gender differences in the physiological response to spinning ( body temperature , mean blood pressure heart ) can be explained in part by the distinct physical characteristics of each individual ."
3,"Gender differences in the response to spinning ( body temperature , mean blood pressure and heart rate ) can be explained in part the distinct physical characteristics of each individual ."
3,"Gender in the physiological response to spinning ( body temperature , mean blood pressure and heart rate ) can be explained in part by the physical characteristics of each individual ."
3,"differences in the physiological response to spinning ( body temperature , mean blood pressure and heart rate ) can be explained in part by the distinct physical of each individual ."
0,We investigated real-life oral anticoagulation ( OAC ) treatment after surgical ablation and examined its adherence to current recommendations .
0,We investigated real-life oral ( OAC ) treatment after surgical ablation and examined its adherence to current recommendations .
0,We investigated real-life oral anticoagulation ( OAC ) treatment after surgical ablation and examined its adherence current recommendations .
0,We investigated real-life oral anticoagulation ( OAC ) treatment after surgical ablation and examined its to current recommendations .
0,investigated real-life oral anticoagulation ( OAC ) treatment after surgical ablation and examined its adherence to current recommendations .
2,Participants had better health behaviors and fewer health problems than those who did not participate .
2,Participants had better behaviors and fewer health problems than those who did not participate .
2,Participants had better health behaviors and fewer health problems than those who did not .
2,Participants had better health behaviors and fewer health problems those who did not participate .
2,Participants had better health behaviors and health problems than those who did not participate .
4,This study was conducted to answer this question .
4,This study was conducted answer this question .
4,This study was conducted to answer question .
4,This study was to answer this question .
4,study was conducted to answer this question .
2,"Furthermore , this main effect was not particularly pronounced when the game was played online ."
2,", this main effect was not particularly pronounced when the game was played online ."
2,"Furthermore , this main effect was not particularly pronounced when the game played online ."
2,"Furthermore , this main effect was not particularly pronounced when the game was online ."
2,"Furthermore , this main effect was not pronounced when the game was played online ."
1,"Treatment-naive patients with HCV genotype 1 infection were assigned randomly to 1 of thefollowing groups : PEG-IFN/RBV for 48 weeks ( group A , n = 31 ) , PEG-IFN/RBV for 4 weeks followed by PEG-IFN/RBV for 44 weeks with 6 injections of TG4040 ( group B , n = 63 ) , or TG4040 for 12 weeks ( 7 injections ) followed by PEG-IFN/RBV for 48 weeks with 6 injections of TG4040 ( group C , n = 59 ) ."
1,"Treatment-naive patients HCV genotype 1 infection were assigned randomly to 1 of thefollowing : PEG-IFN/ for 48 weeks ( group A , = 31 ) , PEG-IFN/RBV for 4 weeks followed by PEG-IFN/RBV for 44 weeks with 6 injections of TG4040 ( group B , n = 63 ) , or TG4040 for 12 weeks ( 7 injections ) by PEG-IFN/RBV for 48 weeks with 6 injections TG4040 ( group C , n = 59 ) ."
1,"Treatment-naive patients with HCV 1 infection were assigned randomly to 1 of thefollowing groups : PEG-IFN/RBV for 48 weeks ( group A , n = 31 ) , PEG-IFN/RBV for 4 weeks followed by PEG-IFN/RBV for 44 weeks 6 injections of TG4040 ( group B , n = 63 ) , or 12 ( 7 injections ) followed by PEG-IFN/RBV for 48 weeks with 6 injections TG4040 ( group C , n = 59 ) ."
1,"Treatment-naive patients with HCV genotype 1 infection were assigned randomly to 1 of thefollowing groups : PEG-IFN/RBV for 48 weeks ( group A , n = 31 ) , PEG-IFN/RBV for 4 weeks followed by/RBV 44 weeks 6 of TG4040 ( group B , n = 63 ) , or TG4040 for 12 weeks ( injections ) followed by PEG-IFN/RBV for 48 weeks with 6 injections TG4040 ( group C , n = 59 ) ."
1,"Treatment-naive with HCV genotype 1 infection were assigned to 1 of thefollowing groups : PEG-IFN/RBV for 48 weeks ( group A , n = 31 ) ,/RBV for 4 weeks followed by PEG-IFN/RBV 44 weeks 6 injections of TG4040 ( group B , n = 63 ) , or TG4040 for 12 weeks ( 7 injections ) followed by PEG-IFN/RBV for 48 weeks with 6 injections of TG4040 ( group C , n = ) ."
1,Both groups used a secure website to upload data and to receive feedback from their endocrinologist .
1,Both groups used a secure website to upload data and to receive feedback from endocrinologist .
1,Both groups used a secure website to upload data and to receive feedback from their .
1,Both groups used a website to upload data and to receive feedback from their endocrinologist .
1,Both groups used secure website to upload data and to receive feedback from their endocrinologist .
0,We aimed to investigate whether the solitary addition of nonfat dairy products to the normal routine diet was capable of lowering blood pressure in middle-aged and older adults with elevated blood pressure .
0,We aimed to investigate whether solitary addition of nonfat dairy products to normal routine diet was capable of lowering blood pressure in middle-aged and older adults with blood pressure .
0,We aimed to investigate whether the solitary addition of dairy products to the normal routine diet was capable of lowering blood in and older adults with elevated blood pressure .
0,We aimed to investigate whether the solitary of nonfat dairy products to the normal routine was capable lowering blood pressure in middle-aged and older adults with elevated blood pressure .
0,aimed to investigate whether the solitary addition of nonfat dairy products to the normal routine diet was capable of blood pressure in middle-aged and adults with elevated blood pressure .
2,"Both BIS values and OAA/S scores were lower in Group P than in Group S. Patients ' satisfaction was higher in Group P , although there was no significant difference with respect to surgeons ' satisfaction between the groups ."
2,"Both BIS values OAA/S scores were lower in Group P than in Group S. Patients ' satisfaction was in Group P , although there was no significant difference with respect to surgeons ' satisfaction the groups ."
2,"Both BIS values and OAA/ scores were lower in Group P than in Group S. Patients ' was in Group P , although there was no significant difference with respect to surgeons ' satisfaction between the groups ."
2,"Both BIS values and OAA/S scores were lower Group P than in Group S. Patients ' satisfaction in Group P , although there was no significant difference with respect to surgeons ' satisfaction between the groups ."
2,"Both BIS values and/S scores were lower in Group P than in Group S. ' was higher in Group P , although there was no significant difference with respect to surgeons ' satisfaction between the groups ."
4,German Cancer Aid ( Deutsche Krebshilfe ) .
4,Cancer Aid ( Deutsche Krebshilfe ) .
4,German Cancer ( Deutsche Krebshilfe ) .
4,German Cancer Aid ( Deutsche ) .
4,German Cancer Aid ( Krebshilfe ) .
1,Time to first development of PDR was analyzed by Kaplan-Meier methods to calculate cumulative probabilities by group .
1,Time first development of PDR was analyzed by Kaplan-Meier methods to calculate cumulative probabilities by group .
1,Time to first development of PDR was analyzed Kaplan-Meier methods to calculate cumulative probabilities by group .
1,Time to first development of PDR was analyzed by Kaplan-Meier methods calculate cumulative probabilities by group .
1,Time to first development of PDR was by Kaplan-Meier methods to calculate cumulative probabilities by group .
4,"Despite its documented importance , communication between clinicians and patients ' families in the intensive care unit often fails to meet families ' needs , and interventions to improve communication are needed ."
4,"Despite its documented importance , communication between clinicians and patients ' families in the care often fails to meet families ' needs , and interventions to improve communication are needed ."
4,"Despite its documented importance , communication between clinicians and patients ' families in the intensive care often fails to meet families ' needs , and interventions to improve communication are ."
4,"Despite its documented importance , communication between clinicians and patients ' families in the intensive care unit often fails meet families ' needs , and to improve communication are needed ."
4,"Despite its documented importance , communication between clinicians and patients ' families in the intensive care unit often meet families ' needs , and interventions to improve communication are needed ."
3,"Furthermore , higher baseline HIV RNA and lower creatinine clearance were associated with the development of renal insufficiency requiring treatment modification ."
3,"Furthermore , higher baseline HIV RNA lower creatinine clearance were associated with the development of renal requiring treatment modification ."
3,"Furthermore , higher baseline HIV RNA lower creatinine clearance were associated with the development renal insufficiency requiring treatment modification ."
3,"Furthermore , higher baseline RNA and creatinine clearance were associated with the development of renal insufficiency requiring treatment modification ."
3,"Furthermore , higher baseline RNA and lower creatinine clearance were associated with the development of insufficiency requiring treatment modification ."
3,"The PDE-5 inhibitor improves quality of life and urinary symptoms in patients with LUTS suggestive of BPH , but does n't have any significant effect on Qmax and RUV ."
3,"PDE-5 inhibitor quality of life and urinary symptoms in patients with LUTS suggestive of BPH , but does n't have any significant effect on Qmax and RUV ."
3,"The PDE-5 inhibitor improves quality of and urinary symptoms in patients with LUTS suggestive of BPH , but does have any significant effect on Qmax and RUV ."
3,"The PDE-5 inhibitor improves quality of life and urinary symptoms in patients with LUTS suggestive of BPH , does n't have any significant on Qmax and RUV ."
3,"The PDE-5 inhibitor improves quality of life and urinary symptoms in with LUTS suggestive of BPH , but does n't have any significant effect Qmax and RUV ."
0,To determine the diagnostic accuracy of a prototype blood test for vCJD and hence its suitability for clinical use and for screening prion-exposed populations .
0,To determine the diagnostic accuracy of a prototype blood test for vCJD and hence its suitability for clinical and for screening prion-exposed .
0,To determine the diagnostic accuracy of a prototype blood test for vCJD and hence its suitability for use and for screening prion-exposed .
0,To determine the diagnostic accuracy of a prototype blood test for vCJD hence its suitability for clinical use and screening prion-exposed populations .
0,To determine the diagnostic of a prototype blood test for vCJD and hence its suitability for clinical use and screening prion-exposed populations .
4,The randomized Nordic Stent Technique Study showed similar 6-month clinical and 8-month angiographic results with the crush and culotte stent techniques of de novo coronary artery bifurcation lesions using sirolimus-eluting stents .
4,The randomized Nordic Stent Technique Study showed similar 6-month and 8-month angiographic results the crush and culotte stent of de novo coronary artery bifurcation lesions using sirolimus-eluting stents .
4,The randomized Nordic Stent Technique Study showed similar 6-month clinical 8-month results with crush and culotte stent techniques of de novo coronary artery bifurcation lesions using sirolimus-eluting stents .
4,The randomized Nordic Stent Technique Study showed similar 6-month clinical and angiographic with the crush and culotte stent techniques de novo coronary artery bifurcation lesions using sirolimus-eluting stents .
4,The randomized Nordic Technique Study showed similar clinical and 8-month angiographic results with the crush and culotte stent techniques of de novo coronary artery bifurcation using sirolimus-eluting stents .
0,"The aim of this study was to compare gait and cognitive performance before and after the use of rivastigmine in patients with HLGD , free from cognitive impairment or Parkinsonism ."
0,"The aim of this study was to compare gait and cognitive before and after the use of rivastigmine in patients with HLGD , free from cognitive or Parkinsonism ."
0,"The aim of this study was to compare gait and cognitive performance before and after the use of rivastigmine in with HLGD , free from cognitive impairment Parkinsonism ."
0,"The aim of this study was to compare gait and cognitive performance before and the use of rivastigmine in patients with HLGD , from cognitive impairment or Parkinsonism ."
0,"of this study was to compare gait and cognitive performance before and after the use of rivastigmine in patients with HLGD , free from cognitive impairment or Parkinsonism ."
2,"However , the greatest reduction ( 80 % ) was observed when using a combination of all control measures ."
2,", the greatest reduction ( 80 % ) was observed when using a combination of all control measures ."
2,"However , the greatest reduction ( 80 % ) observed when using a combination of all control measures ."
2,"However , the greatest reduction ( 80 % ) was observed when using a combination of all control ."
2,"However , the greatest reduction ( 80 % ) was observed when using a combination of all measures ."
0,Few publications of prospective studies have described patient outcomes in community-acquired bacterial pneumonia ( CABP ) - associated bacteremia .
0,Few of prospective studies have described patient outcomes in community-acquired bacterial pneumonia ( CABP ) - associated bacteremia .
0,Few publications of prospective studies described patient outcomes in community-acquired bacterial pneumonia ( CABP ) - associated bacteremia .
0,Few publications of prospective studies have described patient outcomes in community-acquired pneumonia ( CABP ) - associated bacteremia .
0,Few publications of prospective studies have patient outcomes in community-acquired bacterial pneumonia ( CABP ) - associated bacteremia .
3,Undertaking 12-month trial follow-up will allow us to evaluate the long-term effect of the intervention .
3,Undertaking 12-month trial follow-up will allow us to evaluate long-term effect of the intervention .
3,Undertaking 12-month trial follow-up will allow us to evaluate the long-term of the intervention .
3,Undertaking 12-month trial follow-up will allow us to the long-term effect of the intervention .
3,Undertaking trial follow-up will allow us to evaluate the long-term effect of the intervention .
1,"This is a single-centre , randomized controlled trial , with computer-generated randomization in a 1:1 allocation ratio ."
1,"This is a , randomized controlled trial , with computer-generated randomization in a 1:1 allocation ratio ."
1,"This is a single-centre , controlled trial , with computer-generated randomization in a 1:1 allocation ratio ."
1,"This is a single-centre , randomized controlled trial , with randomization in a 1:1 allocation ratio ."
1,"This is a single-centre , randomized trial , with computer-generated randomization in a 1:1 allocation ratio ."
4,"Standard Trauma Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervasive impact of interparental violence on the family system ."
4,"Standard Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervasive impact of interparental violence on the system ."
4,"Standard Trauma Focused Cognitive Behavioral Therapy be for children traumatized by exposure to interparental violence , given the pervasive impact of interparental violence on the family system ."
4,"Standard Trauma Focused Cognitive Therapy may be insufficient for children traumatized by exposure to interparental violence , the pervasive impact of interparental violence on the family system ."
4,"Trauma Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the impact of interparental violence on the family system ."
1,Data collection for control group A ( CGA ) ( n = 162 ) started before the intervention was initiated .
1,Data collection for control group ( CGA ) ( n = 162 ) started before the intervention was initiated .
1,Data collection for control group A ( CGA ) ( n = 162 ) started before intervention was initiated .
1,Data collection for control group A ( CGA ) ( n = 162 ) started before the intervention initiated .
1,Data collection for group A ( CGA ) ( n = 162 ) started before the intervention was initiated .
0,To evaluate the prevalence of respiratory impairment and dyspnea and their associations with objectively measured physical inactivity and performance-based mobility in sedentary older persons .
0,To evaluate prevalence of respiratory impairment and dyspnea and associations with objectively measured physical inactivity and performance-based mobility in sedentary older persons .
0,To evaluate the of respiratory impairment and dyspnea and their with objectively measured physical inactivity and performance-based mobility in sedentary older persons .
0,To evaluate the prevalence of respiratory impairment and dyspnea and their associations with measured inactivity and performance-based mobility in sedentary older persons .
0,To evaluate the prevalence respiratory impairment and dyspnea and their associations with objectively measured physical inactivity and performance-based mobility in older persons .
3,"The FOSQ and SAQLI are responsive to CPAP intervention , with the FOSQ being more sensitive to differences in CPAP adherence than the SAQLI ."
3,"The FOSQ and SAQLI are responsive to CPAP intervention , the FOSQ being more sensitive to differences in CPAP adherence the SAQLI ."
3,"The FOSQ and SAQLI are responsive to CPAP intervention , with the FOSQ being more sensitive to CPAP adherence than the SAQLI ."
3,"The FOSQ and SAQLI are responsive to CPAP intervention , with the FOSQ being more sensitive to differences in CPAP the SAQLI ."
3,"The FOSQ and SAQLI are responsive to CPAP intervention , with the being more sensitive to differences in CPAP adherence than SAQLI ."
4,"Intermittent normobaric hypoxia training , an alternative to altitude training for athletes , may be beneficial to treat overweight and obesity ."
4,"Intermittent normobaric hypoxia , an alternative to altitude training for athletes , may be beneficial to treat overweight and obesity ."
4,"Intermittent normobaric hypoxia training , an alternative to altitude training for athletes , may be to treat overweight and obesity ."
4,"Intermittent normobaric hypoxia training , an alternative to training for athletes , may be beneficial to treat overweight and obesity ."
4,"normobaric hypoxia training , an alternative to altitude training for athletes , may be beneficial to treat overweight and obesity ."
4,The primary outcome is level of depression at 6 months assessed using the patient health questionnaire-9 ( PHQ9 ) depression scale .
4,The primary outcome is level of depression at 6 months assessed using the health questionnaire-9 ( PHQ9 ) depression scale .
4,The primary outcome is level of depression at 6 months assessed using the patient health questionnaire-9 ( ) depression scale .
4,The primary outcome is level of depression at 6 months using the patient health questionnaire-9 ( PHQ9 ) depression scale .
4,The primary outcome is of depression at 6 months assessed using the patient health questionnaire-9 ( PHQ9 ) depression scale .
2,"Completers and dropouts were equivalent in demographics , the SWEMWBS , and the depression and anxiety subscales of the DASS-21 , but dropouts reported significantly higher levels of stress than completers ."
2,"Completers and dropouts were equivalent demographics , the , and the depression and anxiety subscales of the DASS-21 , but dropouts reported significantly higher levels of stress than completers ."
2,"Completers and dropouts were equivalent in demographics , the , and the depression and anxiety subscales of the DASS-21 , but dropouts reported significantly higher of stress than completers ."
2,"Completers and dropouts were in demographics , the , and the depression and anxiety subscales of the DASS-21 , but dropouts reported significantly higher levels of stress than completers ."
2,"Completers dropouts were equivalent demographics , the SWEMWBS , and the depression and anxiety subscales of the DASS-21 , but dropouts reported significantly higher levels of stress than completers ."
2,"QoL improvement involved mainly affective , emotional , and social dimensions ."
2,"QoL improvement involved affective , emotional , and social dimensions ."
2,"QoL improvement involved mainly affective , emotional , social dimensions ."
2,"QoL improvement mainly affective , emotional , and social dimensions ."
2,"improvement involved mainly affective , emotional , and social dimensions ."
4,"Protein is indispensable in the human diet , and its intake appears tightly regulated ."
4,"Protein is indispensable in the diet , and its intake appears tightly regulated ."
4,"Protein is indispensable in the human diet , and intake appears tightly regulated ."
4,"Protein is indispensable in the human diet , its intake appears tightly regulated ."
4,"Protein is indispensable the human diet , and its intake appears tightly regulated ."
2,The mean times to achieve an AW were longer when operators were equipped with C-PPE as compared with standard clothing .
2,The mean times to achieve an AW were longer when operators were equipped with as compared with standard .
2,The mean times to achieve an AW were longer when operators were with as compared with standard clothing .
2,The mean times to achieve an were longer when operators were equipped with as compared with standard clothing .
2,The times to achieve AW were longer when operators were equipped with C-PPE as compared with standard clothing .
1,Probiotics were administered in Group A ; oral antibiotics were administered in Group B ; and neither probiotics nor oral antibiotics were administered in Group C. Stool samples were collected 9 and 2 days before and 7 and 14 days after the procedure .
1,Probiotics administered in Group A ; oral antibiotics administered in Group B ; neither probiotics oral antibiotics were administered in Group C. Stool samples were collected 9 and 2 days before and 7 and 14 days after the procedure .
1,Probiotics administered in Group A ; oral antibiotics were in Group B ; and neither nor oral antibiotics were administered in Group C. samples were collected 9 and 2 days before and 7 and 14 days after the procedure .
1,Probiotics were administered in A ; oral antibiotics were administered in Group B ; probiotics nor oral antibiotics were administered in Group C. Stool samples were collected 9 and days before and 7 and 14 days after the procedure .
1,Probiotics were administered in Group A ; oral antibiotics were administered in Group B ; and neither probiotics nor oral were in Group C. Stool were collected 9 and days before and 7 and 14 days after the procedure .
2,"In contrast , the proportion of visits with VVC was similar in the intervention ( 10.4 % ) versus placebo ( 11.3 % ) arms ( RR 0.92 , 95 % CI .62 -1.37 ) ."
2,"In contrast , proportion of visits VVC was similar in the intervention ( 10.4 % ) versus placebo ( 11.3 % ) arms ( RR 0.92 , 95 % CI .62 -1.37 ) ."
2,"In contrast , the of visits with VVC was similar in the intervention ( 10.4 % ) versus placebo (.3 % ) arms ( RR 0.92 , 95 % CI .62 -1.37 ) ."
2,"In contrast , the proportion of visits with VVC similar in the intervention ( 10.4 % ) versus ( 11.3 % ) arms ( RR 0.92 , 95 % CI .62 -1.37 ) ."
2,"In contrast , the proportion of visits with VVC was similar in the intervention ( 10.4 % ) versus ( 11.3 % ) arms ( RR 0.92 , 95 % CI . -1.37 ) ."
4,"UK National Health Service Blood and Transplant Research and Development Programme , Pfizer , and Novartis UK ."
4,"UK National Health Service Blood and Research and Development Programme , Pfizer , and Novartis UK ."
4,"UK National Health Service Blood and Transplant Research and Development Programme , , and Novartis UK ."
4,"UK National Health Service Blood and Transplant Research and Development Programme , Pfizer , Novartis UK ."
4,"UK National Health Service Blood and Transplant Research and Programme , Pfizer , and Novartis UK ."
3,"Higher PaCO2 was an independent predictor of sIVH/death , BPD/death and NDI/death ."
3,"Higher PaCO2 was an independent predictor of sIVH/death , BPD/death and NDI/ ."
3,"Higher PaCO2 was an independent predictor of/death , BPD/death and NDI/death ."
3,"Higher PaCO2 was independent predictor of sIVH/death , BPD/death and NDI/death ."
3,"Higher was an independent predictor of sIVH/death , BPD/death and NDI/death ."
3,The use of the heating device upon administration of short-acting insulin analogues in pump-treated type 1 diabetic patients was found to enhance insulin absorption .
3,The of the heating device upon administration of short-acting insulin analogues pump-treated type 1 diabetic patients was found to enhance insulin absorption .
3,The use of the heating device upon administration short-acting insulin analogues in pump-treated type 1 diabetic patients was found enhance insulin absorption .
3,The use of the heating device upon of short-acting insulin analogues in pump-treated type 1 diabetic was found to enhance insulin absorption .
3,use of the heating upon administration of short-acting insulin analogues in pump-treated type 1 diabetic patients was found to enhance insulin absorption .
1,"A subgingival preparation finish line of between 1 and 2 mm was ensured , andthe buccal aspects of 252 ( n = 63 ) teeth were clinically assessed for ease of application , time spent , bleeding , remnants , and dilatation ."
1,"A subgingival finish line of between 1 and 2 mm was ensured , andthe buccal aspects 252 ( n = 63 ) were clinically assessed for ease of application , time spent , bleeding , remnants , and dilatation ."
1,"A subgingival finish line of between and 2 mm was ensured , andthe buccal aspects of 252 ( n = 63 ) teeth were clinically assessed for ease of application , time spent , bleeding , remnants , dilatation ."
1,"A subgingival preparation finish line of between 1 and 2 mm was ensured , andthe aspects of ( n = 63 ) teeth were clinically assessed for of application , time spent , bleeding , remnants , and dilatation ."
1,"A subgingival preparation finish line of between 1 and 2 mm was ensured , andthe buccal aspects of 252 ( n = 63 ) teeth were clinically for ease of application , time spent , , remnants , dilatation ."
4,"The vaginal microbiota may play a role in mediating susceptibility to sexually transmitted infections , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbiota may play a role in mediating susceptibility sexually transmitted infections , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbiota may play a role in mediating susceptibility to sexually infections , including Trichomonas vaginalis ( TV ) ."
4,"The vaginal microbiota may play role in mediating susceptibility to sexually transmitted infections , including Trichomonas vaginalis ( TV ) ."
4,"vaginal microbiota may play a role in mediating susceptibility to sexually transmitted infections , including Trichomonas vaginalis ( TV ) ."
0,"The purpose of this study was to determine whether the SPRINT definition of a `` critical-sized defect '' ( fracture gap at least 1 cm in length and involving over 50 % of the cortical diameter ) was accurate , to discern which factors predict reoperation in patients with these defects , and to compare the patient-based outcomes of these patients with patients without a critical defect ."
0,"The purpose of this study to determine whether the SPRINT definition of a `` critical-sized defect '' ( fracture gap at least 1 cm in length and involving over 50 % of the cortical diameter ) accurate , to discern which factors in patients with these defects , and to compare patient-based outcomes of these with patients without a critical defect ."
0,"The purpose of this study was to determine whether the SPRINT definition of a `` critical-sized defect '' ( fracture gap at least 1 cm in involving over 50 % of the cortical diameter ) was accurate , discern which factors predict in patients with these defects , and to compare the patient-based outcomes these patients with patients without a critical ."
0,"The purpose of this study was to determine whether the SPRINT definition of a critical-sized defect '' ( gap least cm in length and involving over % of the cortical diameter ) was accurate , to discern which factors predict reoperation in patients with these defects , and to compare the patient-based outcomes of these patients patients without a critical defect ."
0,"The purpose of this study was to determine whether the SPRINT definition of a defect '' ( fracture gap at cm in length and involving over 50 % of the cortical diameter ) was accurate , to discern which factors predict reoperation in patients with defects , and compare the patient-based outcomes of these patients with patients without a critical defect ."
4,"Swallowing problems following stroke may result in increased risk of aspiration pneumonia , malnutrition , and dehydration ."
4,"Swallowing problems following stroke may result in increased risk aspiration pneumonia , malnutrition , and dehydration ."
4,"Swallowing problems following stroke may result in increased risk of aspiration pneumonia , malnutrition , dehydration ."
4,"Swallowing problems following stroke may result in increased risk of pneumonia , malnutrition , and dehydration ."
4,"problems following stroke may result in increased risk of aspiration pneumonia , malnutrition , and dehydration ."
4,Research shows that many relatives remain unaware of relevant genetic information and the possible impact on their own health .
4,Research shows that many relatives remain of relevant genetic information and the possible impact on their own health .
4,Research shows that many relatives remain unaware of relevant genetic and the possible impact on their own health .
4,Research shows that many relatives remain unaware of relevant genetic information the possible impact on their own health .
4,Research shows that many relatives unaware of relevant genetic information and the possible impact on their own health .
2,Thirty-four participants receiving memantine and 36 receiving placebo completed the 1-year endpoint assessment ( n = 70 ) .
2,Thirty-four participants receiving and 36 receiving placebo completed the 1-year endpoint assessment ( n = 70 ) .
2,Thirty-four participants receiving memantine and 36 receiving placebo completed 1-year endpoint assessment ( n = 70 ) .
2,Thirty-four participants receiving memantine and 36 receiving placebo the 1-year endpoint assessment ( n = 70 ) .
2,Thirty-four participants receiving memantine and receiving placebo completed the 1-year endpoint assessment ( n = 70 ) .
1,Serum 25 ( OH ) D levels before and after the intervention were measured using the Diasorin Liaison platform immunoassay .
1,Serum 25 ( OH ) D levels before and after the intervention measured using the Diasorin Liaison platform immunoassay .
1,Serum 25 ( OH ) D levels before and after the intervention were measured the Diasorin Liaison platform immunoassay .
1,Serum 25 ( OH ) D levels before and after the intervention were using the Diasorin Liaison platform immunoassay .
1,Serum 25 ( OH ) D levels before and after the were measured using the Diasorin Liaison platform immunoassay .
4,"Also , no studies have attempted to determine otoscopy skills among audiology students ."
4,", no studies have attempted to determine otoscopy skills among audiology students ."
4,"Also , no studies have attempted to determine otoscopy skills among students ."
4,"Also , no studies have attempted to otoscopy skills among audiology students ."
4,"Also , studies have attempted to determine otoscopy skills among audiology students ."
1,"Subjects who underwent monitoring of respiratory and circulatory dynamics without sedation during endoscopic screening examinations were enrolled at the New Ooe Hospital ( Kyoto , Japan ) between April 2008 and March 2009 ."
1,"Subjects underwent monitoring of respiratory and circulatory without sedation during endoscopic screening examinations were enrolled at the New Ooe Hospital ( Kyoto , ) between April 2008 and March 2009 ."
1,"Subjects who underwent monitoring of respiratory and circulatory dynamics without sedation during endoscopic examinations were at the New Ooe Hospital ( Kyoto , Japan ) between April and March 2009 ."
1,"Subjects who underwent monitoring of respiratory and circulatory dynamics without sedation during endoscopic screening examinations were at the New Ooe Hospital ( , ) between April 2008 and March 2009 ."
1,"Subjects who underwent monitoring of respiratory and circulatory dynamics without sedation endoscopic screening examinations were enrolled at the New Ooe ( , Japan ) between April 2008 and March 2009 ."
0,"To compare the cumulative analgesic effect of electroacupuncture ( EA ) stimulation of Sanyinjiao ( SP 6 ) , Xuanzhong ( GB 39 ) and non-acupoint for primary dysmenorrhea patients ."
0,"To compare the analgesic effect of electroacupuncture ( EA ) stimulation of Sanyinjiao ( SP 6 ) , Xuanzhong ( GB 39 ) and non-acupoint for dysmenorrhea patients ."
0,"To compare the cumulative analgesic effect of ( ) stimulation of Sanyinjiao ( SP 6 ) , Xuanzhong ( GB 39 ) and non-acupoint for primary dysmenorrhea patients ."
0,"To compare the cumulative analgesic of electroacupuncture ( EA ) stimulation of Sanyinjiao ( 6 ) , Xuanzhong ( GB 39 ) and non-acupoint for primary dysmenorrhea patients ."
0,"compare the cumulative analgesic effect of electroacupuncture ( EA ) stimulation of Sanyinjiao ( SP 6 ) , Xuanzhong ( GB 39 ) non-acupoint for primary dysmenorrhea patients ."
4,Knowledge among critical care nurses and their adherence to evidence-based guidelines for preventing ventilator-associated pneumonia is reported to be low .
4,Knowledge among care nurses and their adherence to evidence-based guidelines for preventing ventilator-associated pneumonia is reported to low .
4,Knowledge among critical care nurses and adherence evidence-based guidelines for preventing ventilator-associated pneumonia is reported to be low .
4,Knowledge among critical care nurses and their adherence to evidence-based guidelines for ventilator-associated pneumonia is reported to low .
4,Knowledge among critical care nurses and their evidence-based guidelines for preventing ventilator-associated pneumonia is reported to be low .
0,The 5-year clinical outcomes and prognostic factors of nasopharyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IMRT ) were evaluated .
0,5-year clinical and prognostic factors of nasopharyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IMRT ) were evaluated .
0,The 5-year clinical and factors of nasopharyngeal carcinoma ( NPC ) patients treated with intensity modulated radiotherapy ( IMRT ) were evaluated .
0,The 5-year clinical outcomes and prognostic factors of carcinoma ( NPC ) patients treated intensity modulated radiotherapy ( IMRT ) were evaluated .
0,The 5-year clinical outcomes and prognostic factors of carcinoma ( NPC ) patients treated with intensity radiotherapy ( IMRT ) were evaluated .
1,"After each LC , intervention group subjects received video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Options , Wrap-up ) coaching model ."
1,"After each LC , group subjects received video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Options , ) coaching model ."
1,"After each LC , intervention group subjects received video-based coaching by a surgeon , an adaptation of the GROW ( Goals , Reality , , Wrap-up ) coaching model ."
1,"After each LC , intervention subjects received video-based coaching by a surgeon , utilizing adaptation of the GROW ( Goals , Reality , Options , Wrap-up ) coaching model ."
1,"each LC , intervention group subjects received video-based coaching by a surgeon , utilizing an adaptation of the ( Goals , Reality , Options , Wrap-up ) coaching model ."
3,A 12-week RTP improved MVIC and muscle power in MS patients .
3,A 12-week RTP improved MVIC and muscle in MS patients .
3,A 12-week RTP improved MVIC and muscle power in patients .
3,A 12-week RTP improved MVIC and power in MS patients .
3,A 12-week improved MVIC and muscle power in MS patients .
2,"In vitro , 9 of 36 ( 25 % ) Salmonella isolates were inhibited at 90 g of QBAs/mL ; all 36 were inhibited at 179 g of QBAs/mL ."
2,"In vitro , 9 of 36 ( % ) Salmonella isolates were inhibited at 90 g of QBAs/mL ; all 36 were inhibited at 179 of QBAs/mL ."
2,"In vitro , 9 of 36 ( 25 % ) Salmonella isolates inhibited 90 g of QBAs/mL ; all 36 were inhibited at 179 g of QBAs/mL ."
2,"In vitro , 9 of 36 ( 25 % ) Salmonella isolates inhibited at 90 g of QBAs/mL ; all 36 were inhibited at 179 g of QBAs/ ."
2,"In vitro , 9 of 36 ( 25 % ) Salmonella isolates were inhibited at 90 g of/mL ; 36 were inhibited at 179 g of QBAs/mL ."
1,"Eighty participants , aged 18 to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
1,"Eighty participants , 18 to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
1,"Eighty participants , aged 18 to 66 years , completed questionnaires assessing disgust prior to a laboratory session ."
1,"Eighty participants , aged 18 to 66 years , completed questionnaires assessing trait disgust prior to laboratory session ."
1,"Eighty participants , aged to 66 years , completed questionnaires assessing trait disgust prior to a laboratory session ."
2,"All patients had high risk for OSA , as defined by the Stop-Bang questionnaire , and the mean apnea-hypopnea index ( AHI ) was 46.930.4 / h."
2,"All patients had high risk for , as by the Stop-Bang questionnaire , and the mean apnea-hypopnea index ( AHI ) was 46.930.4 / h."
2,"All patients had high risk for OSA , as defined by the Stop-Bang questionnaire , and mean apnea-hypopnea index ( AHI ) was.930.4 / h."
2,"All patients had high risk for OSA , as defined by the Stop-Bang questionnaire , and the apnea-hypopnea index ( AHI ) was 46.930. / h."
2,"All patients had high risk for OSA , as defined the Stop-Bang questionnaire , and mean apnea-hypopnea index ( AHI ) was 46.930.4 / h."
2,"- Blockade lowered the OR for mortality significantly in patients with 3 to 4 cardiac risk factors undergoing NCS ( OR , 0.63 ; 95 % CI , 0.43-0 .93 ) ."
2,"- Blockade lowered the OR for mortality in with 3 to 4 cardiac risk factors undergoing NCS ( OR , 0.63 ; 95 % CI , 0.43-0 .93 ) ."
2,"- Blockade lowered the OR for mortality significantly patients with 3 to 4 cardiac risk factors undergoing NCS ( OR , 0. ; 95 % CI , 0.43-0 .93 ) ."
2,"- Blockade lowered the for mortality significantly in patients with 3 to 4 cardiac factors undergoing NCS ( OR , 0.63 ; 95 % CI , 0.43-0 .93 ) ."
2,"- lowered the OR for mortality significantly in patients with 3 to 4 cardiac risk undergoing NCS ( OR , 0.63 ; 95 % CI , 0.43-0 .93 ) ."
4,"Pulmonary rehabilitation ( PR ) is a multidisciplinary program of care for patients with chronic obstructive pulmonary disease ( COPD ) with the goal of improving the functional capacity and quality of life , as well as maintaining the clinical stability of COPD sufferers ."
4,"Pulmonary rehabilitation ( PR ) is a program of care for patients with chronic obstructive pulmonary disease ( COPD ) with the goal of improving the functional capacity and quality of life , well as maintaining clinical stability of COPD sufferers ."
4,"Pulmonary rehabilitation ( PR ) is multidisciplinary program of care for patients with chronic obstructive pulmonary disease ( COPD ) with the goal of improving the functional capacity and quality life , as well as maintaining the stability of COPD sufferers ."
4,"Pulmonary rehabilitation ( PR ) is multidisciplinary program of care for with chronic obstructive pulmonary disease ( COPD ) with the goal of improving the capacity and quality of life , as well as maintaining the clinical stability of COPD sufferers ."
4,"rehabilitation ( PR ) is a multidisciplinary program of for patients with chronic obstructive pulmonary disease ( COPD ) the goal of improving the functional capacity and quality of life , as well as maintaining the clinical stability of COPD sufferers ."
3,Assay sensitivity was confirmed with moxifloxacin as an active control .
3,Assay sensitivity was confirmed with moxifloxacin as active control .
3,Assay sensitivity was confirmed with moxifloxacin as an control .
3,Assay sensitivity was with moxifloxacin as an active control .
3,Assay was confirmed with moxifloxacin as an active control .
0,To determine the optimal duration of energy corrective treatment of ischemic stroke ( II ) with cytoflavin or ascorbic acid .
0,To determine the duration of energy corrective treatment of ischemic stroke ( II ) with cytoflavin or ascorbic acid .
0,To determine the optimal duration of energy corrective treatment of stroke ( II ) with cytoflavin or ascorbic acid .
0,To determine the optimal of energy corrective treatment of ischemic stroke ( II ) with cytoflavin or ascorbic acid .
0,determine the optimal duration of energy corrective treatment of ischemic stroke ( II ) with cytoflavin or ascorbic acid .
1,Caregivers of persons with chronic conditions who scored 7 or above in the Caregiver Strain Index were randomly assigned to the 8-week MBSR group ( n = 70 ) or the self-help control group ( n = 71 ) .
1,Caregivers of persons with chronic conditions scored 7 or above in the Caregiver Strain Index were randomly assigned to the MBSR group ( = 70 ) or the self-help control group ( n = 71 ) .
1,Caregivers of with chronic conditions scored 7 or above in the Caregiver Strain Index were randomly assigned to the 8-week group ( n = 70 ) or the self-help control group ( n = 71 ) .
1,of persons chronic conditions who scored or above in the Caregiver Strain Index were randomly assigned to the 8-week MBSR group ( n = 70 ) or the self-help control group ( n = 71 ) .
1,of persons with chronic conditions who scored 7 or above the Caregiver Strain Index were randomly assigned to 8-week MBSR group ( n = 70 ) or the self-help control group ( n = 71 ) .
0,Evaluate the sensitivity and specificity of pelvic ultrasound ( US ) and abdominopelvic computed tomography ( CT ) for the identification of ovarian torsion in women presenting to the emergency department with acute lower abdominal or pelvic pain .
0,Evaluate sensitivity and specificity of pelvic ultrasound ( US ) and abdominopelvic computed tomography ( CT ) for the identification ovarian torsion in women presenting to the emergency with acute lower abdominal or pelvic pain .
0,Evaluate the sensitivity and of pelvic ultrasound ( US ) and abdominopelvic computed tomography ( CT ) the identification of ovarian torsion in women presenting to the department with acute lower abdominal or pelvic pain .
0,Evaluate the sensitivity and specificity of pelvic ( US ) and abdominopelvic computed tomography ( ) for the identification of ovarian in women presenting to the emergency department with acute lower abdominal or pelvic pain .
0,Evaluate the sensitivity and specificity of pelvic ultrasound ( US ) and abdominopelvic computed tomography ( CT ) the identification of ovarian in women presenting to the emergency department acute lower abdominal or pelvic pain .
1,Least squares means with 95 % confidence interval were compared using analysis of variance .
1,Least squares means with % confidence interval were compared using analysis of variance .
1,Least squares means with 95 % confidence interval were compared analysis of variance .
1,Least squares means with 95 % confidence interval were using analysis of variance .
1,Least squares means with 95 % confidence were compared using analysis of variance .
2,After 6 months of therapy the level of microalbuminuria decreased significantly in the study group compared with the control group .
2,After 6 months of the level of microalbuminuria decreased significantly in the study group compared the control group .
2,After 6 months of therapy level of microalbuminuria decreased in the study group compared with the control group .
2,After 6 months of therapy level of microalbuminuria decreased significantly in study group compared with the control group .
2,After 6 months of therapy the level microalbuminuria decreased in the study group compared with the control group .
4,"Warfarin is the most widely used oral anticoagulant worldwide , but serious bleeding complications are common ."
4,"Warfarin is the most used oral anticoagulant worldwide , but serious bleeding complications are common ."
4,"Warfarin is the most widely oral anticoagulant worldwide , but serious bleeding complications are common ."
4,"Warfarin is the most widely used oral anticoagulant , but serious bleeding complications are common ."
4,"Warfarin is the most widely used oral anticoagulant worldwide , but serious complications are common ."
2,Only dogs with GER in Group S had significantly lower pH at the end compared to the beginning of anesthesia ( p = 0.004 ) .
2,Only dogs with GER in Group S had significantly lower at the end compared to the beginning of anesthesia ( = 0.004 ) .
2,Only dogs with GER in Group S had significantly pH at the end compared to the beginning of anesthesia ( p = 0. ) .
2,Only with GER in Group S had significantly lower pH at the end compared to the beginning of anesthesia ( p =.004 ) .
2,Only with GER in Group had significantly lower pH at the end compared to the beginning of anesthesia ( p = 0.004 ) .
0,"To assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulation administered to three body sites : quadriceps , gluteus , and abdomen ."
0,"To assess the bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) administered to three body sites : quadriceps , gluteus , and abdomen ."
0,"To assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac b-cyclodextrin ( HPbCD ) formulation administered to three body sites : , gluteus , and abdomen ."
0,"To assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( ) formulation administered to three body sites : , gluteus , and abdomen ."
0,"assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulation administered to three body : quadriceps , gluteus , and abdomen ."
1,The Long program consists of 3 weeks with full rehabilitation days .
1,Long program consists of 3 weeks with full rehabilitation days .
1,The Long consists of 3 weeks with full rehabilitation days .
1,The Long program consists of 3 weeks with full days .
1,The Long program consists of 3 weeks with full rehabilitation .
4,Introduction of calcineurin inhibitors had led to improved survival rates in liver transplant recipients .
4,Introduction of calcineurin had led to improved survival rates in liver transplant recipients .
4,Introduction of calcineurin inhibitors had led to improved survival in liver transplant recipients .
4,Introduction of calcineurin inhibitors had led to improved survival rates in transplant recipients .
4,Introduction of calcineurin inhibitors had led to improved survival rates liver transplant recipients .
4,The objective of this study was therefore to investigate the therapeutic use of the nociceptive withdrawal reflex to support gait training in the subacute post-stroke phase .
4,The objective of this study was therefore investigate the use of the nociceptive withdrawal reflex to support gait training in the subacute post-stroke phase .
4,The objective of this study was therefore to investigate the therapeutic use of the withdrawal reflex to gait training in the subacute post-stroke phase .
4,The of this study was therefore to investigate the therapeutic use of the nociceptive withdrawal reflex to gait training in the subacute post-stroke phase .
4,objective of this study was therefore to investigate therapeutic use of the nociceptive withdrawal reflex to support gait training in the subacute post-stroke phase .
4,The primary aim of the study is to evaluate the effects of this tailored implementation intervention on general practitioners ' adherence to guidelines .
4,The primary aim of the is to evaluate the effects of tailored implementation intervention on general practitioners ' adherence to guidelines .
4,The primary aim of the study is to evaluate effects of this tailored implementation intervention on general practitioners ' adherence to .
4,The primary aim of the study is to evaluate the effects of this implementation on general practitioners ' adherence to guidelines .
4,aim of the study is to evaluate the effects of this tailored implementation intervention on general practitioners ' adherence to guidelines .
4,Many hospitals acute care have begun to restrict visitors and nonessential health team interventions during specific times despite the lack of experimentally designed studies .
4,Many hospitals acute care have begun restrict visitors and health team interventions during specific times despite the lack of experimentally designed studies .
4,Many hospitals acute care have begun to restrict and nonessential health team interventions during times despite the lack of experimentally designed studies .
4,Many hospitals acute care have begun to restrict visitors and nonessential health team interventions during specific times despite lack of experimentally designed .
4,Many hospitals care have to restrict visitors and nonessential health team interventions during specific times despite the lack of experimentally designed studies .
4,Sclavo Vaccines Association and Regione Toscana .
4,Sclavo Vaccines Association Regione Toscana .
4,Sclavo Vaccines Association and Regione .
4,Sclavo Vaccines Association and Toscana .
4,Sclavo Vaccines and Regione Toscana .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( BP ) levels are associated with increased risks of recurrent stroke .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and blood pressure ( BP ) levels are with increased risks of recurrent stroke .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( BP ) levels are with increased of recurrent stroke .
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low high blood pressure ( BP ) levels are with increased risks of recurrent stroke .
0,is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( BP ) levels are associated with increased risks recurrent stroke .
4,http://clinicaltrials.gov/NCT02213601 .
4,://clinicaltrials.gov/NCT02213601 .
4,http://.gov/NCT02213601 .
4,http://clinicaltrials./NCT02213601 .
4,http://clinicaltrials.gov/ .
2,"The frequencies of recurrent pleural effusions requiring reintervention were 5.88 % ( 3/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no significant differences between three groups ( P = 1.000 ) ."
2,"The frequencies of recurrent pleural effusions requiring reintervention were 5.88 % ( 3/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/ ) , , which no significant differences between three groups ( P = 1.000 ) ."
2,"The frequencies of recurrent pleural effusions requiring reintervention were 5.88 % (/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had differences between three groups ( P = 1.000 ) ."
2,"The frequencies of recurrent pleural effusions requiring reintervention were 5.88 % (/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had significant differences between three ( P = 1.000 ) ."
2,"The of recurrent pleural effusions requiring reintervention were 5.88 % ( 3/51 ) , 4.35 % (/46 ) and 5. % ( 3/57 ) , respectively , which had no significant differences between three groups ( P = 1.000 ) ."
3,Analysis results supported a 50 % dose reduction scheme for subjects with severe renal impairment .
3,Analysis results a 50 % dose reduction scheme for subjects with severe renal impairment .
3,Analysis results supported a 50 % dose reduction scheme for subjects severe renal impairment .
3,Analysis results supported a 50 % dose reduction scheme for subjects with renal impairment .
3,Analysis results supported a 50 % dose reduction scheme for with severe renal impairment .
4,"However , optimal settings remain unclear ."
4,", optimal settings remain unclear ."
4,"However , optimal remain unclear ."
4,"However , optimal settings unclear ."
4,"However , settings remain unclear ."
3,Cerebral oxygenation is significantly improved during BCP surgery when ventilation is adjusted to maintain E ' ( CO ) at 40-42 mm Hg compared with 30-32 mm Hg .
3,Cerebral oxygenation is significantly improved BCP surgery ventilation is adjusted to maintain E ' ( CO ) at 40-42 mm Hg compared with 30-32 mm Hg .
3,Cerebral oxygenation is significantly improved during BCP surgery when ventilation is adjusted maintain E ' ( CO ) at 40-42 mm Hg compared with 30-32 Hg .
3,Cerebral oxygenation is significantly improved during BCP surgery when ventilation is adjusted to maintain E ' ( CO ) at 40-42 mm Hg 30-32 mm Hg .
3,oxygenation is significantly improved during BCP surgery when ventilation is adjusted to maintain E ' ( CO ) at 40-42 mm Hg with 30-32 mm Hg .
0,The existing research findings regarding the effects of lemongrass ( Cymbopogon citratus ) tea on renal function indices are conflicting and inconclusive .
0,The existing research findings regarding effects of lemongrass ( Cymbopogon citratus ) on renal function indices are conflicting and inconclusive .
0,The existing research findings regarding effects of lemongrass ( Cymbopogon citratus ) tea on renal function indices are conflicting inconclusive .
0,The existing research findings regarding the lemongrass ( Cymbopogon citratus ) tea on renal function indices are conflicting and inconclusive .
0,The research findings regarding the effects of lemongrass ( Cymbopogon citratus ) tea on function indices are conflicting and inconclusive .
3,A better understanding of extrarenal potassium homeostasis will provide an opportunity to use this drug more safely in patients with diabetic nephropathy as well as other patient populations .
3,A better of extrarenal potassium homeostasis will provide opportunity to use this drug more safely in patients with diabetic nephropathy as well as other patient populations .
3,A better understanding of extrarenal potassium homeostasis will provide an opportunity to use this drug more safely in patients with diabetic nephropathy as other patient populations .
3,A better understanding of extrarenal potassium homeostasis will provide an opportunity use this drug more safely in patients with diabetic nephropathy as as other patient populations .
3,A better understanding of extrarenal potassium homeostasis will provide an to use this drug safely in patients with diabetic nephropathy as well as other patient populations .
0,To investigate whether the type of anesthetic agent administered affects the antitussive effect of remifentanil .
0,To investigate the type of anesthetic agent administered affects the antitussive effect of remifentanil .
0,To investigate whether the type of anesthetic agent administered affects antitussive effect of remifentanil .
0,To investigate whether the type of anesthetic agent administered affects the effect of remifentanil .
0,To whether the type of anesthetic agent administered affects the antitussive effect of remifentanil .
4,"In the last 2 decades , the effectiveness of cricoid pressure ( CP ) in occluding the esophageal entrance has been questioned ."
4,"In the 2 decades , the effectiveness of cricoid pressure ( CP ) in occluding the esophageal entrance has been questioned ."
4,"In the last 2 decades , effectiveness of cricoid pressure ( CP ) in occluding the esophageal entrance has been questioned ."
4,"In the last 2 decades , the effectiveness of cricoid pressure ( CP ) in occluding esophageal entrance has been questioned ."
4,"In the last 2 decades , the effectiveness of cricoid pressure ( CP ) in occluding the esophageal entrance has been ."
1,( Trial registered at ClinicalTrials.gov : NCT00693849 . )
1,( Trial at ClinicalTrials.gov : NCT00693849 . )
1,( Trial registered ClinicalTrials.gov : NCT00693849 . )
1,( Trial registered at ClinicalTrials. : NCT00693849 . )
1,( Trial registered at.gov : NCT00693849 . )
4,There is increasing evidence that measurement of central aortic pressure ( CAP ) better accounts for cardiovascular risk than brachial blood pressure ( BP ) .
4,There is increasing evidence that measurement central aortic pressure ( CAP ) better accounts for cardiovascular risk than brachial blood pressure ( ) .
4,There is increasing evidence that measurement of central aortic pressure ( CAP ) accounts for cardiovascular risk than brachial blood pressure ( ) .
4,There is increasing evidence that measurement of central aortic pressure ( CAP ) better accounts cardiovascular risk than brachial pressure ( BP ) .
4,There is increasing that measurement of central aortic pressure ( CAP ) better accounts for cardiovascular risk brachial blood pressure ( BP ) .
0,The objective of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride injection in healthy Chinese adults .
0,The objective of present study was to determine the ( PK ) of a pilsicainide hydrochloride injection in healthy Chinese adults .
0,The objective of the present study was to determine the ( PK ) of pilsicainide hydrochloride injection in healthy Chinese adults .
0,The objective of the study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride in healthy Chinese adults .
0,objective of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride injection healthy Chinese adults .
3,Biologically relevant differences in methylated targets were found to discriminate locally advanced from early anal cancer .
3,Biologically differences in methylated targets were found to discriminate locally advanced from early anal cancer .
3,Biologically relevant differences in methylated targets found to discriminate locally advanced from early anal cancer .
3,Biologically relevant differences in methylated targets were found to discriminate locally advanced from anal cancer .
3,Biologically relevant differences in methylated targets were found to discriminate locally advanced from early cancer .
2,"The trial met its accrual target , experienced 90 % retention , and caused no serious adverse events ."
2,"The trial met its accrual , experienced 90 % retention , and caused no serious adverse events ."
2,"The trial met its accrual target , experienced 90 % , and caused no serious adverse events ."
2,"The trial met its accrual target , experienced 90 % retention , caused no serious adverse events ."
2,"trial met its accrual target , experienced 90 % retention , and caused no serious adverse events ."
3,Those with a lower educational level and a higher level of obesity were more likely to drop-out .
3,Those with a lower educational and a higher level of obesity were more likely to drop-out .
3,Those with a lower educational level and a higher level of obesity were likely to drop-out .
3,Those with a lower educational level and a higher level of obesity were more to drop-out .
3,Those with a lower educational level and a level of obesity were more likely to drop-out .
4,Two of the more common methods of pain management after TKA are peripheral nerve blocks and intraarticular/periarticular injections .
4,Two of the more common methods of pain management TKA are peripheral nerve blocks and intraarticular/periarticular injections .
4,Two of the more common methods of pain management after TKA are peripheral nerve blocks and/periarticular injections .
4,Two of the more common methods pain management after TKA are peripheral nerve blocks and intraarticular/periarticular injections .
4,Two the more common methods of pain management after TKA are peripheral nerve blocks and intraarticular/periarticular injections .
1,"Two recruitment strategies will be used : contacting men listed in primary care registers , and a community outreach method ( time-space sampling ) ."
1,"Two recruitment strategies will be used : contacting listed in primary care registers , and a community outreach method ( time-space ) ."
1,"Two recruitment strategies will be used : contacting men listed in primary care , and a community outreach ( time-space sampling ) ."
1,"Two recruitment will be used : contacting men listed in primary care registers , and a outreach method ( time-space sampling ) ."
1,"recruitment strategies will be used : contacting men listed in primary care registers , and a community outreach ( time-space sampling ) ."
3,Further studies are necessary to determine the appropriate flow rate and indications for NHF in obese patients .
3,Further studies are necessary to determine the appropriate flow and indications for NHF in obese patients .
3,Further studies are necessary to determine the appropriate flow rate and indications for NHF in patients .
3,Further studies are necessary to determine the flow rate and indications for NHF in obese patients .
3,Further studies are to determine the appropriate flow rate and indications for NHF in obese patients .
1,Randomisation and allocation to trial groups ( n = 27 and n = 27 ) were carried out by a central computer system .
1,Randomisation and allocation to trial groups ( n = 27 and n = ) were carried out by a central computer system .
1,Randomisation and allocation to trial groups ( n = 27 and n = 27 ) were carried out by a computer system .
1,Randomisation and allocation to trial groups ( n = 27 and n = 27 ) were out by a central computer system .
1,Randomisation and allocation to trial groups ( n = and n = 27 ) were carried out by a central computer system .
0,To assess changes in circulating incretin levels and body fat compositions with initial combination therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes ( T2D ) .
0,To assess changes in circulating incretin and body fat compositions with initial combination therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor patients with type 2 diabetes ( T2D ) .
0,To assess changes in circulating incretin levels and fat compositions with initial combination therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 in patients with type 2 diabetes ( T2D ) .
0,To assess changes in circulating incretin levels body compositions with initial combination therapy with - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes ( T2D ) .
0,assess changes in circulating incretin levels and body fat compositions with initial combination therapy - glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes ( T2D ) .
2,The accumulated expelled volumes for an hour were in favor of the ASCD group .
2,The accumulated expelled for an hour were in favor of the ASCD group .
2,The accumulated expelled volumes an hour were in favor of the ASCD group .
2,The accumulated expelled volumes for an hour were in favor of the ASCD .
2,accumulated expelled volumes for an hour were in favor of the ASCD group .
4,Whether this occurs with all PPIs is a matter of debate .
4,Whether occurs with all PPIs is a matter of debate .
4,Whether this occurs with all PPIs is a matter debate .
4,Whether this occurs with all is a matter of debate .
4,Whether this with all PPIs is a matter of debate .
1,"In addition , for all eye drop treatment groups , open-label ranibizumab was administered as needed ."
1,"In , for all eye drop treatment groups , open-label ranibizumab was administered as needed ."
1,"In addition , for all eye drop treatment , open-label ranibizumab was administered as needed ."
1,"In addition , for all eye drop treatment groups , open-label ranibizumab was administered as ."
1,"In addition , for eye drop treatment groups , open-label ranibizumab was administered as needed ."
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TAD ) is approved for both PRN and once-a-day ( OaD ) dosing for ED .
0,Sildenafil ( SIL ) and ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TAD ) is approved both PRN and once-a-day ( OaD ) dosing for ED .
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for ( PRN ) dosing ; tadalafil ( TAD ) is approved for both PRN and once-a-day ( OaD ) dosing for .
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( ) is approved for both PRN and once-a-day ( ) dosing for ED .
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TAD ) is approved for both PRN and once-a-day ( ) dosing ED .
3,"However , US is associated with improved efficiency ( decreased performance time and fewer needle passes ) ."
3,"However , US is associated with improved efficiency ( decreased performance time and fewer needle ) ."
3,"However , US is associated with improved efficiency ( decreased performance time fewer needle passes ) ."
3,"However , US is associated with improved efficiency ( performance time and fewer needle passes ) ."
3,"However , US is with improved efficiency ( decreased performance time and fewer needle passes ) ."
1,The trial was conducted in the City of Edmonton between January 2006 and August 2011 .
1,The trial was conducted in the City Edmonton between January 2006 and August 2011 .
1,The trial was conducted in the of Edmonton between January 2006 and August 2011 .
1,The trial was in the City of Edmonton between January 2006 and August 2011 .
1,The was conducted in the City of Edmonton between January 2006 and August 2011 .
0,"This assessment also offered us the opportunity to evaluate the influence of GI on appetite responses independently of insulinemia , which confounds findings in individuals without diabetes ."
0,"This assessment also offered the opportunity to evaluate the influence of GI on appetite responses independently of insulinemia , which confounds in individuals without diabetes ."
0,"This assessment also offered us the opportunity evaluate the influence of GI on responses independently of insulinemia , which confounds findings in individuals without diabetes ."
0,"This assessment also offered us the opportunity evaluate the influence of on appetite responses independently of insulinemia , which confounds findings in individuals without diabetes ."
0,"This assessment also offered us the opportunity to evaluate influence of GI on appetite responses independently of insulinemia , which confounds findings individuals without diabetes ."
2,"The combined intervention effectively delayed the onset of weekly drinking in the general population of adolescents , and was particularly effective in delaying the onset of heavy weekly drinking in a higher-risk subsample of adolescents ( i.e. those attending lower levels of education and reporting higher levels of externalizing behavior ) ."
2,"The combined intervention effectively delayed the onset of weekly drinking in the general of adolescents , was particularly effective in delaying onset of heavy weekly drinking in a higher-risk subsample of adolescents ( i.e. those attending lower levels education and reporting higher levels of externalizing behavior ) ."
2,"The combined intervention effectively delayed the onset of weekly drinking in the general population of , was particularly effective in delaying the onset of heavy weekly in a higher-risk of adolescents ( i.e. those attending lower levels of education and reporting higher levels of externalizing behavior ) ."
2,"The combined intervention onset of weekly drinking in the general population of adolescents , and was particularly in delaying the onset of heavy weekly drinking in a higher-risk subsample of adolescents ( i.e. those attending lower levels of education and reporting higher levels of externalizing behavior ) ."
2,"The intervention effectively delayed the onset of weekly drinking in the general of adolescents , and was particularly effective delaying the onset of heavy weekly drinking in a higher-risk subsample of adolescents ( i.e. those attending lower levels of education and reporting levels of externalizing behavior ) ."
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and fluorine-18 fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in PET/computed tomography ( CT ) imaging .
0,The objective of this study was to explore the effects of hypotonic and oral mannitol on intestinal distention and fluorine-18 fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in/computed ( CT ) imaging .
0,The objective of this was to explore the effects of and isotonic oral mannitol on intestinal distention and fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in PET/computed tomography ( CT ) imaging .
0,The of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and fluorine-18 fluorodeoxyglucose ( ( ) F-FDG ) intake in/computed tomography ( CT ) imaging .
0,objective of study was to explore the effects of hypotonic and oral mannitol on intestinal distention and fluorine-18 fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in PET/computed tomography ( CT ) imaging .
2,The mean LOS for the standard practice cohort was 5.3 4.6 days versus calculated LOS using the PCT guidance pathway of 3.7 2.8 days .
2,The mean LOS for standard practice cohort was 5.3 4.6 days calculated LOS using the PCT guidance pathway of 3.7 2.8 days .
2,The mean LOS for the standard practice was.3 4.6 days versus calculated LOS using the PCT guidance pathway of 3.7 2.8 days .
2,The mean for the standard practice cohort 5.3 4.6 days versus calculated LOS using the PCT guidance pathway of 3.7 2.8 days .
2,The mean for the standard practice cohort was 5.3 4.6 days versus calculated LOS using PCT guidance pathway of 3.7 2.8 days .
3,"The time of the pain beginning was 8.31 4.58 min in the treatment group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.266 ) ."
3,"The time of the pain beginning was 8.31 4.58 min in the treatment group and.10 3.54 min the placebo group , which not significantly different ( P = 0.266 ) ."
3,"The time the pain beginning was 8.31 4.58 min in the treatment group and 7.10 3. min in the group , which was not significantly different ( P = 0.266 ) ."
3,"time of the beginning was 8.31 4.58 min in the group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.266 ) ."
3,"time of the pain beginning was 8.31 4.58 min in the treatment group and 7.10 3.54 in the placebo group , which was not significantly different ( P =.266 ) ."
1,PiCCO catheter was placed in modified surviving sepsis bundles group .
1,PiCCO catheter was placed in modified surviving bundles group .
1,PiCCO catheter was placed in surviving sepsis bundles group .
1,PiCCO was placed in modified surviving sepsis bundles group .
1,catheter was placed in modified surviving sepsis bundles group .
2,"Quantitatively , the senofilcon A lens was 40 % more comfortable than the lotrafilcon A lens and 65 % more comfortable than the balafilcon A lens on average ."
2,"Quantitatively , the A lens was 40 % more comfortable than the lotrafilcon A and 65 % more comfortable than the balafilcon A lens on average ."
2,"Quantitatively , the senofilcon A lens was 40 % more comfortable than lotrafilcon A lens and 65 % comfortable than the balafilcon A lens on average ."
2,"Quantitatively , the senofilcon A lens was 40 % more comfortable than the A lens and 65 % more comfortable than the A lens on average ."
2,"Quantitatively , the senofilcon A was 40 % more comfortable than the lotrafilcon A lens and 65 % more comfortable than the balafilcon A lens average ."
3,Cash incentives might increase participation rates in face-to-face surveys in China .
3,Cash incentives might increase rates in face-to-face surveys in China .
3,Cash incentives might participation rates in face-to-face surveys in China .
3,Cash might increase participation rates in face-to-face surveys in China .
3,incentives might increase participation rates in face-to-face surveys in China .
0,"We sought to assess if the use of a solution of mepivacaine 2 % plus adrenaline with sodium bicarbonate 1.4 % results in less pain associated with local infiltration anesthesia preceding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
0,"We sought to assess if the use of a solution of mepivacaine 2 % plus adrenaline with sodium bicarbonate 1.4 % results in associated with local infiltration anesthesia preceding phlebectomies , compared with standard preparation diluted normal saline ."
0,"We sought to if the use of a solution of mepivacaine % plus adrenaline with bicarbonate 1.4 % results in less pain associated with local infiltration anesthesia preceding ambulatory phlebectomies , compared with standard preparation diluted with normal ."
0,"We sought to if the use of a solution of mepivacaine 2 % plus adrenaline with sodium 1.4 % results in less pain associated with local infiltration anesthesia phlebectomies , compared with standard preparation diluted with normal saline ."
0,"sought if the use of a solution of mepivacaine 2 % plus adrenaline with sodium bicarbonate 1.4 % results in less pain with local infiltration anesthesia preceding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
0,Little is known about the transfer of essential fatty acids ( FAs ) across the human blood-brain barrier ( BBB ) in adulthood .
0,Little is known about the transfer of essential fatty acids ( FAs ) across the blood-brain barrier ( BBB ) in adulthood .
0,Little is known about the transfer of essential fatty acids ( FAs ) across the human blood-brain barrier ( BBB ) adulthood .
0,Little is known about the transfer of essential fatty acids ( FAs ) the human blood-brain barrier ( BBB ) in adulthood .
0,Little known about the transfer of essential fatty acids ( FAs ) across the human blood-brain barrier ( BBB ) in adulthood .
3,Our data did not show a significant improvement in overall survival with immediate versus deferred chemotherapy after radical cystectomy and bilateral lymphadenectomy for patients with muscle-invasive urothelial carcinoma .
3,Our data did not show a improvement in overall survival with immediate versus deferred chemotherapy after cystectomy and bilateral lymphadenectomy for patients with muscle-invasive urothelial carcinoma .
3,Our data did not show a significant improvement in overall survival immediate versus deferred chemotherapy after radical cystectomy and bilateral lymphadenectomy for patients with muscle-invasive urothelial .
3,Our data did not show a significant improvement overall survival immediate versus deferred chemotherapy after radical cystectomy and bilateral lymphadenectomy for patients with muscle-invasive urothelial carcinoma .
3,Our data did not show significant improvement in overall survival with immediate versus deferred chemotherapy after radical cystectomy and bilateral for patients with muscle-invasive urothelial carcinoma .
4,Pregabalin may be an effective alternative .
4,Pregabalin be an effective alternative .
4,Pregabalin may an effective alternative .
4,Pregabalin may be an alternative .
4,may be an effective alternative .
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 years ) .
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 ) .
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean.7 years ) .
1,Follow-up in the ACCORD Lipid Trial was years ( mean 4.7 years ) .
1,Follow-up in the ACCORD Trial was 4-8 years ( mean 4.7 years ) .
2,"Across all studies , 757 , 198 , 454 , and 1,058 subjects were randomized to placebo or 1.5 , 6 , or 12 Amb a 1-U of MK-3641 , respectively ."
2,"Across all studies , 757 , , 454 , and 1,058 subjects were randomized to placebo or 1.5 , 6 , 12 Amb a 1-U of MK-3641 , respectively ."
2,"Across all studies , 757 , 198 , 454 , and 1, subjects were randomized to placebo or 1.5 , 6 , or 12 Amb a 1-U of MK-3641 , ."
2,"Across all studies , 757 , 198 , 454 , and 1, subjects were randomized to placebo or 1.5 , 6 , or 12 Amb a of MK-3641 , respectively ."
2,"Across all studies , 757 , 198 , 454 , and 1,058 subjects were randomized to placebo or 1.5 , , or 12 Amb a 1-U of , respectively ."
0,To evaluate the effects of systemic doxycycline on clinical and microbiological parameters of diabetic subjects with chronic periodontitis .
0,To evaluate effects of systemic doxycycline on clinical and microbiological parameters of diabetic subjects with chronic periodontitis .
0,To evaluate the effects of doxycycline on clinical and microbiological parameters of diabetic subjects with chronic periodontitis .
0,To evaluate the effects of systemic doxycycline on clinical and parameters of diabetic subjects with chronic periodontitis .
0,To evaluate the effects of systemic on clinical and microbiological parameters of diabetic subjects with chronic periodontitis .
1,Women with confirmed preterm prelabour rupture of membranes between 16 ( +0 ) and 24 ( +0 ) weeks ' gestation .
1,Women confirmed preterm prelabour rupture of membranes between 16 ( +0 ) and 24 ( +0 ) weeks ' gestation .
1,Women with confirmed preterm prelabour rupture of membranes between 16 ( +0 ) and ( +0 ) weeks ' gestation .
1,Women with confirmed preterm prelabour rupture of membranes between 16 ( +0 ) and 24 ( + ) weeks ' gestation .
1,with confirmed preterm prelabour rupture of membranes between 16 ( +0 ) and 24 ( +0 ) weeks ' gestation .
1,"On Day 5 , desmopressin ( 03g/kg ) or saline intravenous infusions were administered ."
1,"Day 5 , desmopressin ( 03g/kg ) or saline intravenous infusions were administered ."
1,"On Day 5 , desmopressin ( 03g/ ) or saline intravenous infusions were administered ."
1,"On Day 5 , desmopressin ( 03g/kg ) or intravenous infusions were administered ."
1,"On Day 5 , desmopressin ( 03g/kg ) or saline intravenous infusions administered ."
1,"We used linear mixed models to compare the outcomes of both groups immediately after training , after 6 months , and after 12 months , adjusted for baseline ."
1,"We used linear mixed models to compare the outcomes both groups immediately after training , after 6 months , and after 12 , adjusted for baseline ."
1,"We used linear mixed models to compare the outcomes of both groups after training , after 6 months , and after 12 , adjusted for baseline ."
1,"We used linear mixed models to compare the outcomes of both groups immediately after , 6 months , and after 12 months , adjusted for baseline ."
1,"We used linear mixed models to compare the outcomes of both immediately after training , after 6 , and after 12 months , adjusted for baseline ."
0,"Whether statin drug use influences the risk of screen detected disease is less clear , possibly because of complex detection biases ."
0,"Whether statin drug influences the risk screen detected disease is less clear , possibly because of complex detection biases ."
0,"Whether statin drug use influences the risk detected disease is less clear , possibly because of complex detection biases ."
0,"Whether statin drug use influences the risk of screen detected disease is less , possibly because of complex detection ."
0,"statin drug use influences the risk of screen detected disease is less clear , because of complex detection biases ."
3,"Consistent with the hypothesis that ALS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Consistent the hypothesis that ALS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Consistent with hypothesis that ALS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Consistent with the hypothesis ALS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Consistent with the hypothesis that ALS is a multisystem disorder , deficit is related to disease in prefrontal regions ."
3,Overall the clinical performance of Vitremer was better than Ketac molar and is to be considered as a preferable material for restoration of primary molars .
3,Overall clinical performance of Vitremer was better than Ketac molar and is to be considered as a preferable for restoration of primary molars .
3,Overall clinical performance of Vitremer was better than Ketac molar and is to be considered as a preferable material for restoration primary molars .
3,Overall the clinical of Vitremer was better than Ketac molar and is to be considered as a preferable material for restoration of primary .
3,Overall the clinical performance of was better than Ketac molar and is to considered as a preferable material for restoration of primary molars .
2,There were relevant differences between patients and healthy control subjects in postural sway and DTI diffusion-tensor imaging parameters ( P < .05 ) .
2,There were relevant differences between patients and control subjects in sway and DTI diffusion-tensor imaging parameters ( P < .05 ) .
2,There were relevant differences between patients and control subjects postural sway and DTI diffusion-tensor imaging parameters ( P < .05 ) .
2,There were relevant differences between patients and healthy control subjects in postural sway and DTI imaging parameters ( < .05 ) .
2,There were relevant differences between patients and healthy control subjects in postural sway and imaging parameters ( P < .05 ) .
1,"This trial is registered with ClinicalTrials.gov , number NCT01584830 ."
1,"This trial is registered ClinicalTrials.gov , number NCT01584830 ."
1,"This trial is registered with ClinicalTrials.gov , number ."
1,"This trial is with ClinicalTrials.gov , number NCT01584830 ."
1,"This trial registered with ClinicalTrials.gov , number NCT01584830 ."
4,ClinicalTrials.gov : NCT01654341 .
4,.gov : NCT01654341 .
4,ClinicalTrials. : NCT01654341 .
4,ClinicalTrials.gov : .
4,ClinicalTrials.gov : NCT01654341 .
0,"However , the association between ARD and increased risk of dementia is uncertain ."
0,"However , the association ARD and increased risk of dementia is uncertain ."
0,"However , the association between ARD and increased of dementia is uncertain ."
0,"However , the association between ARD and increased risk dementia is uncertain ."
0,"However , the between ARD and increased risk of dementia is uncertain ."
2,"Forty-three patients underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CABG + valve surgery , 13 underwent major vascular surgery , and three underwent other surgeries ."
2,"Forty-three patients underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent + valve surgery , 13 underwent major vascular surgery , and three underwent other ."
2,"Forty-three patients underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CABG + valve surgery , 13 major surgery , and three underwent other surgeries ."
2,"Forty-three patients underwent coronary artery bypass grafting ( CABG ) , valve surgery , 13 underwent CABG + valve surgery , 13 underwent major vascular surgery , and three underwent other surgeries ."
2,"patients underwent coronary artery bypass grafting ( CABG ) , 23 underwent valve surgery , 13 underwent CABG + valve surgery , 13 underwent major vascular surgery , and three underwent surgeries ."
4,Xuezhikang ( XZK ) is an extract of fermented red yeast rice that has lipid-lowering properties .
4,Xuezhikang ( XZK ) an extract of fermented red yeast rice that has lipid-lowering properties .
4,Xuezhikang ( XZK ) is an extract of fermented red yeast rice that has properties .
4,Xuezhikang ( XZK ) is an extract of fermented yeast rice that has lipid-lowering properties .
4,Xuezhikang ( XZK ) is an of fermented red yeast rice that has lipid-lowering properties .
4,Animal data and in vitro studies suggest that prucalopride also affects gastric and esophageal motor function .
4,Animal data and in vitro studies suggest prucalopride also affects gastric and esophageal motor function .
4,Animal data and in vitro studies suggest that prucalopride also affects and esophageal motor function .
4,Animal data and in vitro studies suggest that prucalopride also affects gastric and esophageal motor .
4,Animal data and vitro studies suggest that prucalopride also affects gastric and esophageal motor function .
0,To compare the clinical benefit of a periodontal dressing applied after a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic periodontitis up to 3months after therapy .
0,To compare the benefit of a periodontal dressing applied after a one-stage full-mouth disinfection ( ) in patients with chronic periodontitis up to 3months after therapy .
0,To compare the clinical benefit of a dressing applied after a one-stage full-mouth disinfection ( OSFMD ) patients with chronic periodontitis up to 3months after therapy .
0,To compare the clinical benefit of a periodontal dressing applied a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic up to 3months after therapy .
0,To compare the clinical benefit of a periodontal dressing applied after one-stage full-mouth disinfection ( ) in patients with chronic periodontitis up to 3months after therapy .
3,Monotherapy with amikacin as an empirical antibiotic did not result in a higher incidence of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
3,Monotherapy with amikacin an empirical antibiotic not result in a higher incidence of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
3,Monotherapy with amikacin as an empirical antibiotic did not result in a higher incidence of failure in neonates at risk for early-onset sepsis compared with piperacillin-tazobactum .
3,Monotherapy with amikacin as an empirical antibiotic did not result in a higher incidence of treatment failure in neonates at risk for sepsis as compared piperacillin-tazobactum .
3,Monotherapy with amikacin as empirical antibiotic did not result in a higher incidence of failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum .
1,"An acute resistance exercise protocol was administered at 0 , 6 , and 12 weeks of training ."
1,"An acute resistance exercise protocol was administered at 0 , , and 12 weeks of training ."
1,"An acute resistance exercise protocol was administered at 0 , 6 , and 12 of training ."
1,"An acute resistance exercise was administered at 0 , 6 , and 12 weeks of training ."
1,"An resistance exercise protocol was administered at 0 , 6 , and 12 weeks of training ."
1,"The Modified Ashworth Scale , manual muscle test ( MMT ) , Manual Function Test ( MFT ) , Fugl-Meyer Scale ( FMS ) , and Box and Block Test were used to assess UE function ."
1,"The Modified Ashworth Scale , manual muscle ( MMT ) , Function Test ( MFT ) , Fugl-Meyer Scale ( FMS ) , and Box and Block Test were used to assess UE function ."
1,"The Modified Ashworth Scale , manual muscle test ( MMT ) , Manual Function ( MFT ) , Fugl-Meyer Scale ( FMS ) , and Box and Test were used to assess UE function ."
1,"The Modified Ashworth Scale , manual muscle test ( MMT ) , Manual Function Test ( MFT ) , Fugl-Meyer Scale ( FMS ) , and Box and Block Test used to assess UE ."
1,"The Modified Ashworth Scale , manual test ( MMT ) , Manual Function Test ( MFT ) , Fugl-Meyer ( FMS ) , and Box and Block Test were used to assess UE function ."
2,"Six-month mortality was 6.5 % in the ICP group and 9.1 % in the control group ( P < 0.05 ) , and neurological outcome was better in the ICP group compared with the control group ( P < 0.05 ) ."
2,"Six-month mortality 6.5 % in the group and 9.1 % in the control group ( P < 0.05 ) , and neurological was better in the ICP group compared with the control group ( P < 0.05 ) ."
2,"Six-month mortality was 6.5 % in the ICP and 9.1 % in the group ( P < 0.05 ) , and neurological was better in the ICP group compared with the control group ( P < 0.05 ) ."
2,"Six-month mortality was 6.5 % in the ICP group and 9.1 % group ( P < 0.05 ) , and neurological outcome was better in the ICP group compared with the control group ( P < 0.05 ) ."
2,"Six-month mortality was 6.5 % the ICP group and 9.1 % in the control group ( P < 0.05 ) , and neurological outcome was in the ICP group compared with control group ( P < 0.05 ) ."
2,There were large discrepancies in the number of silicosis cases found .
2,There large discrepancies in the number of silicosis cases found .
2,There were large discrepancies in the number of cases found .
2,There were large discrepancies in the number of silicosis cases .
2,There were large discrepancies in the number silicosis cases found .
2,"However , the time taken to insert the ProSeal LMA was significantly longer when the FAST technique was used ( p < 0.001 ) ."
2,"However , the time taken to ProSeal LMA was significantly longer when the FAST technique was used ( p < 0.001 ) ."
2,"However , the time taken to insert the LMA was significantly longer when the FAST was used ( p < 0.001 ) ."
2,"However , the time taken to insert the ProSeal LMA was significantly longer when the FAST was ( p < 0.001 ) ."
2,"However , the time taken to insert the ProSeal was longer when the FAST technique was used ( p < 0.001 ) ."
3,"This study provides evidence for the improved efficacy of high-dose melphalan plus salvage ASCT when compared with cyclophosphamide in patients with relapsed multiple myeloma eligible for intensive therapy , which might help to guide clinical decisions regarding the management of such patients ."
3,"This study provides evidence for the improved efficacy of high-dose melphalan plus salvage ASCT compared with cyclophosphamide in patients with multiple myeloma eligible for intensive therapy , which might help guide clinical decisions regarding the management of such ."
3,"This study provides evidence for the improved efficacy of high-dose melphalan plus salvage ASCT compared with cyclophosphamide in patients with relapsed multiple myeloma eligible for intensive therapy , which might to guide clinical decisions the management of such ."
3,"This study provides evidence for the improved efficacy of high-dose melphalan plus salvage ASCT when compared cyclophosphamide in patients with relapsed multiple myeloma eligible intensive therapy , which might to guide decisions regarding the management of such patients ."
3,"This study provides evidence for the improved efficacy of high-dose melphalan salvage when compared with cyclophosphamide in with relapsed multiple myeloma eligible for intensive therapy , which might help guide clinical decisions regarding the management of such patients ."
1,"The treatment group was treated with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV 17 ) , etc. in qijie area combined with spine muscle-relieving massage and comprehensive chiropractic ."
1,"The treatment group was treated EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL ) , Danzhong ( CV 17 ) , etc. in area combined with spine muscle-relieving massage and comprehensive chiropractic ."
1,"The treatment group was treated with EA at ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fengchi ( GB 20 ) , ( BL 23 ) , Danzhong ( CV 17 ) , etc. in area combined with spine muscle-relieving massage and comprehensive chiropractic ."
1,"The treatment group was treated with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV 17 ) , etc. in qijie with spine muscle-relieving massage and comprehensive chiropractic ."
1,"The treatment group was treated with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Fengchi ( GB 20 ) , Shenshu ( BL 23 ) , Danzhong ( CV 17 ) , etc. qijie area with spine muscle-relieving massage and chiropractic ."
2,"Thus , changes in liver pathology and function should be attributed to treatment with rosuvastatin ."
2,"Thus , changes in liver and function should be attributed to treatment with rosuvastatin ."
2,"Thus , changes in liver pathology and function should be to treatment with rosuvastatin ."
2,"Thus , changes in liver pathology and should be attributed to treatment with rosuvastatin ."
2,"Thus , in liver pathology and function should be attributed to treatment with rosuvastatin ."
4,Neuroplasticity drives recovery of walking after a lesion of the descending tract .
4,Neuroplasticity drives recovery of walking a lesion of the descending tract .
4,Neuroplasticity drives recovery of walking after a lesion of descending tract .
4,Neuroplasticity drives recovery of walking after a lesion of the tract .
4,Neuroplasticity drives recovery of walking after a of the descending tract .
1,"Participants completed measures related to latent variables of illness-related distress , social integration , spiritual perspective , family environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postintervention ( T2 ) , and 100 days posttransplant ( T3 ) ."
1,"Participants completed measures related latent variables of illness-related distress , integration , spiritual perspective , family environment , coping , hope-derived meaning , and resilience at ( T1 ) , postintervention ( T2 ) , and 100 days posttransplant ( T3 ) ."
1,"Participants completed measures related to latent variables of illness-related distress , integration , spiritual , family environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postintervention ( T2 ) , and 100 days posttransplant ( ) ."
1,"Participants completed measures related to latent variables of illness-related distress , social integration , spiritual perspective , family environment , coping , hope-derived meaning , and baseline ( T1 ) , postintervention ( T2 ) , and 100 days posttransplant ( ) ."
1,"Participants completed related latent variables illness-related distress , social integration , spiritual perspective , family environment , coping , hope-derived meaning , and resilience at baseline ( T1 ) , postintervention ( T2 ) , and 100 days posttransplant ( T3 ) ."
4,A preliminary report showed that autologous blood is an effective and easily applicable technique that can control actively bleeding gastroduodenal ulcers .
4,A preliminary report showed that autologous blood is an effective and applicable technique that can control actively bleeding gastroduodenal .
4,A preliminary report showed that autologous blood is an effective and easily applicable technique can actively bleeding gastroduodenal ulcers .
4,A preliminary report showed that blood is an effective and easily applicable technique that can control actively bleeding gastroduodenal .
4,preliminary report showed that autologous is an effective and easily applicable technique that can control actively bleeding gastroduodenal ulcers .
2,"All patients in the r-hLH 2,750 ( 13/13 ) , 5,500 ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 12 / 12 ) groups ovulated ; 3/5 patients in the r-hLH 825 IU and 2/12 in the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between evaluable groups ) ."
2,"All in the r-hLH 2,750 ( 13/13 ) , 5,500 ( 12 / 12 ) , 11,000 IU (/ ) , and u-hCG 5,000 IU ( 12 / 12 ) groups ovulated ; 3/5 patients in the 825 IU and 2/12 in the r-hLH 22,000 group failed to ovulate ( p = 0.105 between evaluable groups ) ."
2,"All patients in the r-hLH 2,750 ( 13/ ) , 5, ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 12 / 12 ) ovulated ; 3/ patients in the r-hLH 825 IU and 2/12 in the r-hLH 22,000 IU group failed ovulate ( p = 0.105 between evaluable groups ) ."
2,"All patients in the r-hLH 2,750 ( 13/13 ) , 5,500 ( 12 / 12 ) , 11, IU ( 13/13 ) , and u-hCG 5,000 ( 12 / ) groups ovulated ; 3/5 patients in r-hLH 825 IU and 2/12 in the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between groups ) ."
2,"All patients in the r-hLH,750 ( 13/13 ) ,,500 ( 12 / 12 ) , 11,000 IU ( 13/13 ) , and u-hCG 5,000 IU ( 12 / 12 ) groups ovulated ; 3/5 patients in the r-hLH 825 IU and 2/12 the r-hLH 22,000 IU group failed to ovulate ( p = 0.105 between ) ."
1,64 obese adult patients without diabetes and 58 normal weight control subjects were enrolled in this study .
1,64 obese adult patients diabetes and 58 normal weight control subjects were enrolled in this study .
1,64 obese adult patients without and 58 normal weight control subjects were enrolled in this study .
1,64 obese adult patients without diabetes and 58 normal weight control subjects were enrolled in study .
1,64 obese adult patients without diabetes and 58 normal weight control were enrolled in this study .
0,The AeroChamber Plus ( AC ) valved holding chamber has been enhanced to include the Flow-Vu ( FV ) inspiratory flow indicator that provides visual inhalation feedback during use .
0,AeroChamber Plus ( AC ) valved holding has been enhanced to include the Flow-Vu ( FV ) inspiratory flow indicator that provides visual inhalation feedback during use .
0,The AeroChamber Plus ( AC ) valved holding chamber has been enhanced to include the ( FV ) inspiratory flow indicator that provides visual inhalation feedback during .
0,The AeroChamber Plus ( AC ) valved holding chamber has been enhanced to the Flow-Vu ( FV ) inspiratory indicator that provides visual inhalation feedback during use .
0,The AeroChamber Plus ( AC ) valved holding chamber has enhanced to include the Flow-Vu ( FV ) inspiratory flow indicator that visual inhalation feedback during use .
2,"As expected , RTL declined with increasing age in both cases and controls ."
2,"As , RTL declined with increasing age in both cases and controls ."
2,"As expected , RTL declined increasing age in both cases and controls ."
2,"As expected , RTL declined with increasing age both cases and controls ."
2,"As expected , RTL declined with increasing age in both and controls ."
4,Atherosclerosis is a postprandial phenomenon .
4,Atherosclerosis a postprandial phenomenon .
4,Atherosclerosis is a phenomenon .
4,Atherosclerosis is postprandial phenomenon .
4,is a postprandial phenomenon .
1,"Secondary outcomes include time until full sustainable return to work , health related quality of life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
1,"Secondary outcomes include time until full return to work , health related quality life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
1,"Secondary outcomes include time until full sustainable return to work , health related quality of life , health behavior , functional status , somatic and health , and perceptions of work ."
1,"Secondary outcomes include time until full sustainable return to work , health related quality of life , health related behavior , status , somatic and mental , and perceptions of work ."
1,"Secondary outcomes include time until full sustainable return to work , health related quality of life , health related behavior , status , somatic and mental health , and perceptions of ."
1,Protocol therapy was either vandetanib 300 mg oral daily plus bicalutamide 50 mg oral daily ( Arm A ) or bicalutamide 50 mg oral daily alone ( Arm B ) with cross-over to vandetanib monotherapy at progression .
1,Protocol therapy either 300 mg oral daily plus bicalutamide 50 mg oral daily ( Arm A ) or bicalutamide 50 mg oral daily alone ( Arm ) with cross-over to vandetanib monotherapy at progression .
1,Protocol therapy was either vandetanib 300 mg oral daily plus bicalutamide 50 mg oral daily ( A ) or 50 mg oral daily alone ( Arm B ) with cross-over vandetanib monotherapy at progression .
1,Protocol therapy was either vandetanib 300 mg oral daily plus bicalutamide 50 mg oral daily ( Arm A ) bicalutamide 50 mg oral daily alone ( Arm B ) with cross-over to vandetanib monotherapy .
1,therapy was either vandetanib 300 mg daily plus bicalutamide 50 mg oral daily ( Arm A ) or bicalutamide 50 oral daily alone ( Arm B ) with cross-over to vandetanib monotherapy at progression .
0,Frequent refresher training and in situ simulation are promising interventions .
0,Frequent refresher and in situ simulation are promising interventions .
0,Frequent refresher training and in simulation are promising interventions .
0,Frequent refresher training and in situ simulation are interventions .
0,Frequent refresher training and in situ simulation promising interventions .
3,"The 4F-PCC dose-dependently reversed the effects of edoxaban ( 60 mg ) , with complete reversal of bleeding duration and endogenous thrombin potential and partial reversal of prothrombin time following 50 IU/kg ."
3,"4F-PCC dose-dependently reversed the effects of edoxaban ( 60 mg ) , with complete reversal bleeding duration and endogenous thrombin potential and partial of prothrombin time following 50 IU/kg ."
3,"The 4F-PCC dose-dependently reversed the effects of edoxaban ( 60 mg ) , with complete reversal of bleeding duration and endogenous thrombin potential and reversal prothrombin time following 50/kg ."
3,"The 4F-PCC dose-dependently reversed the effects of edoxaban ( 60 mg ) , with complete reversal of duration and thrombin potential and partial reversal of prothrombin time following 50 IU/ ."
3,"The 4F-PCC dose-dependently the effects of edoxaban ( 60 mg ) , with reversal of bleeding and endogenous thrombin potential and partial reversal of prothrombin time following 50 IU/kg ."
4,The authors aimed to assess the effect of lower extremity nerve decompression surgery for painful diabetic polyneuropathy on pain and sensibility .
4,The authors aimed to assess the effect of lower extremity nerve decompression surgery for diabetic polyneuropathy on pain sensibility .
4,The authors aimed to assess the effect of lower extremity nerve surgery for painful diabetic on pain and sensibility .
4,The authors aimed to assess the effect of lower nerve decompression surgery for painful diabetic polyneuropathy on and sensibility .
4,authors aimed to assess the effect of lower extremity nerve decompression for painful diabetic polyneuropathy on pain and sensibility .
4,DNA methylation has been linked to many important biological phenomena .
4,DNA methylation has been linked many important biological phenomena .
4,DNA methylation has been linked to important biological phenomena .
4,DNA methylation has been linked to many biological phenomena .
4,DNA methylation has been linked to many important phenomena .
3,"The results suggest that there is an increased risk of postdischarge NM-PO among injured patients with at-risk drinking , particularly among those with a recent history of drug use or NM-PO ."
3,"The results suggest that there is an increased risk of postdischarge among patients with at-risk drinking , particularly among those a recent history of drug use or NM-PO ."
3,"The results suggest there is an increased risk of postdischarge NM-PO among patients with at-risk drinking , particularly those with a recent history of drug use or NM-PO ."
3,"The results that there an increased risk of postdischarge NM-PO among injured patients with at-risk drinking , particularly among those a recent history of drug use or NM-PO ."
3,"The suggest that there is an increased risk of postdischarge NM-PO among injured with at-risk drinking , particularly among those with a recent history of use or NM-PO ."
3,"Pregabalin at doses up to 10 mg/kg/day in children aged 1 month to 16 years , and at doses up to 15 mg/kg/day in those aged < 6 years , demonstrated acceptable safety and tolerability ."
3,"Pregabalin at doses up to 10 mg/kg/ in 1 month to 16 years , and at doses up to 15 mg/kg/day in those aged < 6 years , demonstrated acceptable safety and tolerability ."
3,"Pregabalin at doses up to 10 mg/kg/day in 1 month to 16 years , and at up to 15 mg/kg/day in those aged < 6 years , demonstrated acceptable safety and tolerability ."
3,"Pregabalin at doses up to 10 mg/kg/day in children aged 1 month to 16 years , and at doses to mg/kg/day in those aged < 6 years , acceptable safety and tolerability ."
3,"at doses up to 10 mg/kg/day in children aged 1 month to 16 , and doses up to 15 mg/kg/day in those aged < 6 years , demonstrated acceptable safety and tolerability ."
1,"Regular assessment of knowledge , attitudes and practices on MIYCN will be done , coupled with assessments of nutritional status of the mother-child pairs and diarrhea morbidity for the children ."
1,"Regular assessment of knowledge , attitudes and on MIYCN will be done , coupled with assessments of nutritional status of the mother-child pairs and diarrhea morbidity for the ."
1,"Regular assessment of knowledge , attitudes and practices on MIYCN be done , coupled with assessments of nutritional status of the mother-child pairs and diarrhea morbidity for the ."
1,"Regular assessment of knowledge , attitudes and practices on MIYCN will be done , coupled with assessments of nutritional of the mother-child and diarrhea morbidity for the children ."
1,"Regular assessment of knowledge , attitudes and practices on MIYCN will done , with assessments of nutritional status of the mother-child pairs and diarrhea morbidity for the children ."
2,"Preoperatively but after nasoalveolar molding , the nostril width ratio was wider for the Figueroa group than for the Grayson group ."
2,"Preoperatively but after nasoalveolar molding , the nostril width ratio was for the Figueroa than for the Grayson group ."
2,"Preoperatively but after nasoalveolar molding , the nostril width ratio was wider for the group than the Grayson group ."
2,"Preoperatively but after nasoalveolar molding , the nostril width ratio wider for the Figueroa group than the Grayson group ."
2,"Preoperatively but after nasoalveolar molding , the nostril width was wider for the group than for the Grayson group ."
2,"The postoperative voice recovery time were 7.2 days for the group of patients received conventional laryngeal microsurgery and 7.6 days for the group of patients treated with 2 W CO2 laser , which were hoch significantly different from that in the group of patients treated with 6 W CO2 laser ( P < 0.05 ) ."
2,"The postoperative voice recovery time were 7.2 days for the group of patients received conventional laryngeal microsurgery and.6 days for the group of patients treated with 2 W CO2 laser , were hoch significantly different from that in the of treated with 6 W laser ( P < 0.05 ) ."
2,"The postoperative voice recovery time were 7.2 days for the group patients conventional laryngeal microsurgery and 7. days for the group of patients treated with 2 W CO2 laser , which were hoch significantly different from that in the group of patients treated with 6 W CO2 ( P <.05 ) ."
2,"The postoperative voice recovery time were 7.2 days group of patients received conventional laryngeal and 7.6 days for the group of patients treated with 2 W CO2 laser , were hoch significantly different from that in group of patients treated with 6 W CO2 laser ( P < 0.05 ) ."
2,"The postoperative voice recovery time were.2 days for the group of patients received conventional laryngeal microsurgery and 7.6 days for the of patients treated with 2 W CO2 laser , were hoch significantly different from that in the group of patients 6 W CO2 laser ( P < 0.05 ) ."
4,Ready-to-use supplementary food ( RUSF ) made of locally available food ingredients can improve micronutrient status and growth of children .
4,Ready-to-use supplementary food ( ) made of locally available food ingredients can improve micronutrient status and growth of children .
4,Ready-to-use supplementary food ( RUSF ) made of locally available food ingredients can improve micronutrient and growth of children .
4,Ready-to-use supplementary food ( RUSF ) made of locally available food ingredients improve micronutrient status and growth of children .
4,Ready-to-use supplementary food ( RUSF ) made of locally available ingredients can improve micronutrient status and growth of children .
0,"Here , we directly compared the effects of monthly minodronate with those of a standard single weekly 35-mg dose of alendronate ( weekly alendronate ) on L-BMD and baPWV in postmenopausal women with osteoporosis across a 12-month period ."
0,"Here , we directly compared effects of monthly minodronate with those of a standard single weekly 35-mg dose of alendronate ( weekly alendronate ) on L-BMD and baPWV in women osteoporosis across a 12-month period ."
0,"Here , we directly compared the effects of monthly minodronate with those of a standard single weekly 35-mg dose of ( weekly alendronate ) on L-BMD and baPWV in postmenopausal women with a 12-month period ."
0,"Here , we directly compared the effects of monthly minodronate with those of a standard single weekly 35-mg of alendronate ( weekly alendronate ) on L-BMD and baPWV in postmenopausal women with osteoporosis a period ."
0,"Here , we directly compared the of monthly with those of a standard single 35-mg dose of alendronate ( weekly alendronate ) on L-BMD and baPWV in postmenopausal women with osteoporosis across a 12-month period ."
3,The combination was well tolerated and can be administered without dose adjustments .
3,The combination was well tolerated and can be administered dose adjustments .
3,The combination was well tolerated and can be administered without dose .
3,The combination was well tolerated and can be without dose adjustments .
3,combination was well tolerated and can be administered without dose adjustments .
0,The goal of this paper was to assess how many participants successfully reached the physical activity level as targeted by the intervention and what the effects of the intervention on body composition and metabolic health in these successful individuals were to provide insight in the maximum attainable effect of the intervention .
0,The goal of this paper was to assess how many participants successfully reached the activity level as targeted by the intervention and what the of the on body composition and metabolic in successful individuals were to provide insight in the maximum attainable effect of the intervention .
0,The goal of this paper was to assess how many participants successfully reached the physical activity level as by the intervention and what the effects the intervention on composition and metabolic health in these individuals were to provide insight in the attainable effect of the intervention .
0,The goal of this paper was to assess participants successfully reached the physical level as targeted by the intervention and the effects of the intervention on body composition and metabolic health in these successful individuals were to provide in the maximum attainable effect of the intervention .
0,goal of this paper was to assess how many participants successfully reached the physical activity level as targeted by the intervention and what the of intervention on body composition and metabolic health in these successful individuals to provide insight the maximum attainable effect of the intervention .
3,Chinese herbal fomentation might be an effective treatment for chronic neck pain .
3,Chinese fomentation might be an effective treatment for chronic neck pain .
3,Chinese herbal fomentation might be an effective treatment for chronic neck .
3,Chinese herbal might be an effective treatment for chronic neck pain .
3,herbal fomentation might be an effective treatment for chronic neck pain .
3,These data demonstrate that the acarbose/metformin FDC is bioequivalent to the loose combination of these agents .
3,These data demonstrate that the acarbose/metformin FDC bioequivalent to the loose combination of these agents .
3,These data demonstrate that the acarbose/metformin FDC is bioequivalent to loose combination of these agents .
3,These data demonstrate that the acarbose/metformin FDC is bioequivalent to the loose combination these agents .
3,These data that the acarbose/metformin FDC is bioequivalent to the loose combination of these agents .
0,"We aimed to examine associations of quantitative gastrointestinal and psychological traits with obesity , and to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We aimed examine associations of quantitative gastrointestinal and psychological traits with obesity , and to validate ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We aimed to examine associations of quantitative gastrointestinal and psychological traits with , to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We aimed to examine associations of quantitative gastrointestinal psychological traits with obesity , to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We aimed to examine associations quantitative gastrointestinal and psychological with obesity , and to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
4,Post-concussion syndrome is associated with significant disability in the child and his/her family and yet there are no evidence-based medical treatments available .
4,Post-concussion syndrome is associated with significant disability in the and his/her family and yet there are no evidence-based medical treatments .
4,Post-concussion syndrome is associated with significant disability in the child his/her family and yet there are evidence-based medical treatments available .
4,Post-concussion syndrome is associated with significant disability the child and his/ family and yet there are no evidence-based medical treatments available .
4,Post-concussion syndrome is with significant disability in the child and his/her family yet there are no evidence-based medical treatments available .
1,Hyperhidrosis Disease Severity Scale was assessed before and after treatment up to 20 weeks .
1,Disease Severity Scale was assessed before and after treatment up to 20 weeks .
1,Hyperhidrosis Disease Scale was assessed before and after treatment up to 20 weeks .
1,Hyperhidrosis Disease Severity Scale was assessed before and after treatment up 20 weeks .
1,Hyperhidrosis Disease Severity Scale was assessed before and after up to 20 weeks .
4,ClinicalTrials.gov NCT00746031 .
4,.gov NCT00746031 .
4,ClinicalTrials. NCT00746031 .
4,ClinicalTrials.gov .
4,ClinicalTrials.gov NCT00746031 .
0,"However , recent evidence in well-trained cyclists has not consistently reported improved cycling economy or performance ."
0,"However , recent evidence in well-trained cyclists has not consistently reported improved cycling economy or ."
0,"However , recent evidence in well-trained cyclists has not reported improved cycling economy or performance ."
0,"However , recent evidence in well-trained has not consistently reported improved cycling economy or performance ."
0,"However , recent evidence well-trained cyclists has not consistently reported improved cycling economy or performance ."
1,Both groups then entered a preplanned phase with IM interferon -- 1a for 12 months .
1,Both groups then entered a preplanned phase with IM -- 1a for 12 months .
1,Both groups then entered a preplanned phase with IM interferon -- 1a for 12 .
1,Both groups then entered preplanned phase with IM interferon -- 1a for 12 months .
1,groups then entered a preplanned phase with IM interferon -- 1a for 12 months .
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostium stenosis after endoscopic surgery were assessed using a grading scale ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostium after endoscopic surgery were using a grading scale ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and frontal sinus ostium stenosis endoscopic surgery were assessed using a scale ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and sinus ostium stenosis after endoscopic surgery assessed using a grading scale ."
1,"Crusting , adhesion , bleeding , granulation tissue formation , infection , and sinus ostium stenosis after endoscopic surgery were assessed using a scale ."
1,"This is a pragmatic , individually randomised , controlled , feasibility study comparing interpersonal problem-solving therapy plus treatment-as-usual with treatment-as-usual alone , for adults attending a general hospital following self-harm ."
1,"This is a , individually randomised , controlled , feasibility study comparing interpersonal problem-solving therapy plus treatment-as-usual with treatment-as-usual alone , for adults attending a hospital following self-harm ."
1,"This is a pragmatic , individually randomised , controlled , feasibility study comparing interpersonal problem-solving therapy plus treatment-as-usual with treatment-as-usual alone , for adults a general hospital self-harm ."
1,"This is pragmatic , individually randomised , controlled , study comparing interpersonal problem-solving therapy plus treatment-as-usual with treatment-as-usual alone , for adults attending a general hospital following self-harm ."
1,"is a pragmatic , individually randomised , controlled , feasibility study comparing interpersonal problem-solving therapy plus treatment-as-usual with treatment-as-usual alone , for adults attending a hospital following self-harm ."
4,"We hypothesised that deep-fried Mars bar ingestion would impair cerebrovascular reactivity , which is associated with increased risk of ischaemic stroke ."
4,"We hypothesised that deep-fried Mars bar ingestion would cerebrovascular reactivity , which is associated with increased of ischaemic stroke ."
4,"We hypothesised that deep-fried Mars bar ingestion would impair cerebrovascular , which is associated with increased risk of stroke ."
4,"We hypothesised that deep-fried Mars bar ingestion would impair cerebrovascular , which is associated with risk of ischaemic stroke ."
4,"We hypothesised that deep-fried Mars bar ingestion would impair cerebrovascular reactivity , associated with increased risk of ischaemic stroke ."
2,"The groups ( digital , 191 patients ; traditional , 190 patients ) were well matched for baseline and surgical characteristics ."
2,"The groups ( digital , 191 patients ; traditional , 190 patients ) were matched for baseline and surgical characteristics ."
2,"The groups ( digital , 191 patients ; traditional , 190 patients ) were well matched baseline and surgical characteristics ."
2,"The groups ( digital , 191 patients ; traditional , patients ) were well matched for baseline and surgical characteristics ."
2,"The groups ( digital , patients ; traditional , 190 patients ) were well matched for baseline and surgical characteristics ."
1,Analyses were done by intention to treat .
1,Analyses were done by intention to .
1,Analyses were done by intention treat .
1,Analyses were done by to treat .
1,were done by intention to treat .
1,The values obtained before were compared to those obtained 12 weeks after the injections .
1,The values obtained before were compared those obtained 12 weeks after the injections .
1,The values obtained before were compared to those obtained 12 after the injections .
1,The values obtained before were compared to those obtained 12 weeks after injections .
1,The values obtained before were compared to those obtained 12 weeks the injections .
4,"The aim of this trial was to compare the effects of resistance training versus passive physical therapy on quality of life ( QoL ) , fatigue , and emotional distress outcomes during radiation therapy in patients with spinal bone metastases under radiotherapy ( RT ) ."
4,"The aim of this trial to compare the effects of resistance versus physical therapy on quality of life ( QoL ) , fatigue , and emotional distress outcomes during radiation therapy in patients with spinal bone metastases under radiotherapy ( RT ) ."
4,"The aim of this trial was compare the effects of resistance training versus passive physical therapy on quality of life ( QoL ) , fatigue , emotional distress outcomes during radiation therapy in patients with spinal bone metastases radiotherapy ( RT ) ."
4,"The aim of this trial was to compare the effects of resistance training passive physical therapy on quality of life ( QoL ) , fatigue , and emotional distress outcomes during radiation therapy in spinal bone metastases under radiotherapy ( RT ) ."
4,"The aim of this trial was to compare the effects resistance training versus passive physical therapy on quality of life ( QoL ) , fatigue , and emotional distress outcomes during therapy patients with spinal bone metastases under radiotherapy ( RT ) ."
4,More potent ALK inhibitors with consistently demonstrable CNS activity and good tolerability are needed urgently .
4,More ALK inhibitors with consistently demonstrable CNS activity and good tolerability are needed urgently .
4,More potent ALK inhibitors consistently demonstrable CNS activity and good tolerability are needed urgently .
4,More potent ALK inhibitors with consistently demonstrable CNS activity good tolerability are needed urgently .
4,More potent ALK with consistently demonstrable CNS activity and good tolerability are needed urgently .
3,In another study a new concept allowing a rapid pathology review before randomization of patients has now been successfully tested and it may well have potential to form the basis for modern networking consultation pathology .
3,In another a new concept allowing a rapid pathology review before randomization of patients has now been successfully tested it may well have potential form the basis for modern networking consultation pathology .
3,In another study a new allowing a rapid before randomization of patients has now been successfully tested and it may well have potential to form the basis for modern networking consultation pathology .
3,In another study a new concept allowing a rapid pathology review before randomization of patients has now been successfully and it may well have potential to form the basis for modern consultation .
3,another study a new concept a rapid pathology review before of patients has now been successfully tested and it may well have potential to form the basis for modern networking consultation pathology .
1,Seed migration was defined as a seed position > 1 cm from the cluster of other seeds on radiography .
1,Seed migration was defined a seed position > 1 cm from the cluster of other seeds on radiography .
1,Seed migration was defined as a position > 1 cm from the cluster of other seeds on radiography .
1,Seed migration was defined as a seed position > 1 cm from the cluster other seeds on radiography .
1,Seed migration was defined as a seed position > 1 cm from the of other seeds on radiography .
4,Haemodialysis patients suffer from accelerated vascular calcification .
4,Haemodialysis patients from accelerated vascular calcification .
4,Haemodialysis patients suffer from accelerated vascular .
4,Haemodialysis suffer from accelerated vascular calcification .
4,patients suffer from accelerated vascular calcification .
4,"Preclinical studies show that the opioid antagonist naltrexone ( NTX ) can block this cascade , but its ability to do so in treatment-seeking alcoholics has not been examined ."
4,"Preclinical studies show that opioid antagonist naltrexone ( NTX ) can block cascade , but its ability to do so in treatment-seeking alcoholics has not been examined ."
4,"Preclinical studies show that the antagonist naltrexone ( NTX ) can block this cascade , but its ability to do so in treatment-seeking alcoholics has not examined ."
4,"Preclinical studies show that the opioid antagonist ( NTX ) can block this cascade , but its ability to so in treatment-seeking alcoholics has not been examined ."
4,"Preclinical studies show that the opioid antagonist naltrexone ( NTX ) can block this cascade , but its to do so treatment-seeking alcoholics has not been examined ."
1,Patients diagnosed with CTS will be recruited from an outpatient neurology clinic and randomly assigned to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
1,Patients diagnosed with CTS be recruited from an outpatient neurology and randomly assigned to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
1,Patients diagnosed with CTS will be recruited from an outpatient neurology clinic and randomly assigned to the intervention group ( mechanical ) or control group ( care as usual ) .
1,Patients diagnosed with CTS will be recruited from an outpatient neurology clinic and randomly to the intervention group ( mechanical traction ) or the control group ( care usual ) .
1,Patients diagnosed with CTS will be recruited from outpatient neurology clinic and randomly assigned to the group ( mechanical traction ) or the control group ( care as usual ) .
0,The purpose of this study was to determine whether 24 months of combined denosumab and teriparatide will increase hip and spine BMD more than either individual agent .
0,The purpose of study was to determine whether 24 months of combined denosumab and teriparatide increase hip and spine BMD more than either individual agent .
0,The purpose of this study to determine whether 24 months of combined denosumab and teriparatide will increase and spine BMD more than either individual agent .
0,The purpose of this study was to whether 24 months of combined denosumab and teriparatide will increase and spine BMD more than either individual agent .
0,The purpose of this was to determine whether 24 months of combined denosumab and teriparatide will increase hip spine BMD more than either individual agent .
2,"These effects were neutralized in subjects receiving both interventions ( OR 0.97 ; 95 % CI , 0.55-1 .71 ) ."
2,"These effects were neutralized in receiving both interventions ( OR 0.97 ; 95 % CI , 0.55-1 .71 ) ."
2,"These effects were neutralized in subjects receiving both interventions ( OR 0. ; 95 % CI , 0.55-1 .71 ) ."
2,"These effects were neutralized in subjects receiving both interventions ( OR 0.97 ; % CI , 0.55-1 .71 ) ."
2,"These were neutralized in subjects receiving both interventions ( OR 0.97 ; 95 % CI , 0.55-1 .71 ) ."
3,"Furthermore , optimally programmed AVD reduces BNP and improves exercise tolerance and functional class ."
3,"Furthermore , optimally programmed AVD BNP and improves exercise tolerance and functional class ."
3,"Furthermore , optimally programmed AVD reduces BNP and improves tolerance and functional class ."
3,"Furthermore , optimally programmed AVD reduces BNP improves exercise tolerance and functional class ."
3,"Furthermore , optimally programmed AVD reduces and improves exercise tolerance and functional class ."
1,The primary outcome was complete ulcer healing .
1,The primary outcome complete ulcer healing .
1,The primary outcome was complete healing .
1,The primary outcome was complete ulcer .
1,The primary was complete ulcer healing .
3,"When the adoption of optimized CFRs is constrained by economic access for or acceptability of nutrient-dense foods , other strategies need to be incorporated into interventions to ensure adequate intakes of these nutrients ."
3,"When the adoption of CFRs is constrained by economic access for or acceptability of nutrient-dense foods , other strategies need to be incorporated into to ensure adequate intakes these nutrients ."
3,"When the adoption of optimized CFRs is constrained by economic access for or acceptability foods , other strategies need to be incorporated into interventions ensure adequate intakes of these nutrients ."
3,"When the adoption of optimized CFRs is constrained by for or acceptability of nutrient-dense , other strategies need to be incorporated into interventions to ensure adequate intakes of these nutrients ."
3,"When the adoption of optimized is constrained by economic access for acceptability of nutrient-dense foods , other need to be incorporated into interventions to ensure adequate intakes of these nutrients ."
4,"Early risk-stratified chemotherapy is a standard treatment for breast , colorectal , and lung cancers , but not for high-risk localised prostate cancer ."
4,"Early risk-stratified chemotherapy is a standard treatment for breast , , and lung , but not for high-risk localised prostate cancer ."
4,"Early risk-stratified chemotherapy is a standard treatment for breast , colorectal , and lung cancers , not for high-risk localised cancer ."
4,"Early risk-stratified chemotherapy is standard treatment for breast , colorectal , and lung cancers , but not for localised prostate cancer ."
4,"Early risk-stratified chemotherapy is standard treatment for breast , colorectal , and lung cancers , not for high-risk localised prostate cancer ."
0,We conducted a three-arm parallel study with balanced randomization to evaluate the effect of various disease-modifying therapies ( DMTs ) on cognitive function in MS.
0,We conducted a three-arm parallel study with balanced randomization to evaluate effect of various disease-modifying therapies ( DMTs ) on cognitive function MS.
0,We conducted a three-arm parallel study with balanced randomization to evaluate of various disease-modifying therapies ( DMTs ) on cognitive function in MS.
0,We conducted a three-arm parallel study with balanced randomization to evaluate the effect of various disease-modifying ( DMTs ) on cognitive in MS.
0,We conducted a three-arm parallel study with balanced randomization to evaluate the various disease-modifying therapies ( DMTs ) on cognitive function in MS.
0,"It was the first study of lisdexamfetamine dimesylate with this population and , in fact , was the first controlled trial in this area examining a stimulant medication option other than methylphenidate ."
0,"It the first study of lisdexamfetamine dimesylate with this population and , in fact , the controlled trial in this area examining a stimulant medication option other than methylphenidate ."
0,"It was the first study of lisdexamfetamine dimesylate with population , in fact , was the first controlled trial in this area examining a stimulant medication option than methylphenidate ."
0,"It was the first study of lisdexamfetamine dimesylate with this population and , in fact , was the trial in this area examining a stimulant medication option other methylphenidate ."
0,"It was the first study of lisdexamfetamine with this population and , in fact , was the first controlled trial in this examining a stimulant medication option other than ."
1,"The present study will enroll , at 64 medical institutions in Japan , 400 Japanese patients aged 20 years or older who have hyperuricemia without gouty arthritis , who present CKD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/dL ."
1,"The present study enroll , at 64 medical institutions in Japan , 400 Japanese patients aged years or older who have gouty arthritis , who present CKD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/dL ."
1,"The present study will enroll , at 64 medical institutions in Japan , 400 Japanese patients aged 20 years who have hyperuricemia without gouty arthritis , who present CKD stage 3 , and whose is 7.1-10 .0 mg/dL ."
1,"The present study will enroll , at 64 medical institutions in Japan , 400 aged 20 years older who have hyperuricemia without gouty arthritis , who CKD stage 3 , and whose SUA concentration is 7.1-10 .0 mg/dL ."
1,"The present study will enroll , at 64 medical institutions in Japan , Japanese patients aged 20 years or older who have without gouty arthritis , who present CKD 3 , and whose SUA is 7.1-10 .0 mg/dL ."
2,Reported adverse events were mild to moderate in intensity ; none resulted in discontinuation .
2,Reported adverse events were mild to moderate in ; none resulted in discontinuation .
2,Reported adverse events were mild to moderate in intensity ; resulted in discontinuation .
2,Reported adverse events were mild to moderate intensity ; none resulted in discontinuation .
2,adverse events were mild to moderate in intensity ; none resulted in discontinuation .
3,Early diagnosis and treatment did not prevent ASD as an outcome of IS .
3,Early diagnosis and did not prevent ASD as an outcome of IS .
3,Early diagnosis and treatment did not prevent ASD an outcome of IS .
3,Early diagnosis and treatment did not prevent ASD as an outcome of .
3,diagnosis and treatment did not prevent ASD as an outcome of IS .
1,A clinical evaluation was performed by the pediatrician at the start and end of the treatment period .
1,A clinical evaluation was performed by pediatrician at the start and end of the treatment period .
1,A clinical evaluation was performed by the pediatrician at the start end of the treatment period .
1,A clinical evaluation was performed the pediatrician at the start and end of the treatment period .
1,A clinical was performed by the pediatrician at the start and end of the treatment period .
0,Study participants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
0,Study participants randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
0,Study participants were randomly assigned to amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
0,Study participants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 .
0,Study participants were randomly assigned to receive amantadine hydrochloride 100 twice daily versus equivalent placebo for 28 days .
4,The aim of the present study was to evaluate the long-term effect of MBP regarding cancer recurrence and survival after colonic resections .
4,The aim of present study was to evaluate the effect of MBP regarding cancer recurrence and survival after colonic resections .
4,The aim of the present study to evaluate the long-term effect of MBP regarding recurrence and survival after colonic resections .
4,The aim of the present study was to evaluate long-term effect of MBP cancer recurrence and survival after colonic resections .
4,The aim of the present study was to evaluate long-term effect of MBP regarding cancer recurrence and survival after resections .
2,"Within the MRD intermediate-risk group , iAMP21 cases ( n = 27 ) had a worse 8-year EFS ( 56 11 % vs. 78 2 % , p = 0.0077 ) and CIR ( 44 11 % vs. 20 2 % , p = 0.003 ) with 6/10 relapses occurring after 2 years ."
2,"Within the MRD group , iAMP21 cases ( = 27 ) had a worse 8-year EFS ( 56 11 % vs. 78 2 % , = 0.0077 ) and CIR ( 44 11 % vs. 20 % , p = 0.003 ) with 6/10 relapses occurring after 2 years ."
2,"Within the MRD intermediate-risk group , cases ( = 27 ) had a worse 8-year EFS ( 56 11 % vs. 78 2 % , p =. ) and CIR ( 44 11 % vs. 20 2 % , p = 0.003 ) with 6/10 relapses occurring after 2 years ."
2,"Within the MRD intermediate-risk group , cases ( n = 27 ) had a worse 8-year EFS ( 56 11 % vs. 78 2 % , = 0.0077 ) and CIR ( 44 11 % vs. 20 2 % , p = 0. ) 6/10 relapses occurring after 2 years ."
2,"Within the MRD intermediate-risk group , iAMP21 cases ( n = ) had a worse 8-year ( 56 % vs. 78 2 % , p = 0.0077 ) CIR ( 44 11 % vs. 20 2 % , p = 0.003 ) with 6/10 relapses occurring after 2 years ."
0,The aims of the present study were to assess the efficacy and safety of BT injection and combined treatment with BT injection and lowered dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
0,The aims of the present study to assess the efficacy and safety of BT injection and combined treatment with BT injection dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
0,The aims of the present study were to assess the efficacy safety of injection and combined treatment with injection and lowered dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
0,aims of the present study were to assess the efficacy and safety of BT injection and combined treatment BT injection and lowered glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
0,aims of the study to assess the efficacy and safety of BT injection and combined treatment with BT injection and lowered dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
4,Adenosine is the first-line medication in patients with paroxysmal supraventricular tachycardia .
4,Adenosine is the first-line in patients with paroxysmal supraventricular tachycardia .
4,Adenosine is the first-line medication in patients with paroxysmal supraventricular .
4,Adenosine is the first-line medication in with paroxysmal supraventricular tachycardia .
4,Adenosine the first-line medication in patients with paroxysmal supraventricular tachycardia .
0,To assess whether adding clopidogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effect in patients with lacunar stroke while taking ASA .
0,To assess whether adding clopidogrel acetylsalicylic acid ( ASA ) has a long-term protective vascular effect in patients with lacunar stroke taking ASA .
0,To assess whether adding clopidogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effect in lacunar stroke while taking ASA .
0,To assess whether adding clopidogrel to acid ( ASA ) has a long-term protective vascular effect in patients with lacunar stroke while taking .
0,To whether adding clopidogrel to acetylsalicylic acid ( ASA ) has a long-term protective vascular effect in patients with lacunar stroke while ASA .
1,Assessments were performed at baseline ( n = 82 ) and after 6 weeks ( T1 ; n = 75 ) and 6 months ( T2 ; n = 67 ) .
1,Assessments were performed at ( n = 82 ) after 6 weeks ( T1 ; n = 75 ) and 6 months ( T2 ; n = 67 ) .
1,Assessments were performed at baseline ( n = 82 ) and 6 weeks ( T1 ; n = 75 ) and 6 months ( ; n = 67 ) .
1,Assessments were performed at baseline ( n = 82 ) and after 6 weeks ( T1 ; n = ) 6 months ( T2 ; n = 67 ) .
1,Assessments were performed at baseline ( n = 82 ) and after weeks ( T1 ; n = ) and 6 months ( T2 ; n = 67 ) .
2,"Insulin AUC ( IU/mL min ) after patients consumed the HGI-LF meal [ 65.72 ( 38.24 , 93.19 ) ] was higher than after the HGI-HF meal [ 57.24 ( 32.44 , 82.04 ) ] ( P 0.05 ) ."
2,"Insulin ( IU/mL min ) after patients consumed the HGI-LF meal [ 65.72 ( 38.24 , 93.19 ) ] was higher than after the HGI-HF meal [ 57.24 (.44 , 82.04 ) ] ( 0.05 ) ."
2,"Insulin AUC ( IU/mL min ) after consumed the HGI-LF meal [ 65.72 ( 38.24 , 93.19 ) ] was higher than the HGI-HF meal [ 57.24 ( 32.44 , 82.04 ) ] ( P 0. ) ."
2,"Insulin AUC ( IU/mL min ) after patients consumed the HGI-LF meal [ 65.72 ( 38.24 , 93.19 ) ] was higher after the HGI-HF meal [ 57.24 ( 32.44 , 82.04 ) ] ( 0. ) ."
2,"Insulin AUC ( IU/mL min ) after patients the HGI-LF meal [ 65.72 ( 38.24 , 93.19 ) ] was than after the meal [ 57.24 ( 32.44 , 82.04 ) ] ( P 0.05 ) ."
0,"To evaluate a novel aqueous oxygen peroxide ( AOP ) wound therapy ( BioxyQuell ) in a multi-centre , primary care-based , randomised , double-blind , placebo-controlled , parallel-group trial , monitoring long-term healing outcomes over 12 months ."
0,"To evaluate a novel aqueous oxygen peroxide ( AOP ) wound therapy ( BioxyQuell ) in a multi-centre , primary care-based , , double-blind , placebo-controlled , parallel-group trial , monitoring long-term healing outcomes 12 months ."
0,"To evaluate a novel oxygen peroxide ( AOP ) wound therapy ( BioxyQuell ) in a multi-centre , primary care-based , randomised , , placebo-controlled , parallel-group trial , monitoring long-term healing outcomes over 12 months ."
0,"To evaluate novel aqueous oxygen peroxide ( AOP ) wound therapy ( BioxyQuell ) in a multi-centre , primary care-based , randomised , double-blind , placebo-controlled , parallel-group trial , monitoring long-term healing outcomes over months ."
0,"evaluate a novel aqueous oxygen ( AOP ) wound therapy ( BioxyQuell ) in a multi-centre , primary care-based , randomised , double-blind , placebo-controlled , parallel-group trial , monitoring long-term healing outcomes over 12 months ."
2,Twenty-six patients were enrolled and 25 were analyzed .
2,Twenty-six patients were enrolled 25 were analyzed .
2,Twenty-six patients were enrolled and 25 were .
2,Twenty-six patients were enrolled and were analyzed .
2,Twenty-six were enrolled and 25 were analyzed .
2,"Difficulties encountered were low norovirus disease rate , and inability to define illness by quantitative RT-PCR or further antibody rise in vaccinees due to high vaccine-induced titers ."
2,"Difficulties encountered were low disease rate , and inability to define illness by quantitative RT-PCR or further antibody rise in vaccinees to high vaccine-induced titers ."
2,"Difficulties encountered were low norovirus disease rate , and inability to define illness by quantitative RT-PCR or further antibody rise due to high vaccine-induced titers ."
2,"Difficulties encountered were low norovirus disease rate , and inability to define illness by quantitative RT-PCR or further rise in vaccinees due to vaccine-induced titers ."
2,"Difficulties encountered were low norovirus disease rate , and to define illness by quantitative RT-PCR or further antibody rise in vaccinees due high vaccine-induced titers ."
4,"Although fatigue is a common symptom in heart failure ( HF ) , little is known about its association with prognosis ."
4,"Although fatigue is a common symptom heart failure ( HF ) , little is known about its association with prognosis ."
4,"Although fatigue is a common symptom in failure ( HF ) , little is known about its association with prognosis ."
4,"Although fatigue is common symptom in heart failure ( HF ) , little is known about its association with prognosis ."
4,"Although is a common symptom in heart failure ( HF ) , little is known about its association with prognosis ."
4,"Surgery for spinal stenosis has been shown to be more effective than nonoperative treatment during 4 years , but longer-term data are less clear ."
4,"Surgery for spinal has been shown to more effective than nonoperative treatment during 4 years , but longer-term data are less clear ."
4,"Surgery for spinal stenosis has been shown to be more effective than nonoperative treatment during 4 years , but longer-term are clear ."
4,"Surgery for spinal stenosis has shown be more effective than nonoperative treatment during 4 years , but longer-term data are less clear ."
4,"Surgery for spinal stenosis has shown to be more effective than nonoperative treatment during 4 , but longer-term data are less clear ."
0,"A 6-month aerobic and resistance training exercise regimen was implemented to examine interrelationships between circulating sex hormones , body composition , aerobic capacity , insulin sensitivity , and insulin resistance ."
0,"A 6-month aerobic and resistance training exercise regimen was implemented to examine interrelationships between circulating sex , body composition , capacity , insulin sensitivity , and insulin resistance ."
0,"A 6-month aerobic and resistance training exercise regimen was implemented to examine interrelationships between circulating sex hormones , body composition , aerobic capacity , insulin sensitivity , resistance ."
0,"A 6-month aerobic and training exercise regimen was implemented to examine interrelationships between circulating sex hormones , composition , aerobic capacity , insulin sensitivity , and insulin resistance ."
0,"A 6-month and resistance training regimen was implemented to examine interrelationships between circulating sex hormones , body composition , aerobic capacity , insulin sensitivity , and insulin resistance ."
0,This study evaluated the safety and effects of sapropterin on hepatic and systemic hemodynamics in patients with cirrhosis and PHT .
0,This study evaluated the safety and effects of sapropterin hepatic systemic hemodynamics in patients with cirrhosis and PHT .
0,This study evaluated the safety and effects sapropterin on hepatic and systemic hemodynamics in patients with cirrhosis PHT .
0,This study evaluated the safety effects of sapropterin on and systemic hemodynamics in patients with cirrhosis and PHT .
0,study evaluated the safety and effects of sapropterin on hepatic and systemic hemodynamics patients with cirrhosis and PHT .
4,"Centre for Clinical Research and Biostatistics , http://www.cct.cuhk.edu.hk/Registry/publictriallist.aspx , CUHK_CCT00291 ."
4,"Centre Clinical Research and Biostatistics , http://www.cct.cuhk.edu.hk/Registry/publictriallist.aspx , CUHK_CCT00291 ."
4,"Centre for Clinical Research and , http://www.cct.cuhk.edu.hk/Registry/publictriallist.aspx , CUHK_CCT00291 ."
4,"Centre for Clinical Research and Biostatistics , http://www.cct.cuhk.edu.hk/Registry/.aspx , CUHK_CCT00291 ."
4,"Centre for Clinical Research and Biostatistics ,://www.cct.cuhk.edu.hk/Registry/publictriallist.aspx , CUHK_CCT00291 ."
0,Evaluate the performance of a robotic system for CT-guided lung biopsy in comparison to the conventional manual technique .
0,Evaluate the performance of a robotic for CT-guided lung biopsy in comparison to the conventional manual technique .
0,Evaluate the performance of a robotic system for CT-guided lung biopsy comparison to the conventional manual technique .
0,Evaluate the performance of a robotic system for CT-guided lung biopsy in comparison to the conventional manual .
0,Evaluate the performance of a system for CT-guided lung biopsy in comparison to the conventional manual technique .
1,The primary endpoint was progression-free survival and overall survival was a secondary endpoint .
1,The primary endpoint progression-free survival and overall survival was a secondary endpoint .
1,The primary endpoint was progression-free and overall survival was a secondary endpoint .
1,The primary endpoint was progression-free survival and overall survival a secondary endpoint .
1,primary endpoint was progression-free survival and overall survival was a secondary endpoint .
3,"Moreover , future research should consider investigating factors predicting individual response ."
3,"Moreover , future research consider investigating factors predicting individual response ."
3,"Moreover , future research should consider investigating factors individual response ."
3,"Moreover , future research should consider investigating factors predicting response ."
3,"Moreover , research should consider investigating factors predicting individual response ."
1,A cutoff of 5 % mutant/wild-type sequences was selected to define RAS status ; we also report an analysis using a cutoff based on the technical lower limit for mutation identification ( 0.1 % ) .
1,A cutoff of 5 % mutant/wild-type sequences was selected to define RAS status ; we also an analysis using a cutoff based on lower limit for mutation identification ( 0.1 % ) .
1,A cutoff of 5 % mutant/wild-type sequences was to define RAS status ; we also report an analysis a cutoff based on the technical lower limit for mutation ( 0.1 % ) .
1,A of 5 % mutant/ sequences selected to define RAS status ; we also report an analysis using a cutoff based on the technical lower limit for mutation identification ( 0.1 % ) .
1,cutoff of 5 % mutant/wild-type sequences was selected to RAS status ; we also report an analysis using a cutoff based on the technical lower limit mutation identification ( 0.1 % ) .
2,"In the IGF-1 group , 66.7 % ( 95 % confidence interval [ CI ] , 52.9-78 .6 % ) of the patients showed hearing improvement compared to 53.6 % ( 95 % CI , 39.7-67 .0 % ) of the patients in the Dex group ( P = 0.109 ) ."
2,"In IGF-1 group , 66.7 % ( 95 % confidence interval [ CI ] , 52.9-78 .6 % ) of the patients showed hearing improvement compared to 53.6 % ( 95 % CI , 39.7-67 . % ) of the patients in Dex group ( P = 0.109 ) ."
2,"In the IGF-1 group , 66.7 % ( 95 % confidence interval [ CI ] , 52.9-78 .6 % ) of the patients showed improvement 53.6 % ( 95 % CI , 39.7-67 .0 % ) of the patients in the Dex group ( P = 0.109 ) ."
2,"In the IGF-1 group , 66.7 % ( 95 % confidence interval [ CI ] , 52.9-78 .6 % ) of the patients showed improvement compared to 53.6 % ( % CI ,.7-67 .0 % ) of the patients in the Dex group ( P = 0.109 ) ."
2,"In the IGF-1 group , 66.7 % ( 95 % confidence interval [ CI ] , 52.9-78 .6 % ) of the showed hearing improvement compared to 53.6 % ( 95 % CI , 39.7-67 .0 % ) of the patients the group ( P = 0.109 ) ."
0,We estimate the effect size of hypoglycemia risk reduction on closed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,We estimate effect size hypoglycemia risk reduction on closed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,We estimate the effect size hypoglycemia reduction on closed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,We estimate the effect size of hypoglycemia reduction on control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,estimate the effect size of hypoglycemia risk reduction on closed-loop control ( CLC ) versus ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
2,"Fibrotic scars developed in 24.7 % of eyes , and nonfibrotic scars developed in 20.6 % of eyes ."
2,"Fibrotic developed in 24.7 % of eyes , and nonfibrotic scars developed in 20.6 % of eyes ."
2,"Fibrotic scars developed in 24.7 % of eyes , and nonfibrotic scars developed in 20.6 % of ."
2,"Fibrotic scars developed in 24.7 % of eyes , and nonfibrotic scars developed in.6 % of eyes ."
2,"scars developed in 24.7 % of eyes , and nonfibrotic scars developed in 20.6 % of eyes ."
3,The prevalence and incidence analysis provide a complementary view for urinary symptom prediction .
3,The and incidence analysis provide a complementary view for urinary symptom prediction .
3,The prevalence and incidence analysis provide a complementary for urinary symptom prediction .
3,The prevalence and incidence analysis provide a complementary view for symptom prediction .
3,The prevalence and incidence analysis provide a complementary view for urinary symptom .
3,It was shown that students in the open discussion group had better MCQ and MEQ scores than those in the lecture group .
3,It was shown students in the open discussion group had better MCQ MEQ scores than those in the lecture group .
3,It was shown students in the open discussion group had better and MEQ scores than those in the lecture group .
3,It was shown that in the open discussion group had better MCQ and MEQ scores than those in the group .
3,It was shown that students in the open group had MCQ and MEQ scores than those in the lecture group .
2,"In total , 1178 children ( 93.2 % ) completed the study ."
2,"In total , 1178 ( 93.2 % ) completed the study ."
2,"In total , 1178 children ( 93. % ) completed the study ."
2,"In total , 1178 children (.2 % ) completed the study ."
2,"total , 1178 children ( 93.2 % ) completed the study ."
3,Short-term use of CTM compared with radiant warmers and other modes of warming is non-inferior to SoC and efficacious in maintaining body temperature .
3,Short-term use CTM compared with radiant warmers and other modes of warming is non-inferior to SoC efficacious in maintaining body temperature .
3,Short-term use of CTM compared with radiant warmers and other modes of warming is SoC and efficacious in maintaining body temperature .
3,Short-term use of CTM compared with radiant warmers other modes warming is non-inferior to SoC and efficacious in maintaining body temperature .
3,use CTM compared with radiant warmers and other modes of warming is non-inferior to SoC and efficacious in maintaining body temperature .
4,"Secondarily , the trial aims to determine whether inpatient rehabilitation yields superior recovery in patient-reported function ."
4,"Secondarily , the aims to determine whether inpatient rehabilitation yields superior recovery in patient-reported function ."
4,"Secondarily , the trial aims to determine whether inpatient rehabilitation superior recovery in patient-reported function ."
4,"Secondarily , the trial aims to determine whether inpatient yields superior recovery in patient-reported function ."
4,"Secondarily , the trial to determine whether inpatient rehabilitation yields superior recovery in patient-reported function ."
0,To compare anatomical and patient-reported outcomes at 12 months postoperatively for women who had anterior compartment pelvic organ prolapse ( POP ) surgery using a repair augmented with porcine small intestine submucosa mesh ( Mesh Group ) compared with those who had a native tissue repair ( No Mesh Group ) .
0,To compare anatomical and patient-reported outcomes at 12 months postoperatively for women who had anterior compartment organ prolapse ( POP ) surgery a repair augmented porcine small intestine submucosa mesh ( Mesh Group ) compared with those who a native tissue repair ( No Mesh Group ) .
0,To compare anatomical and patient-reported outcomes at 12 months postoperatively for women who had anterior compartment pelvic organ prolapse ( POP ) surgery using a repair augmented with porcine intestine submucosa mesh ( Group ) compared those who had a tissue repair ( No Mesh Group ) .
0,To compare anatomical and patient-reported outcomes at 12 months postoperatively for women who had anterior compartment pelvic prolapse ( POP ) surgery using a repair augmented with porcine small intestine submucosa mesh ( Mesh Group ) compared with those who had a native repair ( Group ) .
0,To compare anatomical and patient-reported outcomes at 12 postoperatively for women who had anterior compartment pelvic organ prolapse ( POP ) surgery using a repair augmented with porcine small intestine submucosa mesh ( Mesh ) compared with who had a native tissue repair ( No Mesh ) .
4,We investigated whether offering HPV DNA self-collection during routine home visits by community health workers could increase cervical screening .
4,We investigated whether offering DNA self-collection during routine home visits by community health workers could increase cervical screening .
4,We investigated whether offering HPV DNA self-collection during routine visits by community health workers could increase cervical screening .
4,We whether offering HPV DNA self-collection during routine home visits by community health workers could increase cervical screening .
4,investigated whether offering HPV DNA self-collection during routine home visits by community health workers could increase cervical screening .
3,"Post-ICU hospital-based rehabilitation , including increased physical and nutritional therapy plus information provision , did not improve physical recovery or HRQOL , but improved patient satisfaction with many aspects of recovery ."
3,"Post-ICU hospital-based rehabilitation , including increased and nutritional therapy plus information provision , did not improve physical recovery or HRQOL , but improved satisfaction with many aspects of recovery ."
3,"Post-ICU hospital-based rehabilitation , including increased physical and nutritional therapy plus information provision , did not improve physical recovery or , but improved patient satisfaction many aspects of recovery ."
3,"Post-ICU hospital-based rehabilitation , including increased physical and nutritional therapy plus information provision , did not improve physical recovery or HRQOL , but improved patient satisfaction aspects of recovery ."
3,"Post-ICU hospital-based rehabilitation , increased physical and nutritional therapy plus information provision , did not improve physical recovery or HRQOL , but improved patient with many aspects of recovery ."
0,This study aims to evaluate the effects of nasal packs on surgical success and related complications in septoplasty .
0,This study aims to evaluate effects of nasal packs on surgical success and related complications in septoplasty .
0,This study aims to evaluate the effects nasal packs on surgical success and related complications in septoplasty .
0,This study aims to evaluate the effects of nasal packs on surgical success related complications in septoplasty .
0,This study aims to evaluate the effects of packs on surgical success and related complications in septoplasty .
4,This paper identifies factors that could enhance participation of the target population in future interventions .
4,This identifies factors that could enhance participation of the target population in future interventions .
4,This paper identifies factors that could enhance participation of the target population future interventions .
4,This paper identifies factors that could enhance participation of the target population in future .
4,This paper identifies that could enhance participation of the target population in future interventions .
0,To investigate functional and macular pigment ( MP ) changes in patients with early age-related macular degeneration ( AMD ) after multiple supplementation with lutein and zeaxanthin .
0,To investigate and macular pigment ( MP ) changes in patients with early age-related macular ( AMD ) after multiple supplementation with lutein and zeaxanthin .
0,To investigate and macular pigment ( MP ) changes in patients with early age-related macular degeneration ( ) after multiple supplementation with lutein and zeaxanthin .
0,To investigate functional and macular pigment ( MP ) changes in patients with early age-related macular ( AMD ) after multiple with lutein and zeaxanthin .
0,To investigate functional and macular pigment ( MP ) in patients early age-related macular degeneration ( AMD ) after multiple supplementation with lutein and zeaxanthin .
3,Slight differences were seen among the reconstruction algorithms .
3,Slight differences seen among the reconstruction algorithms .
3,Slight differences were seen among reconstruction algorithms .
3,Slight differences were seen among the algorithms .
3,Slight differences were seen among the reconstruction .
1,The primary outcome will be levels of depression and secondary outcomes will be severity of psychotic symptoms and cost-effectiveness .
1,The outcome will be levels of depression and secondary outcomes will be severity of psychotic symptoms and cost-effectiveness .
1,The primary outcome be levels of depression and secondary outcomes will be severity of psychotic symptoms and cost-effectiveness .
1,The primary outcome will be levels of depression and secondary outcomes be severity of psychotic symptoms and cost-effectiveness .
1,primary outcome will be levels of depression and secondary outcomes will be severity of psychotic symptoms and cost-effectiveness .
3,"Moreover , it will assess the risks associated with this procedure ."
3,"Moreover , it will assess risks associated with this procedure ."
3,"Moreover , it will assess the associated with this procedure ."
3,"Moreover , it will assess the risks associated with procedure ."
3,"Moreover , it will assess the risks associated with this ."
1,Initial treatment was compared in 4 risk groups .
1,Initial treatment was compared in 4 groups .
1,Initial treatment was compared in risk groups .
1,Initial treatment was in 4 risk groups .
1,treatment was compared in 4 risk groups .
0,"Addressing these challenges requires an intervention that elicits motivation to engage in this activity , minimizes the direct relationship between unwanted internal experiences and inaction , and is also in itself accessible and convenient ."
0,"Addressing these challenges requires an intervention that elicits motivation to engage in activity , minimizes the direct relationship between unwanted internal and inaction , and also in itself accessible and convenient ."
0,"Addressing these challenges requires an intervention that elicits motivation to engage in this activity , minimizes relationship between unwanted internal experiences and , and is also in itself accessible and convenient ."
0,"Addressing these challenges requires an intervention that elicits motivation to engage in this activity , the direct relationship between unwanted internal experiences and inaction , and is also in itself and ."
0,"these challenges requires an intervention that elicits motivation to engage in activity , minimizes the direct relationship between unwanted internal experiences and inaction , and is in itself accessible and convenient ."
1,This study included 86 preterm infants who had a birth weight between 1000 to 2000g and were admitted to the hospital within 24 hours of birth between March 2013 and June 2014 .
1,This included 86 preterm infants who had a birth weight between 1000 to 2000g and were admitted to the hospital within 24 hours of birth between and June 2014 .
1,This included 86 preterm who had a birth between 1000 to 2000g and were admitted to the hospital within 24 hours of birth between March 2013 and June 2014 .
1,This study 86 preterm infants who had a birth weight between 1000 to 2000g and admitted to the hospital within 24 of birth between March 2013 and June 2014 .
1,study included 86 preterm infants who had birth weight between 1000 to 2000g and were admitted to the hospital within 24 hours birth between March 2013 and June 2014 .
3,PCB may produce positive vessel remodeling .
3,PCB may positive vessel remodeling .
3,PCB may produce positive remodeling .
3,PCB produce positive vessel remodeling .
3,may produce positive vessel remodeling .
3,"Longer duration of diabetes is associated with brain volume loss , particularly in the gray matter , possibly reflecting direct neurologic insult ; biochemical measures of glycemia were less consistently related to MR imaging changes ."
3,"Longer duration of diabetes is associated brain loss , particularly in the gray , possibly reflecting direct neurologic insult ; biochemical measures of glycemia were less consistently related to MR imaging changes ."
3,"Longer duration of diabetes is associated with brain volume loss , particularly in the gray matter , possibly direct neurologic ; biochemical measures of glycemia were less consistently related MR imaging changes ."
3,"Longer of diabetes is associated with brain volume loss , particularly in the gray matter , possibly reflecting direct neurologic insult ; biochemical measures of glycemia less consistently related MR imaging changes ."
3,"duration of is associated with brain loss , particularly in the gray matter , possibly reflecting direct neurologic insult ; biochemical measures of glycemia were less consistently related to MR imaging changes ."
4,"We assessed the safety and efficacy of peginterferon beta-1a after 48 weeks of treatment in the placebo-controlled phase of the ADVANCE trial , a study of patients with relapsing-remitting multiple sclerosis ."
4,"We assessed the and of peginterferon beta-1a after 48 weeks of in the placebo-controlled phase of the ADVANCE trial , a study of patients with relapsing-remitting multiple sclerosis ."
4,"We assessed the safety and efficacy of after 48 weeks of in the placebo-controlled phase of the ADVANCE trial , a study of patients with relapsing-remitting multiple sclerosis ."
4,"We assessed the safety and of peginterferon beta-1a after 48 weeks of treatment in the placebo-controlled phase the ADVANCE trial , a study of patients relapsing-remitting multiple sclerosis ."
4,"assessed the safety and efficacy of peginterferon beta-1a after weeks of treatment in the phase of the ADVANCE trial , a study of patients with relapsing-remitting multiple sclerosis ."
3,Frequent exercising and bracing seems effective long-term prevention advices in recurrent LBP .
3,Frequent and bracing seems effective long-term prevention advices in recurrent LBP .
3,Frequent exercising and bracing seems effective long-term advices in recurrent LBP .
3,Frequent exercising and bracing seems effective long-term prevention advices recurrent LBP .
3,Frequent exercising and bracing seems long-term prevention advices in recurrent LBP .
0,To compare visual acuity with two visual acuity charts in preschool children .
0,To compare acuity with two visual acuity charts in preschool children .
0,To compare visual acuity with two acuity charts in preschool children .
0,To compare visual acuity with two visual acuity charts in children .
0,To compare visual with two visual acuity charts in preschool children .
0,Examine psychological and behavioral predictors of 3-year weight loss maintenance in women .
0,Examine psychological and behavioral predictors of 3-year weight loss in women .
0,Examine psychological and behavioral predictors of 3-year weight loss maintenance women .
0,Examine psychological and behavioral predictors of weight loss maintenance in women .
0,Examine psychological behavioral predictors of 3-year weight loss maintenance in women .
0,The aim of this study was to determine the efficacy of electrical stimulation when added to conventional physical therapy with regard to clinical and neurophysiologic changes in patients with Bell palsy .
0,The aim of this study determine the efficacy of electrical stimulation when added to conventional physical therapy with regard to clinical and neurophysiologic changes patients with Bell palsy .
0,The aim of this study was to determine the efficacy of electrical stimulation when added to conventional therapy with to clinical and changes in patients with Bell palsy .
0,The aim of this study was to determine the of stimulation when added to conventional physical therapy with regard to clinical neurophysiologic changes in patients with Bell palsy .
0,The aim this study to determine the efficacy of electrical stimulation when added to conventional physical therapy with regard to clinical and neurophysiologic changes in with Bell palsy .
0,Our goal was to compare the rate of infections among subgroups with and without prophylactic antibiotic treatment .
0,Our goal was to compare rate of infections among subgroups with and without prophylactic antibiotic treatment .
0,Our goal was to compare the rate infections among subgroups with and without prophylactic antibiotic treatment .
0,Our goal was to compare the rate of infections among subgroups with and without prophylactic antibiotic .
0,Our was to compare the rate of infections among subgroups with and without prophylactic antibiotic treatment .
2,"There was no difference between the DHA and placebo groups in the rate of cone ERG functional loss ( 0.028 vs 0.022 log V/y , respectively ; P = .30 ) ."
2,"There was no between the DHA and placebo groups in the rate of cone ERG functional loss ( 0.028 vs 0.022 log V/y , respectively ; P = . ) ."
2,"There was no difference between the DHA and placebo groups in the rate cone ERG functional loss (.028 vs 0.022 log V/y , respectively ; P = .30 ) ."
2,"There was no difference between the DHA and placebo groups in the rate of cone functional loss (.028 vs 0.022 log V/y , respectively ; P = .30 ) ."
2,"There was no difference between the DHA placebo groups in the rate of cone ERG loss ( 0.028 vs 0.022 log V/y , respectively ; P = .30 ) ."
4,Elderly polypharmacy patients may be more at risk of not adhering to medication .
4,Elderly polypharmacy patients be more at risk of not adhering to medication .
4,Elderly polypharmacy patients may be at risk of not adhering to medication .
4,Elderly polypharmacy patients may be more at risk of not adhering medication .
4,Elderly polypharmacy patients may more at risk of not adhering to medication .
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg given over 3 hours .
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg given 3 hours .
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg given over 3 .
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg over 3 hours .
3,Meropenem at 1000mg over 30 minutes achieved a similar % to meropenem at 500mg given over 3 hours .
3,"Although behavioral and technological interventions can result in some modest improvements in glycemic control , these interventions did not fare significantly better than usual care in achieving glycemic control ."
3,"Although and technological interventions can result in some modest improvements in glycemic control , these interventions did not significantly better than usual care in achieving glycemic control ."
3,"Although behavioral and technological interventions can result in some modest improvements in glycemic , interventions did not fare significantly better than usual care in achieving glycemic control ."
3,"Although behavioral and technological interventions can result some modest improvements in glycemic control , these interventions did not significantly better than usual care in achieving glycemic control ."
3,"Although behavioral and technological interventions result in some modest improvements in control , these interventions did not fare significantly better than usual care in achieving glycemic control ."
2,Supplement dose and baseline 25 ( OH ) D level explained 24 % of the variability in response to supplementation .
2,Supplement dose and baseline 25 ( OH ) D explained 24 % of the variability in response to supplementation .
2,Supplement dose and baseline 25 ( OH ) D level 24 % of the variability in response to supplementation .
2,Supplement dose and baseline 25 ( OH ) D level explained % of the variability in response to supplementation .
2,Supplement dose and baseline 25 ( OH ) D level explained 24 % of the variability in to supplementation .
3,"Accelerometer data did not show significant changes in actual amount of arm-hand use after task-oriented training , with or without robot-support ."
3,"Accelerometer data did not show significant changes actual amount of arm-hand after task-oriented training , with or without robot-support ."
3,"Accelerometer data did show significant changes in actual of arm-hand use after task-oriented training , with or without robot-support ."
3,"Accelerometer data not show significant changes in actual amount of arm-hand use after task-oriented training , with or robot-support ."
3,"data did not show changes in actual amount of arm-hand use after task-oriented training , with or without robot-support ."
4,Antidepressants are often the first-line treatment for depression in primary care .
4,Antidepressants are often the first-line treatment depression in primary care .
4,Antidepressants are often the first-line treatment for depression in care .
4,Antidepressants are often the first-line treatment for depression in primary .
4,Antidepressants are the first-line treatment for depression in primary care .
2,Average variable costs per patient were $ 31 for screening and $ 79 for intervention .
2,Average variable costs per patient were $ 31 for screening and $ 79 for .
2,Average variable costs per patient were $ 31 for screening and $ 79 intervention .
2,Average variable costs per patient were $ 31 screening and $ 79 for intervention .
2,Average variable per patient were $ 31 for screening and $ 79 for intervention .
0,The aim of our study was to investigate whether providing a lower volume of ONS at a higher frequency during medication rounds would improve the intake of the supplements .
0,The aim of our study was to investigate whether providing a lower volume of ONS at a frequency during medication rounds would improve the of the supplements .
0,The aim of our study was to investigate whether providing a lower volume of ONS at a higher frequency during medication rounds would the of the supplements .
0,The aim of our was to investigate whether providing a lower volume of ONS at a frequency during medication rounds would improve the intake of the supplements .
0,aim of our study was to investigate whether providing a lower volume of at a higher frequency during medication rounds would improve the intake of the supplements .
1,"Other assessment measures included the 10-minute psychomotor vigilance task ( for neurobehavioral functioning ) , the time-line follow-back measure ( for alcohol consumption ) , the Penn Alcohol Craving Scale ( for alcohol craving ) , the Patient Health Questionnaire-9 item scale ( for depressive symptoms ) , and the Beck Anxiety Inventory ( for anxiety symptoms ) ."
1,"Other assessment measures included the 10-minute psychomotor vigilance task ( for neurobehavioral functioning ) , the time-line follow-back measure ( for alcohol consumption ) , the Penn Craving Scale ( for alcohol ) , the Patient Health Questionnaire-9 item scale ( for depressive symptoms ) , and Beck Anxiety Inventory ( for anxiety ) ."
1,"Other assessment measures the psychomotor vigilance task ( for neurobehavioral functioning ) , the measure ( for alcohol consumption ) , the Penn Alcohol Craving Scale ( for alcohol craving ) , the Patient Health Questionnaire-9 item scale ( for depressive symptoms ) , and the Beck Anxiety Inventory ( for anxiety symptoms ) ."
1,"Other measures included the 10-minute psychomotor vigilance task ( for neurobehavioral functioning ) , the time-line follow-back ( for alcohol consumption ) , the Penn Alcohol Craving Scale ( for alcohol craving ) , the Patient Health Questionnaire-9 scale ( for depressive symptoms ) , and the Beck Anxiety Inventory ( for anxiety ) ."
1,"assessment measures included the 10-minute psychomotor vigilance task ( for neurobehavioral functioning ) , the time-line follow-back measure ( for consumption ) , the Penn Craving Scale ( for alcohol craving ) , the Patient Health Questionnaire-9 scale ( for depressive symptoms ) , and the Beck Anxiety Inventory ( for anxiety symptoms ) ."
0,"In clinical trials with first-generation drug-eluting stents , the complex strategy was not superior to the simple approach ."
0,"In clinical trials with first-generation drug-eluting stents , the complex strategy was not superior the simple approach ."
0,"In clinical trials with first-generation drug-eluting stents , the complex strategy was not superior to simple approach ."
0,"In clinical trials with first-generation stents , the complex strategy was not superior to the simple approach ."
0,"clinical trials with first-generation drug-eluting stents , the complex strategy was not superior to the simple approach ."
0,We evaluated ego-integrity and rumination as mediators and assessed whether the effects of the intervention did not differ across middle-aged and older adults .
0,We evaluated ego-integrity and rumination as and assessed the effects of the intervention did not differ across middle-aged and older adults .
0,We evaluated ego-integrity and rumination as mediators and assessed whether the effects of the did differ across middle-aged and older adults .
0,We evaluated ego-integrity and rumination as mediators and assessed whether the effects of the intervention not differ across middle-aged older adults .
0,We evaluated ego-integrity and rumination as mediators and assessed whether the of the intervention did not differ across and older adults .
1,"Additionally , PSD was applied once per week during the treatment ."
1,"Additionally , PSD was applied once per week the treatment ."
1,"Additionally , PSD was applied once week during the treatment ."
1,"Additionally , PSD was applied per week during the treatment ."
1,"Additionally , PSD was once per week during the treatment ."
0,To examine the influence of spinal fusion on adjacent segment disc space height as an indicator of disc degeneration at LTFU .
0,To examine the influence fusion on adjacent segment disc space height as an indicator of disc degeneration at LTFU .
0,To examine the influence of spinal fusion on adjacent segment disc height as indicator of disc degeneration at LTFU .
0,To examine the influence of spinal fusion segment disc space height as an indicator of disc degeneration at LTFU .
0,To examine the of spinal fusion on adjacent segment disc space height as an indicator disc degeneration at LTFU .
0,The aim of this study is to evaluate whether BMD changes after cessation of ronacaleret treatment .
0,The aim of this study is to evaluate BMD changes after cessation of ronacaleret treatment .
0,The aim of this study is to evaluate whether BMD changes after cessation ronacaleret treatment .
0,The aim of this study is to evaluate whether changes after cessation of ronacaleret treatment .
0,The of this study is to evaluate whether BMD changes after cessation of ronacaleret treatment .
1,Subjects in both arms used either treatment or placebo devices for 20 minutes daily for 4 weeks .
1,Subjects in both arms used either treatment or devices for 20 minutes daily for 4 weeks .
1,Subjects in both arms used either treatment or placebo devices for 20 minutes daily 4 weeks .
1,Subjects in both arms used treatment or placebo devices for 20 minutes daily for 4 weeks .
1,Subjects in both used either treatment or placebo devices for 20 minutes daily for 4 weeks .
0,"The aim of the present study was to evaluate the effect of Erythrinamu lungu on the control of dental anxiety in patients who had under gone bilateral extraction of asymptomatic , impacted mandibular third molars ."
0,"The aim of present study was to evaluate the effect of Erythrinamu lungu on the control of dental anxiety in patients who had gone extraction of asymptomatic , impacted mandibular third molars ."
0,"The aim of the present study was to evaluate the effect lungu on the control of dental anxiety in patients who had under gone extraction of asymptomatic , impacted mandibular third molars ."
0,"The aim of the present study was to evaluate the effect of Erythrinamu lungu the control of dental anxiety in patients who under bilateral extraction of asymptomatic , impacted mandibular third molars ."
0,"The aim the present study was to evaluate the effect of Erythrinamu lungu on the control of dental in patients who had under gone bilateral of asymptomatic , impacted mandibular third molars ."
2,Comparison of participants ' self-reported PA revealed a significant intervention effect for time spent walking in the at-risk sample ( P = .02 ) .
2,Comparison of participants ' self-reported PA revealed a significant intervention for time spent walking the at-risk sample ( P = .02 ) .
2,Comparison of participants ' self-reported revealed a significant intervention effect for time spent walking in at-risk sample ( P = .02 ) .
2,Comparison participants ' self-reported PA revealed a significant intervention effect for time spent walking in the at-risk ( P = .02 ) .
2,of participants ' self-reported revealed a significant intervention effect for time spent walking in the at-risk sample ( P = .02 ) .
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs ( NSAIDs ) reduce pain during and 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory ( NSAIDs ) pain during and 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs ( NSAIDs ) pain and 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs ( NSAIDs ) pain during 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal misoprostol oral nonsteroidal anti-inflammatory drugs ( NSAIDs ) reduce pain during and 30 minutes after ( HSG ) .
2,"The number of cases of moderate or severe acute pancreatitis was similar in the somatostatin ( 2.4 % ) and the placebo ( 3.5 % ) groups ( RR 0.67 , 95 % CI 0.24-1 .85 , P = 0.43 ) ."
2,"The number of cases moderate or severe acute pancreatitis was in the somatostatin ( 2.4 % ) and the placebo ( 3.5 % ) groups ( RR 0.67 , 95 % CI 0.24-1 .85 , P =.43 ) ."
2,"The number of cases moderate or severe pancreatitis was similar in the somatostatin ( 2.4 % ) and the placebo (.5 % ) groups ( RR 0.67 , 95 % CI 0.24-1 .85 , P = 0.43 ) ."
2,"The number of cases of moderate or severe acute pancreatitis was in the somatostatin ( 2.4 % ) and the placebo ( 3.5 % ) groups ( RR 0.67 , % CI 0.24-1 .85 , P = 0. ) ."
2,"The number of of moderate or severe acute pancreatitis was similar in the somatostatin ( 2.4 % ) and the placebo ( 3.5 % ) groups ( RR 0. , 95 % CI 0.24-1 .85 , = 0.43 ) ."
3,"Future investigations will be needed to determine the full effects of the Imagine HEALTH intervention on insulin resistance , stress , and stress biomarkers ."
3,"Future investigations will be needed determine the full effects of the Imagine HEALTH intervention on insulin resistance , stress , and stress ."
3,"Future investigations will be needed to determine the full effects of the Imagine HEALTH intervention on insulin resistance , stress , stress ."
3,"Future investigations will be needed to the full effects of the Imagine HEALTH intervention on resistance , stress , and stress biomarkers ."
3,"investigations will be needed to determine the full effects the Imagine HEALTH intervention on insulin resistance , stress , and stress biomarkers ."
3,The pharmacogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on heavy drinking .
3,The pharmacogenetic also implicate the kainate receptor in the mechanism of topiramate 's effects on heavy drinking .
3,The pharmacogenetic findings also implicate the kainate receptor in the mechanism of 's effects on heavy drinking .
3,The pharmacogenetic findings also implicate the receptor in the mechanism of topiramate 's effects on heavy drinking .
3,pharmacogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on heavy drinking .
1,"Between september 2013 and may 2014 , 60 women with urethral syndrome and trigonitis were incuded in this study ."
1,"Between september 2013 and 2014 , 60 women with urethral syndrome and trigonitis were incuded in this study ."
1,"Between september 2013 and may 2014 , 60 women with syndrome and trigonitis were incuded in this study ."
1,"Between september 2013 and may 2014 , 60 women with urethral syndrome and trigonitis incuded in this study ."
1,"september 2013 and may 2014 , 60 women with urethral syndrome and trigonitis were incuded in this study ."
0,To determine the optimal method for use of the Canine Brief Pain Inventory ( CBPI ) to quantitate responses of dogs with osteoarthritis to treatment with carprofen or placebo .
0,To determine the optimal method for use Canine Brief Pain Inventory ( CBPI ) to quantitate responses of dogs with osteoarthritis to treatment with carprofen or placebo .
0,To determine the optimal method for use of Canine Brief Pain Inventory ( CBPI ) to quantitate responses of dogs with osteoarthritis to treatment with carprofen placebo .
0,To determine the optimal method for use of the Canine Brief Inventory ( CBPI ) to quantitate responses of dogs with osteoarthritis to treatment with carprofen or .
0,To determine the optimal method for use of the Canine Brief Pain Inventory ( ) to quantitate responses of dogs osteoarthritis to treatment with carprofen or placebo .
0,"To determine whether nalmefene combined with psychosocial support is cost-effective compared with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels ( DRLs ) as defined by the WHO , and to evaluate the public health benefit of reducing harmful alcohol-attributable diseases , injuries and deaths ."
0,"To determine whether nalmefene combined with psychosocial support cost-effective compared with alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels ( DRLs ) as defined by the WHO , and to evaluate the public benefit of reducing alcohol-attributable diseases , injuries and deaths ."
0,"To determine whether nalmefene combined with psychosocial support is cost-effective compared psychosocial support for reducing alcohol alcohol-dependent patients with high/very drinking risk levels ( DRLs ) as defined by the WHO , and to evaluate the public health benefit of reducing harmful alcohol-attributable diseases , injuries and deaths ."
0,"To determine whether nalmefene combined with psychosocial support is cost-effective compared with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with/very high drinking risk ( DRLs ) as defined by the WHO , to evaluate the public health benefit reducing harmful alcohol-attributable diseases , injuries deaths ."
0,"determine whether nalmefene with psychosocial support is cost-effective compared with psychosocial support alone for reducing alcohol in alcohol-dependent patients with high/very high drinking risk levels ( DRLs ) as defined by WHO , and to evaluate the public health benefit reducing harmful alcohol-attributable diseases , injuries and deaths ."
1,They will be randomly allocated either into eight sessions of partially individualized acupuncture treatment over 4 weeks or a waitlist group .
1,They will be allocated either into eight sessions of partially individualized treatment over 4 weeks or a waitlist group .
1,They will be randomly allocated either into eight sessions of partially acupuncture treatment over weeks or a waitlist group .
1,They will be randomly allocated either into eight sessions partially individualized acupuncture treatment over 4 weeks or a waitlist .
1,They will be randomly either into eight sessions of partially individualized acupuncture treatment over 4 or a waitlist group .
4,Traditional Chinese medicine ( TCM ) has accumulated some experience in curing stable angina pectoris ( SAP ) and efficacy has been demonstrated .
4,Traditional Chinese ( TCM ) has accumulated some experience in curing stable angina pectoris ( SAP ) and efficacy has been demonstrated .
4,Traditional Chinese medicine ( TCM ) has accumulated some experience in curing angina pectoris ( SAP ) and efficacy has been demonstrated .
4,Traditional Chinese medicine ( TCM ) has accumulated some experience in curing stable angina pectoris ( ) and efficacy has been demonstrated .
4,Traditional Chinese medicine ( TCM ) has accumulated some experience in curing stable angina pectoris ( SAP ) and efficacy has been .
0,Our objectives were to evaluate whether HRQoL in pHPT is associated with vitamin D insufficiency and whether vitamin D supplementation after parathyroidectomy ( PTX ) could improve HRQoL .
0,Our objectives were to evaluate whether HRQoL in pHPT associated with vitamin D insufficiency and whether vitamin D supplementation after ( PTX ) could improve HRQoL .
0,Our objectives were to evaluate whether HRQoL in pHPT associated with vitamin D insufficiency whether vitamin D supplementation after parathyroidectomy ( PTX ) could improve HRQoL .
0,Our objectives were to evaluate whether HRQoL in pHPT is associated with D insufficiency and whether vitamin D supplementation after parathyroidectomy ( PTX ) could improve .
0,Our were evaluate whether HRQoL in pHPT is associated with vitamin D insufficiency and whether vitamin D supplementation after parathyroidectomy ( PTX ) could improve HRQoL .
2,"Respiratory deterioration without suspected infection occurred with 34 % , and no association was identified in 13 % ."
2,"Respiratory deterioration without infection occurred with 34 % , and no association was identified in 13 % ."
2,"Respiratory deterioration without suspected infection occurred with 34 % , and association was identified in 13 % ."
2,"Respiratory deterioration without suspected infection with 34 % , and no association was identified in 13 % ."
2,"Respiratory deterioration without suspected occurred with 34 % , and no association was identified in 13 % ."
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free diet ( GFD ) , yet no approved or proven nondietary treatment is available ."
0,"Recurrent and symptoms are common despite treatment with a gluten-free diet ( GFD ) , yet no approved or proven nondietary treatment available ."
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free ( GFD ) , yet no approved or proven nondietary treatment is ."
0,"Recurrent signs and symptoms are common despite treatment with gluten-free diet ( ) , yet no approved or proven nondietary treatment is available ."
0,"Recurrent signs symptoms are common despite treatment with a gluten-free diet ( GFD ) , yet approved or proven nondietary treatment is available ."
3,"Treatment of active acne with the 1,550-nm erbium glass laser is effective ."
3,"Treatment of active acne the 1,550-nm erbium glass laser is effective ."
3,"Treatment of active acne with the 1,550-nm erbium glass laser effective ."
3,"Treatment of active acne with the 1,550-nm erbium glass laser is ."
3,"Treatment of active acne with the 1,550-nm glass laser is effective ."
2,"Post hoc analyses indicated that there was a significant fall in ERI for patients with the highest baseline ESA resistance dialysed with the VE ( 9.28 [ 7.70-12 .5 ] versus 7.70 [ 5.34-12 .7 ] IU/week/kg / g/dL Hb , P = 0.01 ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.14 [ 4.44-15 .6 ] IU/week/kg / g/dL Hb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Post hoc analyses indicated that there a significant in ERI for patients with the highest baseline ESA resistance dialysed with VE ( 9.28 [ 7.70-12 .5 ] 7.70 [ 5.34-12 .7 ] IU/week/kg / g/ Hb , = 0.01 ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.14 [ 4.44-15 .6 ] IU/week/kg / g/dL , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Post hoc analyses indicated that there was a fall in ERI for patients with the highest baseline ESA resistance dialysed with the VE ( 9.28 [ 7.70-12 .5 ] versus 7.70 [ 5. .7 ] IU//kg / g/dL Hb , P = 0.01 ) but not control membranes ( 9.45 [ 7.62-12 . ] versus 8.14 [ 4.44-15 . ] IU/week/kg / g/ Hb , P = 0.41 ) ; this was not attributable to changes in CRP levels ."
2,"Post hoc analyses indicated that there was a significant fall ERI for patients with the highest baseline resistance dialysed with the VE ( 9.28 [ 7.70-12 . ] versus 7.70 [ 5.34-12 .7 ] IU/week/kg / g/dL Hb , P = 0. ) not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.14 [ 4.44-15 .6 ] IU/week/kg / g/dL Hb , P =. ) ; this was not attributable to changes in CRP levels ."
2,"hoc analyses indicated there was a significant fall in ERI for patients with the highest baseline ESA resistance dialysed with the VE ( 9. [ 7. .5 ] versus 7.70 [ 5.34-12 . ] IU/week/ / g/dL Hb , P = 0.01 ) but not the control membranes ( 9.45 [ 7.62-12 .3 ] versus 8.14 [ 4.44-15 .6 ] IU/week/kg / g/dL Hb , P = 0.41 ) ; this was not attributable to in CRP levels ."
0,We evaluated the efficacy of high advanced-collagen tripeptide ( HACP ) on wound healing and skin recovery .
0,We evaluated efficacy of high advanced-collagen tripeptide ( HACP ) on wound healing and skin recovery .
0,We evaluated the efficacy high advanced-collagen tripeptide ( HACP ) on wound healing and skin recovery .
0,We evaluated the efficacy of high advanced-collagen tripeptide ( HACP ) on healing and skin recovery .
0,evaluated the efficacy of high advanced-collagen tripeptide ( HACP ) on wound healing and skin recovery .
3,Instructor feedback during proficiency-based laparoscopic simulator training does not affect the long-term retention of skills .
3,Instructor during proficiency-based laparoscopic simulator training does not affect the long-term retention of skills .
3,Instructor feedback during proficiency-based laparoscopic simulator training does not affect the long-term of skills .
3,Instructor feedback during proficiency-based laparoscopic simulator training does not affect the long-term retention of .
3,Instructor feedback during proficiency-based laparoscopic simulator training does not the long-term retention of skills .
0,This prospective multicenter study examined whether elevated fecal calprotec tin ( FC ) concentrations after stopping TNF-blocking therapy can predict clinical or endoscopic relapse .
0,This prospective multicenter study examined whether elevated calprotec tin ( FC ) concentrations after stopping TNF-blocking therapy can predict clinical or endoscopic .
0,This prospective multicenter study examined whether elevated calprotec tin ( FC ) concentrations stopping TNF-blocking therapy can predict clinical or endoscopic relapse .
0,This prospective multicenter study examined whether elevated fecal tin ( FC ) concentrations after stopping therapy can predict clinical or endoscopic relapse .
0,This prospective multicenter study whether elevated fecal calprotec tin ( FC ) concentrations after stopping TNF-blocking therapy can predict clinical or endoscopic .
2,None of the patients in GII showed any significant improvement .
2,None of the in GII showed any significant improvement .
2,None of the patients in GII showed any improvement .
2,None of the patients in showed any significant improvement .
2,of the patients in GII showed any significant improvement .
1,"Pretreatment/posttreatment a fetus protein and Karnofsky Performance Status values , change of tumor according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival time were analyzed ."
1,"Pretreatment/posttreatment a fetus Karnofsky Performance Status values , change of tumor according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and the survival time were analyzed ."
1,"Pretreatment/posttreatment a fetus protein and Karnofsky Performance Status values , change of according to Response Evaluation Criteria in Solid Tumors ( RECIST ) , and survival time were analyzed ."
1,"Pretreatment/posttreatment a fetus protein and Karnofsky Performance Status values , change of tumor according to Response Evaluation Criteria in Tumors ( ) , and the survival time were analyzed ."
1,"Pretreatment/posttreatment a fetus protein and Karnofsky Performance Status values , change of tumor to Response Criteria in Solid Tumors ( RECIST ) , and the survival time were analyzed ."
1,"Comparison of coronary blood flow , ST-segment resolution ( STR ) , duration of hospital stay , 30-day major adverse cardiac events ( MACE ) and complications such as hemorrhage was conducted ."
1,"Comparison of coronary blood , ST-segment ( STR ) , duration of hospital stay , 30-day major adverse cardiac events ( MACE ) and complications such as hemorrhage was conducted ."
1,"Comparison of coronary blood flow , ST-segment resolution ( ) , duration of hospital stay , 30-day major adverse cardiac ( MACE ) and complications such as hemorrhage was conducted ."
1,"Comparison of coronary blood flow , ST-segment resolution ( STR ) , duration of stay , 30-day major adverse cardiac ( MACE ) and complications such as hemorrhage was conducted ."
1,"Comparison of coronary blood flow , resolution ( STR ) , duration of hospital stay , 30-day major adverse cardiac events ( MACE ) and such as hemorrhage was conducted ."
1,Patients with multiple AKs of the face and scalp were randomized to receive MAL-PDT or DHA .
1,Patients multiple AKs of the face and scalp were randomized to receive MAL-PDT or DHA .
1,Patients with multiple AKs of the face and scalp randomized to receive MAL-PDT or DHA .
1,Patients with multiple AKs of the face and scalp were randomized receive MAL-PDT or DHA .
1,Patients with multiple AKs of the face and scalp were randomized to receive MAL-PDT DHA .
2,"The trough inhibition of cholesteryl ester transfer protein ( CETP ) activity was 65 and 84 % at 100 and 300mg , respectively ."
2,"The trough inhibition of cholesteryl ester protein ( CETP ) activity was 65 and 84 % at 100 and 300mg , respectively ."
2,"The trough inhibition of cholesteryl ester transfer protein ( CETP ) activity was 65 84 % at 100 and 300mg , respectively ."
2,"The trough inhibition of cholesteryl ester transfer protein ( CETP ) activity was 65 and % at 100 and 300mg , respectively ."
2,"The trough of cholesteryl ester transfer protein ( CETP ) activity was 65 and 84 % at 100 and 300mg , respectively ."
4,"Most patients in whom recurrent cervical cancer develops have previously received cisplatin with radiation therapy , which reduces the effectiveness of cisplatin at the time of recurrence ."
4,"Most in whom recurrent cervical cancer develops have previously received cisplatin with radiation therapy , which reduces the effectiveness of cisplatin at time of recurrence ."
4,"Most patients in whom recurrent cancer develops have received cisplatin with radiation therapy , which reduces the effectiveness of cisplatin at the time of recurrence ."
4,"Most patients in whom recurrent cervical cancer develops have previously received cisplatin radiation therapy , which reduces the effectiveness of cisplatin at the time recurrence ."
4,"Most patients in whom recurrent cervical cancer develops have previously received cisplatin with radiation , which reduces the effectiveness of cisplatin at the time recurrence ."
2,"Subcutaneous fat mass ( -1,553 [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral fat mass ( -206 [ -783 , 371 ] cm ( 3 ) vs -241 [ -856 , 373 ] cm ( 3 ) , respectively ) and muscle fat content ( -0.09 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -0.10 % , 0.05 % ] , respectively ) decreased similarly ."
2,"Subcutaneous fat mass ( -1, [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , ) visceral fat mass ( -206 [ -783 , 371 ] cm ( 3 ) vs -241 [ -856 , 373 ] ( 3 ) , respectively ) muscle content ( -0.09 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -0.10 % , 0.05 % ] , respectively ) decreased similarly ."
2,"Subcutaneous fat mass ( -1,553 [ -2,767 , -340 ] cm ( 3 ) -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) fat mass ( - [ -783 , 371 ] cm ( 3 ) vs -241 [ -856 , 373 ] cm ( 3 ) , respectively ) and fat content ( -.09 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -0.10 % , 0.05 % ] , respectively ) decreased similarly ."
2,"Subcutaneous mass ( -1,553 [ -2,767 , -340 ] cm ( 3 ) -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral fat mass ( -206 [ -783 , 371 ] ( 3 ) vs -241 [ -856 , 373 ] ( 3 ) , respectively ) and muscle fat content ( -0.09 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -.10 % , 0.05 % ] , respectively ) decreased similarly ."
2,"mass ( -1,553 [ -2,767 , -340 ] cm ( 3 ) vs -751 [ -2,047 ; 546 ] cm ( 3 ) , respectively ) visceral mass ( -206 [ -783 , 371 ] cm ( 3 ) vs - [ -856 , 373 ] cm ( 3 ) , ) and muscle fat content ( -0.09 % [ -0.16 % , -0.02 % ] vs -0.02 % [ -0.10 % , 0.05 % ] , respectively ) decreased similarly ."
0,To explore perceptions of spinal manipulative therapy and exercise among adults aged 65 years and older with chronic neck pain .
0,To explore of spinal manipulative therapy and exercise among adults aged 65 years older with chronic neck pain .
0,To explore perceptions of spinal manipulative therapy and among adults 65 years and older with chronic neck pain .
0,To explore perceptions of spinal therapy and exercise among adults 65 years and older with chronic neck pain .
0,To explore perceptions spinal manipulative therapy and exercise among aged 65 years and older with chronic neck pain .
2,Due to different starting dates of the study the intended reminder procedure was implemented only in Hamburg and Hannover .
2,Due different starting dates of the study the intended reminder procedure was implemented only in Hamburg and Hannover .
2,Due to different starting dates of the study the intended reminder procedure was implemented in Hamburg and Hannover .
2,Due to different starting dates of the study the intended reminder procedure was only in Hamburg and Hannover .
2,Due to starting dates of the study the intended reminder procedure was implemented only in Hamburg and Hannover .
3,"ICS discontinuation after 30 months in COPD can worsen lung function decline , AHR , and QOL during 5-year follow-up ."
3,"ICS discontinuation after 30 months in COPD can lung function decline , AHR , and QOL during 5-year follow-up ."
3,"ICS discontinuation after 30 months in COPD can worsen lung function decline , AHR , and QOL 5-year follow-up ."
3,"ICS discontinuation after 30 months in COPD can worsen lung function decline , AHR , and QOL during follow-up ."
3,"ICS discontinuation after 30 months in COPD can worsen lung function decline , AHR , and during 5-year follow-up ."
4,Date 22nd July 2011 .
4,22nd July 2011 .
4,Date 22nd 2011 .
4,Date 22nd July .
4,Date July 2011 .
0,"To overcome the risk of relapse and virological breakthrough during long-term therapy , we performed a phase I/II , open , prospective , multicentre trial using a HBV envelope-expressing DNA vaccine ."
0,"To overcome risk of relapse and virological breakthrough during long-term therapy , we performed a phase I/II , open , prospective , multicentre trial using HBV envelope-expressing DNA vaccine ."
0,"To overcome the risk of relapse and virological breakthrough during long-term therapy , performed a phase I/II , open , , multicentre trial using a HBV envelope-expressing DNA vaccine ."
0,"To overcome the risk of relapse and virological breakthrough during long-term therapy , we performed phase I/II , open , prospective , multicentre using a HBV envelope-expressing DNA vaccine ."
0,"To overcome the risk of relapse virological breakthrough during long-term therapy , we performed a phase I/II , open , prospective , multicentre trial using a HBV envelope-expressing DNA ."
0,The aims of the study were to assess the efficacy of a multicomponent intervention and evaluate the feasibility and user acceptance of an internet-based home telemedical surveillance system for the evaluation of pain and other key health outcomes in patients with fibromyalgia ( FM ) .
0,The aims of the study were assess the efficacy of a multicomponent and evaluate the and user acceptance of an internet-based home telemedical surveillance system for the evaluation pain and other key health outcomes in patients with fibromyalgia ( FM ) .
0,The aims of the study were to assess the efficacy of a multicomponent intervention and evaluate feasibility and user acceptance of an internet-based home telemedical surveillance system for the evaluation of and other key health patients with fibromyalgia ( FM ) .
0,The aims of the study were to the of a multicomponent and evaluate the feasibility and user acceptance of an internet-based home telemedical surveillance system for the evaluation pain and other key health outcomes in patients with fibromyalgia ( FM ) .
0,The of the study were to assess the efficacy of a and evaluate the feasibility and user acceptance of an internet-based home telemedical surveillance system for the of pain and other key health outcomes in patients with fibromyalgia ( FM ) .
4,Little is known about the impact of coronary calcification on outcomes after PCI for patients presenting with non-ST-segment elevation and ST-segment elevation ACS .
4,Little is known about the impact of coronary calcification on after PCI for patients presenting non-ST-segment elevation and ST-segment elevation ACS .
4,Little is known the impact of coronary calcification on outcomes after PCI patients presenting with non-ST-segment elevation and ST-segment elevation ACS .
4,is known about the impact of calcification on outcomes after PCI for patients presenting with non-ST-segment elevation and ST-segment elevation ACS .
4,is known about the impact of coronary calcification on outcomes after PCI for patients presenting with non-ST-segment and ST-segment elevation ACS .
4,Comparing individuals with SIS to those without shoulder pathology may provide information on the effects of TSM specifically in those with SIS .
4,Comparing individuals with SIS those without shoulder pathology may provide information on the effects of specifically in those with SIS .
4,Comparing individuals with SIS to those shoulder pathology may provide information on the of TSM specifically in those with SIS .
4,Comparing individuals with SIS to those without shoulder pathology may provide information on the of TSM specifically in those SIS .
4,Comparing with SIS to those without shoulder pathology may provide information on the effects of TSM in those with SIS .
1,Skin was assessed for pressure ulcers .
1,Skin assessed for pressure ulcers .
1,Skin was assessed for ulcers .
1,Skin was for pressure ulcers .
1,was assessed for pressure ulcers .
1,Both eyes were treated with topical anesthesia .
1,Both eyes treated with topical anesthesia .
1,Both eyes were treated topical anesthesia .
1,Both eyes were with topical anesthesia .
1,Both were treated with topical anesthesia .
4,"To actually change physicians ' practice , a tailored strategy aimed at barriers that hinder physicians in abandoning the use of erythropoietin and perioperative blood salvage was systematically developed ."
4,"To actually change physicians ' practice , a tailored aimed at barriers that hinder physicians in abandoning the use of erythropoietin and perioperative salvage was systematically developed ."
4,"To actually change physicians ' practice , a tailored strategy aimed at barriers that hinder physicians abandoning the use erythropoietin and perioperative blood salvage was systematically developed ."
4,"To actually change physicians ' practice , a tailored strategy at barriers that hinder physicians in abandoning the use of erythropoietin and perioperative blood salvage was developed ."
4,"actually change physicians ' practice , a tailored strategy aimed at barriers that hinder physicians in abandoning the use erythropoietin and perioperative blood salvage was systematically developed ."
4,Calcium intake during growth is essential for future bone health but varies widely between individuals and populations .
4,Calcium intake during growth essential for future bone health but varies widely between individuals and populations .
4,Calcium intake during growth is essential for bone health but varies widely between individuals and populations .
4,Calcium intake during growth is essential for future bone health but varies widely between and populations .
4,Calcium intake during growth is for future bone health but varies widely between individuals and populations .
0,Prior longitudinal descriptive research has shown that there are distinct trajectories of PTSD symptoms over time in trauma survivors .
0,Prior descriptive research has shown that there are distinct trajectories of PTSD symptoms over time in trauma survivors .
0,Prior longitudinal descriptive research has shown that there are distinct trajectories of PTSD symptoms over time in survivors .
0,Prior longitudinal descriptive research has shown that there are distinct trajectories of PTSD symptoms over time in trauma .
0,Prior longitudinal descriptive research has shown that there are distinct trajectories of PTSD symptoms time in trauma survivors .
0,The aim of the study was to assess the effects of three different testosterone formulations on body weight and composition and metabolic and bone parameters .
0,The aim of the study to assess the effects of three different testosterone formulations on body weight and composition metabolic and bone parameters .
0,The aim of the study was to assess the effects of different testosterone formulations on weight and composition and metabolic and bone parameters .
0,The aim of the study was to assess the effects of different testosterone on body weight and composition and metabolic and bone parameters .
0,The aim of the study was to assess the effects three different testosterone formulations body weight and composition and metabolic and bone parameters .
2,The HRQOL evaluation showed no statistical difference between groups with and without CNI at any interval .
2,The HRQOL evaluation showed no statistical difference between groups with and without CNI any interval .
2,The HRQOL evaluation showed no statistical difference between groups with and without at any interval .
2,The HRQOL evaluation showed no statistical difference groups with and without CNI at any interval .
2,The HRQOL evaluation showed statistical difference between groups with and without CNI at any interval .
1,Blood samples were taken before and after B-TURP for serum chemistry evaluation .
1,Blood samples were taken and after B-TURP for serum chemistry evaluation .
1,Blood samples were taken before and after B-TURP for serum chemistry .
1,Blood samples were taken before and after B-TURP serum chemistry evaluation .
1,Blood samples were taken before and after for serum chemistry evaluation .
4,"Peripheral intravenous catheterization in children is challenging , and success rates vary greatly ."
4,"Peripheral catheterization in children is challenging , and success rates vary greatly ."
4,"Peripheral intravenous catheterization in children challenging , and success rates vary greatly ."
4,"Peripheral intravenous catheterization in children is , and success rates vary greatly ."
4,"Peripheral intravenous catheterization in children is challenging , and success rates vary ."
3,"Reduced fat mass may place the intervention group at a lower risk of obesity-linked sequelae , a hypothesis that can be tested by future studies of this cohort ."
3,"Reduced fat mass may place the intervention group at a lower risk obesity-linked sequelae , a hypothesis that can be tested future studies of this cohort ."
3,"Reduced fat mass may place the intervention group at a lower risk of obesity-linked , a hypothesis can be tested by future studies of this cohort ."
3,"Reduced fat mass may place the intervention group at a lower risk of sequelae , a hypothesis that can be tested by future studies of this ."
3,"Reduced fat mass may place the intervention group at a risk of obesity-linked sequelae , a hypothesis that can be tested by future studies of this ."
0,This includes the antifungal fluconazole .
0,This includes antifungal fluconazole .
0,This includes the antifungal .
0,This includes the fluconazole .
0,This the antifungal fluconazole .
2,The conversion rate from laparoscopic to open surgery was 9 % .
2,The conversion from laparoscopic to open surgery was 9 % .
2,The conversion rate from laparoscopic open surgery was 9 % .
2,The conversion rate from to open surgery was 9 % .
2,The conversion rate laparoscopic to open surgery was 9 % .
2,"SVR12 rates were 52.8 % ( SMV12 ) and 35.8 % ( SMV24 ) for prior non-responders , and 95.9 % for prior relapsers ( SMV12 ; p 0.0001 vs null hypothesis , respectively ) ."
2,"SVR12 rates were 52. % ( SMV12 ) and 35. % ( SMV24 ) for prior non-responders , and 95.9 % for prior relapsers ( SMV12 ; p 0.0001 vs null hypothesis , respectively ) ."
2,"SVR12 rates were 52.8 % ( ) and 35.8 % ( ) for prior non-responders , and 95.9 % for prior relapsers ( SMV12 ; p 0.0001 vs null hypothesis , respectively ) ."
2,"SVR12 rates were 52.8 % ( ) and 35.8 % ( SMV24 ) for prior non-responders , 95.9 % for prior relapsers ( SMV12 ; p 0.0001 vs null hypothesis , respectively ) ."
2,"SVR12 rates were 52.8 % ( SMV12 ) and 35.8 % ( SMV24 ) for prior non-responders , 95.9 % for prior relapsers ( SMV12 ; 0.0001 vs null hypothesis , respectively ) ."
0,"In this double-blind randomized placebo controlled parallel-group trial , we investigated the effects of sodium nitrite administered immediately prior to reperfusion in patients with acute ST-elevation myocardial infarction ( STEMI ) ."
0,"In this double-blind randomized placebo controlled parallel-group trial , we investigated the effects of sodium administered immediately to reperfusion in patients with acute ST-elevation myocardial infarction ( STEMI ) ."
0,"In this double-blind randomized placebo controlled parallel-group trial , we investigated the effects of sodium nitrite administered immediately prior to reperfusion in patients acute ST-elevation myocardial ( STEMI ) ."
0,"In this double-blind randomized placebo controlled parallel-group trial , we investigated the effects of sodium nitrite administered immediately prior to reperfusion in patients with myocardial infarction ( STEMI ) ."
0,"In this randomized placebo controlled parallel-group trial , we investigated the effects sodium nitrite administered immediately prior to reperfusion in patients with acute ST-elevation myocardial infarction ( STEMI ) ."
3,We suggest that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancer .
3,We suggest that one definitive local treatment combined with neoadjuvant chemotherapy is adequate to treat resectable IIIA/N2 non-small-cell lung cancer .
3,We suggest that one definitive local treatment modality with neoadjuvant chemotherapy is adequate to treat resectable stage/N2 non-small-cell lung cancer .
3,We suggest that one definitive local treatment with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancer .
3,We that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to resectable stage IIIA/N2 non-small-cell lung cancer .
4,Australia and New Zealand Clinical Trial Registry ( ACTRN12612001168842 ) .
4,Australia New Zealand Clinical Trial Registry ( ACTRN12612001168842 ) .
4,Australia and New Clinical Trial Registry ( ACTRN12612001168842 ) .
4,Australia and New Zealand Clinical Trial ( ACTRN12612001168842 ) .
4,and New Zealand Clinical Trial Registry ( ACTRN12612001168842 ) .
3,"Trial design , protocol specification , training , and continuous supervision led to a high degree of treatment fidelity for the counseling interventions in this randomized clinical trial and will increase confidence in the interpretation of the trial findings ."
3,"Trial design , protocol specification , training , and continuous supervision led to a high degree of treatment fidelity for the interventions in this randomized clinical trial will increase confidence the interpretation of the trial findings ."
3,"Trial design , protocol specification , training , and continuous supervision led to a high degree of treatment for counseling interventions in this randomized clinical and will increase confidence in the interpretation of the trial findings ."
3,"Trial design , specification , training , and continuous supervision led to a high degree of treatment fidelity for the counseling interventions in this randomized clinical trial will increase confidence in the interpretation of the findings ."
3,"Trial design , specification , training , and continuous supervision to a high degree of treatment fidelity for the counseling interventions in this randomized clinical trial and will increase confidence in the of the trial findings ."
2,Both subgroups showed significant reductions in PLT transfusions with a no-prophylaxis strategy .
2,Both subgroups showed reductions in PLT transfusions with a no-prophylaxis strategy .
2,Both subgroups showed significant reductions in PLT transfusions with a strategy .
2,Both subgroups showed significant reductions in PLT transfusions with no-prophylaxis strategy .
2,Both subgroups showed significant reductions in transfusions with a no-prophylaxis strategy .
4,We investigated the impact of different group sizes on the outcome of resuscitation training .
4,We investigated impact of different group sizes on the outcome of resuscitation training .
4,We investigated the impact different group sizes on the outcome of resuscitation training .
4,We investigated the impact of different group sizes on outcome of resuscitation training .
4,We investigated the impact of different sizes on the outcome of resuscitation training .
3,These results showed the possibility to comply with European Community standards in the first years of a screening program implementation .
3,These results showed the possibility to comply European Community standards in the years of a screening program implementation .
3,These results showed the possibility to comply with Community standards in the first years of a program implementation .
3,These results showed the possibility to comply with European Community in first years of a screening program implementation .
3,These results showed the possibility to comply with European Community standards the first years of a screening program .
2,"In total , 101 patients ( 78 % ) completed questionnaires ."
2,"In , 101 patients ( 78 % ) completed questionnaires ."
2,"In total , 101 patients ( 78 % ) completed ."
2,"In total , 101 patients ( 78 % ) questionnaires ."
2,"total , 101 patients ( 78 % ) completed questionnaires ."
3,"The rates of infection , rash , and abnormalities on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
3,"The of infection , rash , and abnormalities on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
3,"The rates infection , rash , and abnormalities on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
3,"The rates of infection , rash , and abnormalities on liver-function testing were higher with daclizumab than with interferon beta-1a ."
3,"rates of infection , rash , and abnormalities on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered on 15 July 2014 ."
4,"UMIN000014559 , UMIN Clinical Registry , registered on 15 July 2014 ."
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered 15 July 2014 ."
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered on 15 2014 ."
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered on July 2014 ."
2,PI3K/Akt inhibition eliminated the protective effects of exercise training and quercetin treatment .
2,PI3K/ inhibition eliminated the protective effects of exercise training and quercetin treatment .
2,PI3K/Akt inhibition eliminated the protective effects of exercise training and quercetin .
2,PI3K/Akt inhibition eliminated the protective effects of exercise training quercetin treatment .
2,PI3K/Akt inhibition eliminated the protective effects of training and quercetin treatment .
2,Primary outcome data were available for 1308 ( 96 % ) children .
2,Primary outcome data were available 1308 ( 96 % ) children .
2,Primary outcome data were available for ( 96 % ) children .
2,Primary outcome data were available for 1308 ( % ) children .
2,outcome data were available for 1308 ( 96 % ) children .
2,Mean age was 347.6 .
2,Mean age was 347. .
2,Mean age was.6 .
2,Mean was 347.6 .
2,age was 347.6 .
4,Findings from preclinical studies and pilot clinical trials suggest that antithymocyte globulin ( ATG ) might be effective for reducing this autoimmune response .
4,Findings from preclinical studies and pilot clinical trials suggest that antithymocyte globulin ( ATG ) might be effective for reducing response .
4,Findings from preclinical studies and pilot clinical trials suggest that antithymocyte globulin ( ATG ) might effective for this autoimmune response .
4,Findings from preclinical studies and pilot clinical trials suggest that globulin ( ATG ) might be effective reducing this autoimmune response .
4,Findings from studies and pilot clinical trials suggest that antithymocyte globulin ( ATG ) might be effective for reducing this autoimmune .
2,"While the majority of values for IL-1 , granulocyte-macrophage colony-stimulating factor , and tumor necrosis factor fell below the limit of quantification , univariate analysis demonstrated higher plasma levels of IL-6 and IL-8 in nonsurvivors on Day 7 ."
2,"While the majority of values for , granulocyte-macrophage colony-stimulating factor , and tumor necrosis factor fell below the limit of , univariate analysis demonstrated higher plasma levels of IL-6 and IL-8 nonsurvivors on Day 7 ."
2,"While the majority of values for IL-1 , colony-stimulating factor , and tumor necrosis factor fell below the limit of quantification , univariate analysis demonstrated higher plasma of IL-6 and IL-8 nonsurvivors on Day 7 ."
2,"While the majority values for IL-1 , granulocyte-macrophage colony-stimulating , and tumor necrosis factor fell below the limit of quantification , univariate analysis higher plasma levels of IL-6 and IL-8 in nonsurvivors on Day 7 ."
2,"While the of values for IL-1 , granulocyte-macrophage colony-stimulating factor , and tumor factor fell below the limit of quantification , univariate analysis demonstrated higher plasma levels of and IL-8 in nonsurvivors on Day 7 ."
3,"The integrated Chinese and western medicine of acupuncture , HBO and cognitive rehabilitation training is safe and effective in the treatment of cognitive impairment in earthquake brain injury ."
3,"The integrated Chinese and western medicine of acupuncture , HBO and cognitive rehabilitation training is and effective in the treatment cognitive impairment in earthquake brain injury ."
3,"The integrated Chinese and western medicine of acupuncture , HBO and cognitive rehabilitation training is and effective in the treatment of impairment in earthquake brain injury ."
3,"The integrated Chinese and western medicine of acupuncture , HBO and rehabilitation training is safe and effective in treatment of cognitive impairment in earthquake brain injury ."
3,"The integrated and western medicine of acupuncture , HBO and cognitive rehabilitation training is safe and effective in the treatment of cognitive impairment in brain injury ."
1,Participants will receive treatment for 28 days .
1,Participants receive treatment for 28 days .
1,Participants will receive treatment 28 days .
1,Participants will receive treatment for 28 .
1,will receive treatment for 28 days .
0,To demonstrate improved pulmonary function when postoperative analgesia was provided by combined bupivacaine wound infiltration and systemic opioid .
0,To demonstrate improved pulmonary function when postoperative analgesia provided by combined bupivacaine wound infiltration and systemic opioid .
0,To demonstrate improved pulmonary function when postoperative analgesia was provided by combined bupivacaine wound infiltration and systemic .
0,To demonstrate improved pulmonary function when postoperative analgesia was provided by combined wound infiltration and systemic opioid .
0,To demonstrate improved pulmonary function when postoperative analgesia was provided combined bupivacaine wound infiltration and systemic opioid .
0,We investigated the association of baseline circulating levels of TF with stroke events occurred in the European Prospective Investigation into Cancer and Nutrition-Italy cohort .
0,We investigated association of baseline circulating levels of TF with stroke occurred in the European Prospective Investigation into Cancer and Nutrition-Italy cohort .
0,We investigated the association baseline levels of TF with stroke events occurred in the European Prospective Investigation into Cancer and Nutrition-Italy cohort .
0,We investigated the association of circulating levels of TF with stroke events occurred in the European Investigation into Cancer and Nutrition-Italy cohort .
0,investigated the association baseline circulating levels of TF with stroke events occurred in the European Prospective Investigation into Cancer and Nutrition-Italy cohort .
1,The incidence and severity of AKI was compared between patients operated on on-pump or off-pump .
1,The incidence and severity of AKI was between patients operated on on-pump or off-pump .
1,The incidence and severity of AKI was compared between operated on on-pump or off-pump .
1,The incidence and severity of AKI was compared between patients operated on on-pump or .
1,The incidence and severity of AKI was compared patients operated on on-pump or off-pump .
3,These effects do not appear to explain the glucose-lowering effect of rosiglitazone .
3,These do not appear to explain the glucose-lowering effect of rosiglitazone .
3,These effects do not appear to explain the effect of rosiglitazone .
3,These effects do not appear to explain the glucose-lowering effect rosiglitazone .
3,These effects do not appear to the glucose-lowering effect of rosiglitazone .
4,"`` Practice effects '' ( PE ) , or performance improvements due to prior exposure to testing , are known to confound cognitive test results , particularly when short intervals occur between two test sessions ."
4,"`` '' ( PE ) , or performance improvements due to prior exposure to testing , are known to confound cognitive test results , particularly when short intervals occur between two test sessions ."
4,"`` Practice effects '' ( PE ) , or performance improvements due to exposure to testing , are known to confound cognitive test results , particularly when short intervals occur between two test ."
4,"`` Practice effects '' ( PE ) , or performance improvements due to prior exposure to , are known to confound cognitive test results , particularly when short intervals occur two test sessions ."
4,"`` Practice effects '' ( PE ) , or performance improvements due to prior to testing , known to confound cognitive test results , particularly when short intervals occur between two test sessions ."
0,"Widening socioeconomic disparities in mortality in the United States are largely explained by slower declines in tobacco use among smokers of low socioeconomic status ( SES ) than among those of higher SES , which points to the need for targeted tobacco cessation interventions ."
0,"Widening socioeconomic disparities in mortality in the United States are largely explained by slower declines in tobacco among smokers of socioeconomic status ( SES ) than among those of higher SES , which points to need for targeted tobacco cessation ."
0,"Widening socioeconomic disparities in mortality in the United States are largely explained by slower declines in tobacco use smokers of socioeconomic status ( SES ) than among those of higher SES , which points to the need for cessation interventions ."
0,"Widening socioeconomic disparities mortality in the United States are explained by slower declines in tobacco use among smokers of low socioeconomic status ( SES ) than among those of SES , which points the need for targeted tobacco cessation interventions ."
0,"Widening socioeconomic disparities mortality in the United States are largely explained by slower declines in tobacco use among smokers of low socioeconomic status ( SES ) than among those of higher SES , which to the need targeted tobacco interventions ."
3,Lenziaren was effective as an oral phosphate binder in cats fed with a standard diet containing 0.2 % phosphorus .
3,Lenziaren was effective as an oral binder in cats fed with a standard diet containing 0.2 % phosphorus .
3,Lenziaren was effective as an oral phosphate binder in cats fed with a standard containing 0.2 % phosphorus .
3,Lenziaren was effective as an oral phosphate binder in cats fed with standard diet containing 0.2 % phosphorus .
3,Lenziaren was effective as an phosphate binder in cats fed with a standard diet containing 0.2 % phosphorus .
1,"Participants consisted of 101 patients , aged 20-76 years ( mean age 48 years ) , 49 men and 52 women , with burns that covered more than 20 % of the body ."
1,"Participants consisted 101 patients , 20-76 years ( mean age 48 years ) , 49 men and 52 women , with burns that covered more than 20 % of the body ."
1,"Participants consisted of 101 patients , 20-76 ( mean age 48 years ) , 49 men and 52 women , with burns that covered more than 20 % of the body ."
1,"Participants consisted of 101 patients , 20-76 years ( mean age 48 years ) , 49 men and 52 women , burns that covered more than 20 % of the body ."
1,"Participants consisted of 101 patients , aged 20-76 years ( mean 48 years ) , 49 men and 52 women , with burns that covered than 20 % of the body ."
3,"The findings will be of interest to programme implementers , policy makers and evaluation researchers working in the development , education , and sexual and reproductive health fields ."
3,"The findings will be interest to programme implementers , policy makers and evaluation researchers working in the development , education , and and reproductive health fields ."
3,"The findings will be interest to programme implementers , policy makers and evaluation researchers working in the development , education , and sexual and reproductive health ."
3,"The findings will be of interest to programme implementers , policy makers and evaluation researchers in the development , education , and sexual and reproductive fields ."
3,"The findings will be of interest to programme implementers , policy makers and evaluation working in the , education , and sexual and reproductive health fields ."
0,"To determine whether a point-of-care molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid HIV RNA polymerase chain reaction ( Rapid PCR ) and compared patient outcomes with an optimized standard care that included assessment with the World Health Organization clinical algorithm for HIV infection plus a DNA PCR with a turnaround time of several weeks ( standard care ) ."
0,"To determine whether a molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid HIV RNA polymerase chain reaction ( Rapid PCR ) and patient outcomes with an optimized standard that included assessment with World Health Organization clinical algorithm for HIV infection plus a PCR with a turnaround time of weeks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid HIV RNA polymerase chain reaction ( Rapid PCR ) and compared patient outcomes an optimized standard care that assessment with the World Health Organization clinical for HIV infection plus a DNA PCR with a turnaround several weeks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid polymerase chain reaction ( Rapid PCR ) and compared patient outcomes an optimized standard care that included assessment with the World Health Organization clinical algorithm for HIV infection a DNA PCR with a turnaround time several weeks ( standard care ) ."
0,"To determine whether a point-of-care molecular HIV test ART access for hospitalized Malawian infants , we simulated a point-of-care test using HIV RNA polymerase chain reaction ( Rapid PCR ) and compared outcomes with an optimized standard care that included assessment with the World Health Organization algorithm for HIV infection plus a PCR with a turnaround time of several weeks ( care ) ."
2,The reduction of HbA1c was significantly greater in the repaglinide group ( P < 0.01 ) .
2,The reduction of HbA1c was significantly greater in the group ( P < 0.01 ) .
2,The reduction of HbA1c was significantly greater in the repaglinide group ( < 0.01 ) .
2,The reduction of HbA1c was significantly greater in the repaglinide group ( P <.01 ) .
2,The reduction of HbA1c was significantly in the repaglinide group ( P < 0.01 ) .
4,"However , users experience fatigue due to exposure to flickering stimuli ."
4,", users experience fatigue due to exposure to flickering stimuli ."
4,"However , users experience due to exposure to flickering stimuli ."
4,"However , users experience fatigue due exposure to flickering stimuli ."
4,"However , users experience fatigue due to exposure to flickering ."
1,Patients in the trial group received clean liquid integral protein diet for 3 days before operation without mechanical bowel preparation .
1,Patients in the trial group clean liquid integral protein for 3 days before operation without mechanical bowel preparation .
1,Patients in the trial group received clean integral protein diet for days before operation without mechanical bowel preparation .
1,Patients in the trial group received clean liquid integral protein for 3 days before operation without mechanical bowel .
1,in the trial group received clean integral protein diet for 3 days before operation without mechanical bowel preparation .
2,"The FSSG score ( mean SD at 0 , 4 , and 8 weeks ) in both the RKT ( 16.0 7.0 ; 9.9 8.4 ; 7.0 6.4 ) and PL ( 15.1 6.4 ; 10.9 6.7 , 11.1 8.5 ) groups significantly decreased after treatment ."
2,"The FSSG score ( mean SD at 0 , 4 , and 8 weeks ) in both RKT ( 16. 7.0 ; 9.9 8.4 ; 7.0 6.4 ) and PL ( 15.1 6.4 ; 10.9. , 11.1 8.5 ) groups significantly decreased after treatment ."
2,"The FSSG score ( mean SD at 0 , 4 , and 8 weeks ) in both RKT (.0 7.0 ; 9.9 8.4 ; 7.0 6.4 ) and ( 15.1 6.4 ; 10.9 6. , 11.1 8.5 ) groups significantly decreased after treatment ."
2,"The FSSG score ( mean SD at 0 , 4 , and 8 weeks ) in both the RKT (.0 7.0 ; 9..4 ; 7.0 6.4 ) and PL ( 15.1 6.4 ; 10.9 6.7 , 11.1 8.5 ) groups significantly decreased after ."
2,"The FSSG score ( mean SD at 0 , 4 , and 8 weeks ) in both the RKT (.0 7.0 ;.9 8.4 ; 7.0 6.4 ) and PL ( 15.1.4 ; 10.9 6.7 , 11. 8.5 ) groups significantly decreased after treatment ."
3,A responsive stimulation intervention can promote positive caregiving behaviors among impoverished families .
3,A responsive intervention can promote positive caregiving behaviors among impoverished families .
3,A responsive stimulation can promote positive caregiving behaviors among impoverished families .
3,A responsive stimulation intervention can promote positive caregiving behaviors among impoverished .
3,responsive stimulation intervention can promote positive caregiving behaviors among impoverished families .
3,"Cinitapride usage is well tolerated , but its cardiovascular events need further evaluation ."
3,"Cinitapride is well tolerated , but its cardiovascular events need further evaluation ."
3,"Cinitapride usage is tolerated , but its cardiovascular events need further evaluation ."
3,"Cinitapride usage is well tolerated , but its cardiovascular need further evaluation ."
3,"usage is well tolerated , but its cardiovascular events need further evaluation ."
1,The incidence of adverse events was also considered .
1,The incidence of adverse events was also .
1,The incidence of adverse events was considered .
1,The incidence of events was also considered .
1,incidence of adverse events was also considered .
0,The effects of brimonidine on daytime and nighttime intraocular pressure ( IOP ) and aqueous humor dynamics were evaluated in volunteers with ocular hypertension ( OHT ) .
0,The effects brimonidine on daytime nighttime intraocular pressure ( IOP ) and aqueous humor dynamics were evaluated in volunteers with ocular hypertension ( OHT ) .
0,The effects of brimonidine daytime and nighttime intraocular pressure ( IOP ) aqueous humor dynamics were evaluated in volunteers with ocular hypertension ( OHT ) .
0,The effects of on daytime nighttime intraocular pressure ( IOP ) and aqueous humor dynamics were evaluated in volunteers with ocular hypertension ( OHT ) .
0,effects of brimonidine on daytime and nighttime intraocular pressure ( IOP ) and aqueous humor dynamics were evaluated in volunteers ocular hypertension ( OHT ) .
3,"No major clinical differences were observed with regard to implant survival , complications and marginal bone level changes when loading single implants immediately , early or conventionally ."
3,"No major clinical differences were observed with regard to implant , complications and marginal bone level changes when single implants immediately , early or conventionally ."
3,"No major clinical differences were observed with regard to implant survival , complications and marginal level changes when loading single implants immediately , early or ."
3,"No major clinical differences were with regard to implant survival , complications and marginal bone level changes when loading single immediately , early or conventionally ."
3,"No major clinical were observed with regard to implant survival , complications and marginal bone level changes when single implants immediately , early or conventionally ."
1,"Using a car-following procedure in a high-fidelity driving simulator , participants were probed at random times to indicate whether they were on-task at that moment or mind-wandering ."
1,"Using a car-following in a high-fidelity driving simulator , participants probed at random times to indicate whether they were on-task at that moment or mind-wandering ."
1,"Using a car-following procedure in a high-fidelity driving simulator , participants were probed random times to indicate whether they were on-task at that moment mind-wandering ."
1,"Using a procedure in a high-fidelity driving simulator , participants were probed at random times indicate whether they were on-task at that moment or mind-wandering ."
1,"Using a procedure in a high-fidelity driving simulator , participants were probed at random times to indicate whether they were at that moment or mind-wandering ."
1,"The secondary efficacy endpoint included the improvement rate at maximum frown at week 16 and at rest at weeks 4 and 16 by live assessment , and the improvement rate at maximum frown and at rest based on photographic assessment at week 4 ."
1,"The secondary efficacy endpoint included the improvement at maximum frown at week 16 and at at weeks 4 and 16 live assessment , and the improvement rate at maximum frown and at rest based on photographic assessment week 4 ."
1,"The secondary efficacy endpoint included the improvement at maximum frown at week 16 and at rest at weeks 4 and 16 live assessment , and the improvement rate at frown at rest based on photographic assessment at week 4 ."
1,"The secondary efficacy endpoint included the improvement rate at maximum frown at week 16 and at rest at weeks 4 and 16 by , and improvement rate maximum frown and at rest based on photographic assessment at week 4 ."
1,"The secondary efficacy endpoint included the improvement rate maximum frown at week and at rest at weeks 4 and by live assessment , and the improvement rate at maximum frown and at rest on photographic assessment at week 4 ."
3,Similar rates of surgical success were observed with both implants at 5 years .
3,Similar of surgical success were observed with both implants at 5 years .
3,Similar rates of surgical success were observed both implants at 5 years .
3,Similar rates of surgical success were with both implants at 5 years .
3,Similar rates surgical success were observed with both implants at 5 years .
3,"Although the rate of IBTR in the intraoperative radiotherapy group was within the prespecified equivalence margin , the rate was significantly greater than with external radiotherapy , and overall survival did not differ between groups ."
3,"Although rate of IBTR in intraoperative radiotherapy was within the prespecified equivalence margin , the rate was significantly greater than with external radiotherapy , and overall survival did not differ between groups ."
3,"Although the rate of IBTR in the intraoperative group within the prespecified equivalence margin , the rate was significantly greater than with external radiotherapy , and overall survival did not differ between ."
3,"Although the rate of IBTR in the intraoperative radiotherapy group was within the prespecified equivalence margin , the rate greater than with external radiotherapy , and survival did not differ between groups ."
3,"Although the rate of IBTR the intraoperative radiotherapy group was within the prespecified equivalence , the rate was significantly greater than with external radiotherapy , and overall survival did differ between groups ."
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of the chest performed at less than 1 mSv with 2 iterative reconstruction ( IR ) techniques .
0,To assess lesion and diagnostic confidence of computed tomography ( CT ) of chest performed at less than 1 mSv with 2 iterative reconstruction ( IR ) techniques .
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of chest performed at less than mSv with 2 iterative reconstruction ( IR ) techniques .
0,To assess lesion detection and diagnostic confidence of computed tomography ( CT ) of the chest performed at less than with 2 iterative reconstruction ( IR ) techniques .
0,assess lesion detection and confidence of computed tomography ( CT ) of the chest performed at less than 1 mSv with 2 iterative reconstruction ( IR ) techniques .
4,Treatment with rituximab may be accompanied by a systemic cytokine release .
4,Treatment with may be accompanied by a systemic cytokine release .
4,Treatment with rituximab be accompanied by a systemic cytokine release .
4,Treatment with rituximab may be accompanied by a systemic cytokine .
4,Treatment with rituximab may be accompanied by systemic cytokine release .
4,"We investigated the efficacy and safety of three doses of tiotropium , administered in the evening ( via Respimat ( ) SoftMist inhaler ) , versus placebo in asthmatic adolescents symptomatic despite ICS treatment ."
4,"We investigated the efficacy and of three doses of tiotropium , administered in the evening ( Respimat ( ) SoftMist inhaler ) , versus placebo in asthmatic adolescents symptomatic despite ICS treatment ."
4,"We investigated the efficacy and safety of three doses of tiotropium , administered in the ( via Respimat ( ) SoftMist inhaler ) , versus placebo in adolescents symptomatic despite ICS treatment ."
4,"We investigated the efficacy and safety of three doses of tiotropium , administered in the evening ( via Respimat ( ) SoftMist inhaler ) , versus placebo adolescents symptomatic despite ICS treatment ."
4,"We investigated the efficacy and safety of three doses tiotropium , administered in the evening ( via Respimat ( ) inhaler ) , versus placebo in asthmatic adolescents symptomatic despite ICS treatment ."
2,Overall response rate by clinical palpation was 64.5 % in all patients with a final palpation measurement .
2,Overall response rate by clinical palpation was 64.5 % all patients with a final palpation measurement .
2,Overall response rate by clinical palpation was 64.5 % in all patients with a final measurement .
2,Overall response rate by clinical palpation was 64.5 % in all with a final palpation measurement .
2,Overall response rate by clinical palpation was.5 % in all patients with a final palpation measurement .
2,"Relative to placebo , subjective sexual functioning was attenuated under reboxetine along with diminished neural activations within the caudate nucleus ."
2,"Relative to placebo , sexual functioning was attenuated under reboxetine along with diminished neural activations within the caudate nucleus ."
2,"Relative to placebo , subjective sexual functioning was attenuated under reboxetine along with diminished neural activations within caudate nucleus ."
2,"Relative to placebo , subjective sexual functioning was under reboxetine along with diminished neural activations within the caudate nucleus ."
2,"to placebo , subjective sexual functioning was attenuated under reboxetine along with diminished neural activations within the caudate nucleus ."
4,"ISRCTN99175498 FUNDING : The trial is supported by the Medical Research Council , the Wellcome Trust , National Health Service R&D support funding ( including the Primary Care Research and Diabetes Research Networks ) and National Institute of Health Research under its Programme Grants for Applied Research scheme ."
4,"ISRCTN99175498 : The trial is by the Medical Research Council , the Wellcome Trust , National Health Service R&D support funding ( including the Primary Research and Diabetes Research Networks ) and National Institute of Health Research its Programme Grants for Applied Research scheme ."
4,"ISRCTN99175498 FUNDING : The trial is by the Medical Research Council , Wellcome Trust , National Health Service R&D support ( including the Primary Care and Diabetes Research Networks ) and National Institute of Health Research under its Programme Grants for Applied Research scheme ."
4,"ISRCTN99175498 FUNDING : The trial is supported by the Medical Research Council , the , National Health Service R&D support funding ( including the Primary Care Research and Diabetes Research ) and National Institute Health Research under its Programme Grants for Applied Research scheme ."
4,"ISRCTN99175498 FUNDING : The trial is supported by the Medical Research Council , the Wellcome Trust , National Health Service R&D support ( including the Primary Care Research and Diabetes Research Networks ) and Institute of Health Research its Programme Grants Applied Research scheme ."
3,This pilot study provides preliminary evidence for integrating error management skills into medical curricula and for the design of learning goals in simulation-based education .
3,This pilot study provides evidence for integrating error management skills into curricula and for the design of learning goals in simulation-based education .
3,This pilot study provides preliminary evidence for integrating error management skills into curricula and for the design learning goals in simulation-based education .
3,This pilot study provides preliminary evidence for integrating error management skills into medical and for the design of learning goals simulation-based education .
3,This pilot study provides preliminary evidence for integrating error management skills into medical curricula and the design of learning goals in education .
2,The main reason for failure was secondary caries ( 50 % ) .
2,The main for failure was secondary caries ( 50 % ) .
2,The main reason for failure was secondary caries ( % ) .
2,The reason for failure was secondary caries ( 50 % ) .
2,main reason for failure was secondary caries ( 50 % ) .
4,"In this study , autologous platelet-rich plasma ( PRP ) , a concentrated bioactive blood component rich in cytokines and growth factors , was compared to traditional cortisone injection in the treatment of chronic cases of plantar fasciitis resistant to traditional nonoperative management ."
4,"In , autologous platelet-rich plasma ( PRP ) , concentrated bioactive blood component rich in cytokines and growth factors , was compared to traditional cortisone injection in the treatment of chronic cases of plantar fasciitis resistant to traditional nonoperative management ."
4,"In this study , autologous platelet-rich plasma ( ) , a concentrated bioactive blood component rich in cytokines and growth factors , was compared to traditional cortisone injection in the treatment chronic cases of plantar fasciitis resistant to traditional management ."
4,"In this study , autologous platelet-rich plasma ( PRP ) , a concentrated bioactive blood component rich in cytokines and growth factors , was compared to cortisone injection in the treatment of chronic of plantar fasciitis resistant to traditional management ."
4,"In this study , autologous platelet-rich plasma ( PRP ) , a concentrated bioactive blood rich in cytokines and growth factors , was compared to traditional cortisone injection in the of chronic cases of plantar fasciitis resistant to traditional management ."
0,It is unknown if this association is causal .
0,It is unknown if this association is .
0,It is unknown this association is causal .
0,It unknown if this association is causal .
0,is unknown if this association is causal .
1,All participants will undergo standard long down regulation protocol using human menopausal gonadotropin 300IU/day .
1,All participants will undergo standard down regulation protocol using human menopausal gonadotropin 300IU/day .
1,All participants will undergo standard long down regulation protocol using human menopausal gonadotropin 300IU/ .
1,All participants will undergo standard long down regulation protocol using menopausal gonadotropin 300IU/day .
1,All participants will undergo standard long regulation protocol using human menopausal gonadotropin 300IU/day .
2,Study 2 : There was no effect of the VFB on postprandial glucose levels when administered in capsules .
2,Study 2 : There was no effect of the VFB on postprandial glucose levels when administered capsules .
2,Study 2 : There was no effect the VFB on postprandial glucose levels when administered in capsules .
2,Study 2 : was no effect of the VFB on postprandial glucose levels when administered in capsules .
2,Study : There was no effect of the VFB on postprandial glucose levels when administered in capsules .
4,"Dietary patterns that are considered healthy ( eg , the Dietary Approaches to Stop Hypertension diet and Mediterranean diet ) may be more successful in reducing typical cardiovascular disease risks compared to dietary patterns considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
4,"Dietary patterns that are considered healthy ( , the Dietary Approaches to Stop Hypertension diet and diet ) may be more successful reducing typical disease risks compared to dietary patterns considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
4,"Dietary patterns that are considered healthy ( , the Dietary to Stop Hypertension diet and Mediterranean diet ) be more successful in reducing typical cardiovascular disease risks compared to patterns considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
4,"Dietary patterns that are considered healthy ( eg , the Dietary Approaches to Stop Hypertension diet and Mediterranean diet ) may be more successful in reducing typical cardiovascular risks to dietary patterns unhealthy ( eg , energy-dense diets such as typical American diet ) ."
4,"Dietary patterns that are considered healthy ( eg , the Dietary Approaches to Stop Hypertension diet and Mediterranean diet ) may more successful in reducing cardiovascular disease risks compared to dietary considered unhealthy ( eg , energy-dense such as the typical American diet ) ."
4,So far there is no evidence whether oral beta-blockers may reduce myocardial injury after coronary artery bypass grafting .
4,So far there is no evidence whether oral beta-blockers may reduce myocardial injury after coronary bypass grafting .
4,So far there no evidence whether oral beta-blockers may reduce myocardial injury after coronary artery bypass grafting .
4,So there is no evidence whether oral beta-blockers may reduce myocardial injury after coronary artery bypass grafting .
4,far there is no evidence whether oral beta-blockers may reduce myocardial injury after coronary artery bypass grafting .
2,"After each dose , grade 3 fever ( > 40.0 C , rectal measurement ) was reported for maximum one toddler in each group with no differences between investigational formulations and PHiD-CV during primary vaccination ."
2,"After each dose , 3 fever ( > 40.0 C , rectal measurement ) was reported for maximum one toddler in group no differences between investigational formulations and PHiD-CV during primary vaccination ."
2,"After each dose , grade 3 fever ( > 40.0 C , rectal ) was reported for maximum one each group with no differences between investigational formulations and PHiD-CV during primary vaccination ."
2,"After each dose , grade 3 fever ( >. C , rectal measurement ) was reported for maximum one toddler in each group with no differences between investigational formulations and during primary vaccination ."
2,"each dose , grade 3 fever ( > 40.0 C , rectal measurement ) was reported for maximum one toddler each group with no differences between investigational and PHiD-CV during primary vaccination ."
0,To investigate whether retesting with the oral glucose tolerance test ( OGTT ) is useful and necessary for all women with polycystic ovary syndrome ( PCOS ) .
0,To investigate whether retesting the oral glucose tolerance test ( OGTT ) is useful and necessary for all with polycystic ovary syndrome ( PCOS ) .
0,To investigate whether retesting with the oral glucose tolerance test ( OGTT ) is useful and necessary all women polycystic ovary syndrome ( PCOS ) .
0,To whether retesting the oral glucose tolerance test ( OGTT ) is useful and necessary for all women with polycystic ovary syndrome ( PCOS ) .
0,To whether retesting with the oral glucose tolerance test ( OGTT ) is useful and for all women with polycystic ovary syndrome ( PCOS ) .
2,The moderate-dose treatment produced weight losses similar to the high-dose condition and significantly larger than the low-dose and control conditions ( posterior probability > 0.996 ) .
2,The moderate-dose treatment produced weight losses similar to the high-dose condition and significantly than the low-dose and control ( posterior probability > 0.996 ) .
2,The moderate-dose treatment produced weight losses to the high-dose condition and larger than the low-dose and control conditions ( posterior probability > 0.996 ) .
2,The moderate-dose treatment weight losses similar to the high-dose condition and significantly larger than the low-dose and control conditions ( posterior probability >.996 ) .
2,The moderate-dose treatment weight losses to the high-dose condition and significantly larger than the low-dose and control conditions ( posterior probability > 0.996 ) .
1,"We compared age , sex , fracture type ( Sanders classification ) , treatment given , Bhler angle , residual articular surface step-off at healing , type of occupation , and injury insurance between the 2 groups ."
1,"We age , sex , fracture type ( Sanders classification ) , treatment given , Bhler angle , residual articular surface step-off at healing , of occupation , and injury insurance between the 2 groups ."
1,"We compared age , sex , fracture type ( Sanders classification ) , treatment , Bhler angle , residual articular surface step-off at , type of occupation , and injury insurance between the 2 groups ."
1,"We compared age , sex , fracture type ( Sanders classification ) , treatment , Bhler angle , residual articular surface step-off at healing , of occupation , and injury insurance between the 2 groups ."
1,"We compared age , sex , fracture type ( Sanders classification ) , treatment given , Bhler angle , residual articular surface step-off at , type occupation , and injury insurance between the 2 groups ."
2,"Hp phenotype did not significantly influence the odds of having any notch ( p = 0.32 ) , bilateral notches ( p = 0.72 ) , or a resistance index ( p = 0.28 ) or pulsatility index ( p = 0.67 ) above the 90th percentile at 17 weeks ' gestation ."
2,"Hp did not significantly influence the odds having any notch ( p = 0.32 ) , bilateral ( p = 0.72 ) , or a resistance index ( p = 0.28 ) or index ( p = 0.67 ) above the 90th percentile at 17 weeks ' gestation ."
2,"Hp phenotype did not significantly influence the odds of having any notch ( p = 0. ) , bilateral ( p = 0. ) , or a resistance ( p = 0.28 ) or pulsatility index ( p = 0.67 ) above the 90th percentile at 17 weeks ' gestation ."
2,"Hp phenotype did not significantly influence the odds of having any notch ( p = 0.32 ) , bilateral notches ( p = 0. ) , or a resistance index ( p = 0. ) or pulsatility index ( p = 0.67 ) above the 90th 17 weeks ' gestation ."
2,"Hp phenotype did significantly influence the odds of having any notch ( p = 0.32 ) , bilateral notches ( p = 0.72 ) , or a resistance index ( p = 0.28 ) index ( p = 0. ) above the 90th percentile at 17 weeks ' gestation ."
3,"This was evident by increased expression of Th1 cytokines ( INF - , IL-2 ) and the ratio of Th1/Th2 ( INF - / IL-4 , IL-2 / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokines ( IL-4 , IL-5 ) ."
3,"This was evident by increased expression of Th1 cytokines ( INF - , ) and the ratio Th1/Th2 ( INF - / IL-4 , / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokines ( IL-4 , IL-5 ) ."
3,"This was evident by increased expression of Th1 cytokines ( INF - , ) and the ratio of Th1/Th2 ( INF - / IL-4 , IL-2 / ) , as well as by decreased FACT-L scores and the expression of Th2 cytokines ( , IL-5 ) ."
3,"This was evident by increased expression of Th1 cytokines ( INF - , IL-2 ) and the ratio of/Th2 ( INF - / IL-4 , IL-2 / IL-5 ) , as by decreased FACT-L scores and the expression of Th2 cytokines ( IL-4 , IL-5 ) ."
3,"This was evident increased expression Th1 cytokines ( INF - , IL-2 ) and the ratio Th1/Th2 ( INF - / IL-4 , IL-2 / IL-5 ) , as well as by decreased FACT-L scores and the expression of Th2 cytokines ( IL-4 , IL-5 ) ."
1,"According to clinical symptoms , 3 categories : complete remission , partial remission and no remission were mentioned in weekly follow-up ."
1,"According to clinical symptoms , 3 categories : complete remission , partial remission and no remission mentioned in weekly follow-up ."
1,"According to clinical symptoms , 3 categories : complete remission , partial remission and no remission were in weekly follow-up ."
1,"According to clinical symptoms , 3 categories : complete remission , partial remission and no remission were mentioned in weekly ."
1,"According to clinical symptoms , 3 categories : complete remission , partial remission and remission were mentioned in weekly follow-up ."
1,A fourth group served as nonsterilized controls .
1,A fourth group as nonsterilized controls .
1,A fourth group served nonsterilized controls .
1,A fourth served as nonsterilized controls .
1,fourth group served as nonsterilized controls .
1,All patients received standardized general anaesthesia and continuous epidural ropivacaine 0.25 % ; 4-8 ml/hr .
1,All patients received standardized general anaesthesia and continuous epidural ropivacaine 0. % ; 4-8 ml/hr .
1,All patients received standardized general anaesthesia and continuous epidural ropivacaine 0.25 % ; 4-8 ml/ .
1,All patients received standardized general anaesthesia and continuous epidural ropivacaine 0.25 % ; ml/hr .
1,All received standardized general anaesthesia and continuous epidural ropivacaine 0.25 % ; 4-8 ml/hr .
1,"Preoperatively , patients were randomly assigned to receive either a supraclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine bolus via the catheter and ropivacaine perineural infusion initiated postoperatively ."
1,"Preoperatively , patients randomly assigned to receive either a supraclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine bolus via the catheter ropivacaine perineural infusion postoperatively ."
1,"Preoperatively , patients were randomly assigned to receive either a or an infraclavicular catheter ultrasound-guided nonstimulating catheter insertion technique with a mepivacaine bolus via the catheter and ropivacaine perineural infusion initiated postoperatively ."
1,"Preoperatively , patients were randomly assigned to receive either a supraclavicular an infraclavicular catheter using an nonstimulating catheter insertion technique with a mepivacaine bolus via the catheter and perineural infusion initiated postoperatively ."
1,"Preoperatively , patients were randomly assigned to receive either a supraclavicular or an infraclavicular catheter using an ultrasound-guided nonstimulating catheter insertion technique with a bolus the catheter and ropivacaine infusion initiated postoperatively ."
0,The treatment of bipolar disorder type I ( BD-I ) with a comorbid cocaine dependence disorder ( CDD ) is a challenge in current psychiatric practice .
0,The treatment of bipolar disorder type I ( BD-I ) with comorbid cocaine dependence disorder ( ) is a challenge in current psychiatric practice .
0,The treatment of bipolar disorder type I ( BD-I ) with comorbid cocaine dependence disorder ( CDD ) is a challenge in psychiatric practice .
0,The treatment of bipolar disorder type I ( BD-I ) with comorbid cocaine dependence disorder ( CDD ) is challenge in current psychiatric practice .
0,The treatment of disorder type ( BD-I ) with a comorbid cocaine dependence disorder ( CDD ) is a challenge in current psychiatric practice .
2,Budesonide transnasal nebulization consistently reduced eosinophil infiltration and TH2 cell frequency and increased natural regulatory T-cell and type 1 regulatory T-cell frequencies .
2,Budesonide transnasal nebulization consistently reduced eosinophil infiltration and TH2 cell frequency and increased regulatory and type 1 regulatory T-cell frequencies .
2,Budesonide transnasal nebulization reduced eosinophil infiltration and TH2 frequency and increased natural regulatory T-cell and type 1 regulatory T-cell frequencies .
2,transnasal nebulization consistently reduced eosinophil infiltration and TH2 cell frequency and increased natural T-cell and type 1 regulatory T-cell frequencies .
2,transnasal nebulization reduced eosinophil infiltration and TH2 cell frequency and increased natural regulatory T-cell and type 1 regulatory T-cell frequencies .
0,To evaluate the effects and costs of three doses of behavioral weight-loss treatment delivered via Cooperative Extension Offices in rural communities .
0,To evaluate effects and of three doses of behavioral weight-loss treatment delivered via Cooperative Extension Offices in rural communities .
0,To evaluate the effects and costs of three doses weight-loss treatment delivered via Cooperative Extension Offices in rural communities .
0,To evaluate the effects and of three doses of behavioral weight-loss treatment delivered via Cooperative Extension Offices in communities .
0,evaluate the effects and costs of three doses of behavioral weight-loss treatment delivered via Cooperative Offices in rural communities .
1,"Thirty-three patients diagnosed with pancreas , stomach , rectum , colon malignancies , and undergoing major abdominal surgery at Ankara Numune Training and Research Hospital were randomly divided into two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"Thirty-three patients diagnosed pancreas , stomach , rectum , colon malignancies , and undergoing major abdominal at Ankara Numune Training and Research Hospital were randomly divided two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"Thirty-three patients diagnosed pancreas , stomach , rectum , colon malignancies , and undergoing major abdominal surgery at Ankara Numune Training and Research Hospital were randomly divided two groups ; control ( CON ) N-acetyl cysteine ( NAC ) ."
1,"Thirty-three patients diagnosed with pancreas , stomach , rectum , colon malignancies , undergoing major abdominal surgery at Ankara Training and Research Hospital were randomly divided into two ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
1,"patients diagnosed with pancreas , stomach , , colon malignancies , and undergoing abdominal surgery at Ankara Numune Training and Research Hospital were randomly divided into two groups ; control ( CON ) and N-acetyl cysteine ( NAC ) ."
4,Blood collection through intravenous lines frequently causes spurious hemolysis .
4,Blood collection intravenous lines frequently causes spurious hemolysis .
4,Blood collection through intravenous frequently causes spurious hemolysis .
4,Blood collection through intravenous lines frequently causes hemolysis .
4,Blood through intravenous lines frequently causes spurious hemolysis .
3,This trial was registered at clinicaltrials.gov as NCT02100774 .
3,This trial was registered at clinicaltrials. as NCT02100774 .
3,This trial was registered at clinicaltrials.gov NCT02100774 .
3,This trial was registered at.gov as NCT02100774 .
3,This trial was registered clinicaltrials.gov as NCT02100774 .
2,"Significantly higher concentration of systemic endotoxin , neutrophil , neutrophil-elastase , interleukin-6 and -1 , and CRP were detected intraoperatively and/or postoperatively in the ELC group of patients in comparison with the UC group ( P < .05 ) ."
2,"Significantly higher concentration endotoxin , neutrophil , neutrophil-elastase , interleukin-6 and -1 , and CRP were detected intraoperatively/or postoperatively in the ELC group of patients in comparison with the UC group ( P < .05 ) ."
2,"Significantly higher concentration of endotoxin , neutrophil , neutrophil-elastase , interleukin-6 -1 , and CRP were detected intraoperatively and/or postoperatively in the ELC group of patients in comparison the UC group ( P < .05 ) ."
2,"Significantly higher concentration of systemic endotoxin , neutrophil , , interleukin-6 and -1 , CRP were intraoperatively and/or postoperatively in the ELC group of patients in comparison with the UC group ( P < .05 ) ."
2,"Significantly higher concentration of systemic endotoxin , neutrophil , neutrophil-elastase , interleukin-6 and -1 , and CRP were detected and/or in the ELC group patients in comparison with the UC group ( P < .05 ) ."
2,"For every one point increase in AUSDRISK score there was a half point increase in RBGT levels ( coefficient 0.55 , 95 % CI : 0.28 , 0.83 ) ."
2,"For every one point increase in AUSDRISK score there was a half point increase in RBGT ( coefficient 0.55 , 95 % CI : 0. , 0.83 ) ."
2,"For every one point increase in AUSDRISK score there was a half point increase in RBGT levels ( coefficient 0.55 , 95 % CI : 0. ,.83 ) ."
2,"For every one point increase in score there was a half point increase in levels ( coefficient 0.55 , 95 % CI : 0.28 , 0.83 ) ."
2,"For one point increase in AUSDRISK score there was a half point increase in RBGT levels ( coefficient 0.55 , 95 % : 0.28 , 0.83 ) ."
4,Predictive low glucose management ( PLGM ) may help prevent hypoglycemia by stopping insulin pump delivery based on predicted sensor glucose values .
4,Predictive low glucose ( PLGM ) may help prevent hypoglycemia by stopping insulin delivery based on predicted sensor glucose values .
4,Predictive low glucose management ( PLGM ) may prevent hypoglycemia by stopping insulin pump delivery based on predicted sensor values .
4,Predictive low management ( PLGM ) may help prevent hypoglycemia by stopping insulin delivery based on predicted sensor glucose values .
4,low glucose management ( PLGM ) may help prevent by stopping insulin pump delivery based on predicted sensor glucose values .
4,"The objectives were to determine whether pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnaire ( IPAQ ) , and improved quality of life and symptoms as assessed by the St George respiratory questionnaire for IPF ( SGRQ-I ) and the Borg dyspnea index ( BDI ) ."
4,"The objectives were to determine pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity ( IPAQ ) , and improved quality of life and symptoms assessed by the St George respiratory questionnaire for IPF ( SGRQ-I ) and the Borg index ( BDI ) ."
4,"The objectives were to determine whether pulmonary rehabilitation increased as assessed by the International Physical Activity Questionnaire ( IPAQ ) , improved quality of life and symptoms as assessed by the St George respiratory questionnaire for IPF ( SGRQ-I ) and the dyspnea index ( BDI ) ."
4,"The objectives were to determine whether pulmonary rehabilitation physical activity as assessed by the International Physical Activity Questionnaire ( IPAQ ) , and improved quality of life and symptoms as assessed by the St George respiratory for ( ) and the Borg dyspnea index ( BDI ) ."
4,"The objectives were to whether pulmonary rehabilitation physical activity as assessed by the International Physical Activity Questionnaire ( IPAQ ) , and improved quality of life and symptoms as by St George respiratory questionnaire for IPF ( SGRQ-I ) and the Borg dyspnea index ( BDI ) ."
4,"Little is known about the effect of specific anti-interleukin-23 therapy , as compared with established anti-tumor necrosis factor therapies , for the treatment of moderate-to-severe plaque psoriasis ."
4,"Little is about the effect of anti-interleukin-23 therapy , as compared with established anti-tumor necrosis factor therapies , for the treatment of moderate-to-severe plaque psoriasis ."
4,"Little is known about the effect of anti-interleukin-23 therapy , compared with established anti-tumor necrosis factor therapies , for the treatment of moderate-to-severe plaque psoriasis ."
4,"Little is known about the effect of specific anti-interleukin-23 therapy , as compared established anti-tumor necrosis therapies , for the treatment of moderate-to-severe plaque psoriasis ."
4,"Little is known about the effect of specific anti-interleukin-23 therapy , as compared with anti-tumor necrosis factor therapies , for the treatment moderate-to-severe plaque psoriasis ."
1,The primary outcome of the effect evaluation is the percentage of patients undergoing primary elective total hip or knee arthroplasty in which erythropoietin or perioperative blood salvage is applied .
1,The primary outcome of the effect evaluation is the percentage of patients primary elective hip or knee arthroplasty in which erythropoietin or perioperative blood salvage is applied .
1,The primary outcome of the effect evaluation is the percentage of patients undergoing elective total hip or knee arthroplasty in which or perioperative blood salvage is applied .
1,The primary outcome of the evaluation is the percentage of patients primary elective total hip or knee arthroplasty in which erythropoietin or perioperative blood salvage is applied .
1,primary outcome of the evaluation is the percentage of patients undergoing primary elective total hip or knee arthroplasty in which erythropoietin or perioperative blood salvage is applied .
0,A patient-centered collaborative care program for depression and uncontrolled diabetes and/or coronary heart disease ( CHD ) demonstrated improved clinical outcomes relative to usual care .
0,A patient-centered collaborative care program for depression and diabetes and/or coronary heart disease ( CHD ) demonstrated improved clinical outcomes relative usual care .
0,A patient-centered collaborative care program for depression and uncontrolled diabetes and/or coronary heart ( CHD ) demonstrated improved clinical relative to usual care .
0,A patient-centered collaborative care program for depression and uncontrolled diabetes and/or heart disease ( CHD ) demonstrated improved clinical outcomes relative usual care .
0,A patient-centered collaborative care program for depression and uncontrolled diabetes/or coronary heart disease ( CHD ) demonstrated improved clinical outcomes relative usual care .
2,"The period of endotracheal intubation was 7.0 ( 6.8 , 9.5 ) days , and 7.7 % ( 2/26 ) patients underwent re-intubation in sequential group ."
2,"The period of endotracheal intubation 7.0 ( 6. , 9.5 ) days , and 7.7 % ( 2/26 ) patients underwent re-intubation in sequential group ."
2,"The period of endotracheal intubation was 7.0 ( 6.8 , 9.5 ) days , and.7 % ( 2/ ) patients underwent re-intubation in sequential group ."
2,"The period of endotracheal intubation was.0 ( 6. , 9.5 ) days , and 7.7 % ( 2/26 ) patients underwent re-intubation in sequential group ."
2,"The period of endotracheal was 7.0 ( 6.8 , 9.5 ) , and 7.7 % ( 2/26 ) patients underwent re-intubation in sequential group ."
2,Thirty-four percent of patients had baseline symptoms .
2,Thirty-four of patients had baseline symptoms .
2,Thirty-four percent of had baseline symptoms .
2,Thirty-four percent patients had baseline symptoms .
2,percent of patients had baseline symptoms .
1,"Preoperative , intraoperative , and postoperative variables and mortality were compared among groups ."
1,", intraoperative , and postoperative variables and mortality were compared among groups ."
1,"Preoperative , intraoperative , and postoperative variables and mortality compared among groups ."
1,"Preoperative , intraoperative , and postoperative variables and mortality were among groups ."
1,"Preoperative , intraoperative , and postoperative variables mortality were compared among groups ."
3,This study represents a first approach to the application of a passive relaxation technique in residential programs for the elderly .
3,This study represents a first approach to application a passive relaxation technique in residential programs for the elderly .
3,This study represents a first approach to the application of a passive relaxation technique in programs for the .
3,This study represents a first approach to the of a passive relaxation technique in residential programs for the .
3,study represents a first approach to the application of a passive technique in residential programs for the elderly .
1,"Eligible subjects were randomized to either an intervention with low GI diet ( consisting of 45-50 % carbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chinese diet as control ( consisting of 55-60 % carbohydrate , 25-30 % fat and 10-15 % protein ) ."
1,"Eligible subjects randomized to either an intervention with low GI ( consisting 45-50 % carbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chinese diet as control ( consisting of 55-60 % carbohydrate , 25-30 % fat and 10-15 % protein ) ."
1,"Eligible subjects were randomized to either an intervention with low GI diet ( consisting 45-50 % carbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chinese diet as control ( consisting 55-60 % carbohydrate , 25-30 % fat and % protein ) ."
1,"Eligible were randomized to either an intervention with low GI diet ( consisting of 45-50 % carbohydrate , % fat and 15-20 % protein ) or conventional Chinese diet as control ( consisting of 55-60 % , 25-30 % fat and 10-15 % protein ) ."
1,"Eligible were randomized to either an intervention with low GI diet ( consisting of 45-50 % carbohydrate , 30-35 % fat and 15-20 % protein ) or conventional Chinese diet control ( consisting of 55-60 % carbohydrate , 25-30 % fat and % protein ) ."
0,This study aims to determine the outcome of double-bundle anterior cruciate ligament ( ACL ) reconstruction using an allograft in comparison with ACL reconstruction using a double-bundle autograft or a single-bundle allograft .
0,This aims to determine the of double-bundle anterior cruciate ligament ( ACL ) reconstruction using allograft in comparison with ACL reconstruction using a double-bundle autograft or a single-bundle allograft .
0,This study aims determine the outcome of double-bundle anterior ligament ( ACL ) reconstruction using an allograft in comparison with ACL reconstruction using a double-bundle autograft or single-bundle allograft .
0,This study aims to determine the outcome of anterior cruciate ligament ( ACL ) reconstruction using allograft in comparison with ACL reconstruction a double-bundle autograft or a single-bundle allograft .
0,This study aims to determine the outcome of double-bundle anterior cruciate ( ACL ) reconstruction using an allograft in comparison with ACL using a double-bundle autograft or a allograft .
3,"Objective study of occupational health activities and measures were enabled by devising methods and procedures , e.g. , applying the waiting-list method for the control group ."
3,"Objective study occupational health activities and measures were enabled by devising methods and procedures , e.g. , applying the waiting-list method for the group ."
3,"Objective study occupational health activities and measures were enabled devising methods and procedures , e.g. , applying the waiting-list method for the control group ."
3,"Objective study of occupational health activities and measures were enabled by devising methods and procedures , e.. , applying the waiting-list for the control group ."
3,"Objective study of occupational health activities and measures were enabled by devising methods procedures , e.g. , applying the waiting-list method for control group ."
3,The choice of their application could be left to the discretion of the ophthalmologist .
3,The choice of their application be left to the discretion of the ophthalmologist .
3,The choice of their application could be left to the discretion of ophthalmologist .
3,The choice of their application could left to the discretion of the ophthalmologist .
3,choice of their application could be left to the discretion of the ophthalmologist .
2,"Mortality rate was 12.8 % and 14.6 % in PCI and CABG patients , respectively ( hazard ratio , 0.88 [ 95 % confidence interval , 0.58-1 .32 ] ; P = 0.53 ) ."
2,"Mortality rate was 12. % and 14.6 % in PCI and CABG patients , respectively ( hazard ratio , 0.88 [ 95 % interval , 0.58-1 .32 ] ; P = 0.53 ) ."
2,"Mortality rate was 12.8 % and 14. % in PCI and CABG patients , respectively ( hazard ratio , 0.88 [ 95 % interval , 0.58-1 .32 ] ; P = 0.53 ) ."
2,"Mortality rate was 12.8 % and.6 % in PCI and CABG patients , respectively ( hazard ratio , 0.88 [ 95 % interval , 0.58-1 .32 ] ; P = 0.53 ) ."
2,"rate was 12.8 % and 14.6 % in PCI and CABG patients , respectively ( hazard ratio , 0.88 [ 95 % confidence , 0.58-1 .32 ] ; P = 0.53 ) ."
0,"This study used an in-depth mixed-methods design to examine individual variation in ( 1 ) impact on self-reported goal engagement ( ie , motivation , self-efficacy , awareness , effort , achievement ) of access to a weight management app ( POWeR Tracker ) when provided alongside a Web-based weight management intervention ( POWeR ) and ( 2 ) usage and views of POWeR Tracker ."
0,"This study used an in-depth mixed-methods design to examine individual variation in ( 1 ) impact on self-reported goal engagement ( ie , motivation , self-efficacy , awareness , effort , achievement ) of access to a weight app ( POWeR ) when provided alongside a weight management intervention ( ) and ( 2 ) usage views of POWeR Tracker ."
0,"This study used an in-depth mixed-methods design to examine individual variation in ( 1 ) on self-reported engagement ( ie , , self-efficacy , awareness , effort , achievement ) of access to a weight ( POWeR Tracker ) when provided alongside a Web-based weight management intervention ( POWeR ) and ( 2 ) usage and views of POWeR Tracker ."
0,"This study used mixed-methods design to individual variation in ( 1 ) impact on goal engagement ( ie , motivation , self-efficacy , awareness , effort , achievement ) of access a weight management app ( POWeR Tracker ) when provided alongside a Web-based weight management intervention ( POWeR ) and ( 2 ) usage and views of POWeR Tracker ."
0,"study used an in-depth design to examine individual variation in ( 1 ) impact on self-reported goal engagement ( ie , motivation , self-efficacy , awareness , effort , achievement ) of access to a management app ( POWeR ) when provided a Web-based weight management intervention ( POWeR ) and ( 2 ) usage and views of POWeR Tracker ."
2,Injection site erythema ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injection erythema ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injection site ( 68 % ) and induration ( 86 % ) peaked 1 week after revaccination .
2,Injection site erythema ( 68 % ) and induration ( % ) peaked 1 week after revaccination .
2,Injection site erythema ( 68 % ) induration ( 86 % ) peaked 1 week after revaccination .
1,Subject reported outcomes about the preparations were elicited .
1,Subject reported outcomes about preparations were elicited .
1,Subject reported outcomes about the preparations elicited .
1,Subject reported outcomes about the preparations were .
1,reported outcomes about the preparations were elicited .
2,"Duration of the operation , incision length and hip pain occurrence were significantly less in the Gamma nail group ."
2,"Duration of operation , incision length and hip pain occurrence were significantly less in the Gamma nail group ."
2,"Duration of the operation , incision length and hip pain occurrence were significantly less in the Gamma nail ."
2,"Duration of the operation , length and hip pain occurrence were significantly less in the Gamma nail group ."
2,"of the operation , incision length and hip pain occurrence were significantly less in the Gamma nail group ."
2,Five shoulders in the DCR+RCR group and 6 in the isolated RCR group were excluded from analysis due to loss of follow-up .
2,Five shoulders in the DCR+RCR group 6 in the isolated RCR group were excluded from analysis to loss of follow-up .
2,Five shoulders in the DCR+RCR group and 6 in the isolated group were excluded from analysis due to loss of .
2,Five shoulders in the DCR+RCR group and in the isolated RCR group were excluded from analysis due to loss of .
2,shoulders in the DCR+RCR group and 6 in the isolated RCR group were excluded from analysis due loss of follow-up .
2,"The intervention group had better knowledge of precautions related to taking additional acetaminophen ( usual care 18.2 % , 95 % confidence interval [ CI ] = 10.9 % to 25.5 % vs. intervention 38 % , 95 % CI = 28.3 % to 47.7 % ; difference = 27.6 , 95 % CI of difference = 21.5 to 33.7 ) and knowledge of side effects ( usual care median = 1 , interquartile range [ IQR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"The intervention group better knowledge of precautions related to taking additional acetaminophen ( usual care 18.2 % , 95 % confidence interval [ CI ] = 10.9 % to.5 % vs. intervention 38 % , 95 % CI = 28.3 % 47.7 % ; difference = 27.6 , 95 % CI of difference =. to 33.7 ) and knowledge of side ( usual median = 1 , interquartile range [ IQR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"The intervention group had better knowledge of precautions related to taking additional acetaminophen ( usual care 18.2 % , 95 % confidence interval [ CI ] = 10.9 % to 25.5 % vs. intervention % , 95 % CI = 28.3 % to 47.7 % ; difference = 27.6 , % CI of difference = 21.5 to 33.7 ) knowledge of effects ( usual care median = 1 , interquartile range [ ] 0 2 vs. intervention = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
2,"The intervention had better knowledge of precautions related to taking additional acetaminophen ( usual care.2 % , 95 % confidence [ CI ] = 10.9 % to 25.5 % vs. intervention 38 % , 95 % = 28.3 % to 47.7 % ; difference = 27.6 , 95 % CI of difference = 21.5 33.7 ) knowledge of side effects ( usual care median = 1 , interquartile range [ IQR ] 0 to 2 vs. intervention median = 2 , = 1 to 2 ; p < 0.0001 ) ."
2,"intervention group had better knowledge precautions related to taking acetaminophen ( usual care 18.2 % , 95 % confidence interval [ CI ] = 10.9 % to.5 % vs. intervention 38 % , 95 % CI = 28.3 % to.7 % ; difference = 27.6 , % CI of difference = 21.5 to 33.7 ) and knowledge side effects ( usual care median = 1 , interquartile range [ IQR ] 0 to 2 vs. intervention median = 2 , IQR = 1 to 2 ; p < 0.0001 ) ."
3,10 % Chlorhexidine was highly effective in high risk participants with more than two cavities at the initial examination .
3,10 % Chlorhexidine was highly effective in high participants with more than two cavities at the initial examination .
3,10 % Chlorhexidine was highly effective in high risk participants with more than cavities at the initial examination .
3,10 % Chlorhexidine was highly effective in high risk participants with more than two cavities at the examination .
3,10 % Chlorhexidine was highly effective in high risk participants with than two cavities at the initial examination .
3,The ocular vestibular-evoked myogenic potential ( oVEMP ) test yields the same information as the rotational test in sleep-deprived subjects as evidenced by increased vestibulo-ocular reflex ( VOR ) asymmetry .
3,The ocular myogenic potential ( oVEMP ) test yields the same information as the rotational test in sleep-deprived subjects evidenced by increased vestibulo-ocular reflex ( VOR ) asymmetry .
3,The ocular vestibular-evoked myogenic potential ( oVEMP ) test yields the same information the rotational test in sleep-deprived subjects as evidenced by increased reflex ( VOR ) asymmetry .
3,The vestibular-evoked myogenic potential ( oVEMP ) test yields the same information as the rotational test in sleep-deprived subjects evidenced by increased vestibulo-ocular reflex ( VOR ) asymmetry .
3,ocular vestibular-evoked myogenic potential ( oVEMP ) test yields the same information as the rotational test sleep-deprived subjects as evidenced by increased vestibulo-ocular reflex ( VOR ) asymmetry .
1,All patients were premedicated orally 1 h before the induction of anesthesia .
1,All patients premedicated orally 1 h before the induction of anesthesia .
1,All patients were premedicated orally 1 h before the induction anesthesia .
1,All patients were premedicated orally 1 h before the induction of .
1,All patients were premedicated orally h before the induction of anesthesia .
2,"One-month physical fatigue scores were similar in both groups ( mean : laparoscopy , 12.28 ; 95 % CI , 11.37 to 13.19 v open surgery , 12.05 ; 95 % CI , 11.14 to 12.96 ; adjusted mean difference , -0.23 ; 95 % CI , -1.52 to 1.07 ) ."
2,"One-month physical fatigue scores similar in both groups ( mean : , 12.28 ; 95 % CI ,.37 to 13.19 v open surgery , 12.05 ; 95 % CI , 11.14 to 12. ; adjusted mean difference , -0.23 ; 95 % CI , -1.52 to 1.07 ) ."
2,"One-month physical fatigue scores were similar in both groups ( mean : laparoscopy , 12.28 ; 95 % CI , 11.37 to 13.19 v open surgery , 12.05 ; 95 % CI , 11. to 12.96 ; adjusted difference , -. ; 95 % CI , -1.52 to 1.07 ) ."
2,"One-month physical fatigue scores were similar in groups ( mean : laparoscopy ,.28 ; 95 % CI , 11.37 13.19 v open , 12.05 ; 95 % CI , 11.14 to 12.96 ; adjusted mean difference , -0.23 ; 95 % CI , -1.52 to 1.07 ) ."
2,"physical fatigue scores were similar in both groups ( mean : laparoscopy , 12.28 ; 95 % CI , 11.37 to 13.19 open , 12.05 ; 95 % CI , 11.14 to 12.96 ; adjusted mean difference , -0.23 ; 95 % CI , -1. to 1.07 ) ."
1,Five sham acupoints are used in the control group .
1,Five acupoints are used in the control group .
1,Five sham acupoints are in the control group .
1,Five sham acupoints are used in the control .
1,Five sham acupoints used in the control group .
3,A combination BRSV vaccine administered intranasally to young calves induced protective immunity in the presence of maternal antibodies .
3,A combination BRSV vaccine administered intranasally to young calves induced protective immunity in presence of maternal antibodies .
3,A combination BRSV vaccine administered intranasally young calves induced protective immunity in the presence of maternal antibodies .
3,A combination BRSV vaccine administered to young calves induced protective immunity in the presence of maternal antibodies .
3,A combination BRSV vaccine intranasally to young calves induced protective immunity in the presence of maternal antibodies .
2,The mean enhancement value of the hepatic parenchyma and the tumor-to-liver contrast of HCCs with diameters greater than 1cm in the post-contrast all phases did not differ significantly between two groups ( P > 0.05 ) .
2,The mean enhancement value of the hepatic parenchyma and tumor-to-liver contrast HCCs with diameters greater than 1cm in the post-contrast all phases did not differ significantly between two groups ( P >.05 ) .
2,The mean enhancement value of the hepatic parenchyma tumor-to-liver contrast of HCCs with diameters greater than 1cm in the post-contrast all phases did not differ significantly between two ( P > 0.05 ) .
2,The mean value of the hepatic parenchyma and the tumor-to-liver contrast of HCCs with diameters than 1cm in the post-contrast all phases did not differ between two groups ( P > 0.05 ) .
2,mean enhancement value of the hepatic parenchyma and the tumor-to-liver contrast HCCs with diameters greater than 1cm in the post-contrast all phases not differ significantly between two groups ( P > 0.05 ) .
3,Accompanying routine acupuncture with time method acupuncture can enhance the efficacy of treatment and the persistence of its benefits in individuals with cLBP .
3,Accompanying acupuncture with time method acupuncture can enhance the efficacy of treatment the persistence of its benefits in individuals with cLBP .
3,Accompanying routine acupuncture time method acupuncture enhance the efficacy of treatment and the persistence of its benefits in individuals with cLBP .
3,Accompanying routine acupuncture with time acupuncture can enhance the efficacy of treatment and the persistence of benefits in individuals with cLBP .
3,Accompanying routine acupuncture with time method acupuncture can the efficacy of treatment and the persistence of its in individuals with cLBP .
3,"In patients with longer cardiopulmonary bypass times , a single intravenous bolus of CsA administered prior to CABG surgery reduced the extent of PMI ."
3,"In patients longer cardiopulmonary bypass times , a intravenous bolus of CsA administered prior to CABG surgery reduced the extent of PMI ."
3,"In patients with longer cardiopulmonary times , a single intravenous bolus of CsA administered prior to CABG surgery the extent of PMI ."
3,"In patients with longer cardiopulmonary times , a single intravenous bolus of CsA prior to CABG surgery reduced the extent of PMI ."
3,"patients with cardiopulmonary bypass times , a single intravenous bolus of CsA administered prior to CABG surgery reduced the extent of PMI ."
0,To determine and compare the adverse events and long-term effectiveness for patients with small hepatocellular carcinoma ( HCC ) ( 3cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine and compare the adverse events and long-term effectiveness for patients with small hepatocellular carcinoma ( HCC ) ( 3cm ) treated percutaneous ablation ( RFA ) or hepatectomy .
0,To determine and compare the adverse events long-term effectiveness for with small hepatocellular carcinoma ( HCC ) ( 3cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine and the adverse events long-term effectiveness for patients with small hepatocellular carcinoma ( HCC ) ( 3cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
0,To determine compare adverse events and long-term effectiveness for patients with small hepatocellular carcinoma ( HCC ) ( 3cm ) treated by percutaneous radiofrequency ablation ( RFA ) or hepatectomy .
3,No difference in incidence of UTI was found in residents with low UTI risk .
3,No difference in incidence of UTI found in residents with low UTI risk .
3,No difference in incidence of UTI was found in residents with low risk .
3,No difference in incidence of UTI was found in with low UTI risk .
3,No in incidence of UTI was found in residents with low UTI risk .
2,"Compared with the control diet , the high-fructose diet significantly increased IHCLs by 102 36 % and HGP by 16 3 % and decreased fasting lipid oxidation by 100 29 % ( all P < 0.05 ) ."
2,"Compared with the control , the high-fructose diet significantly increased IHCLs by 102 36 % and HGP by 16 3 % and decreased oxidation by 100 29 % ( all P < 0.05 ) ."
2,"Compared with the control diet , high-fructose diet significantly increased IHCLs by 102 36 % and HGP by 16 3 % and decreased fasting lipid oxidation by 100 % ( all < 0.05 ) ."
2,"Compared with the control diet , the high-fructose diet IHCLs by 102 % and HGP by 16 3 % and decreased fasting lipid oxidation by 100 29 % ( all P < 0.05 ) ."
2,"Compared with the control diet , the high-fructose diet significantly increased IHCLs 102 36 % and by 16 3 % and decreased fasting lipid oxidation by 100 29 % ( all P < 0. ) ."
2,The MS group showed a higher incidence of hypoxaemia .
2,The MS group showed a higher incidence of .
2,The MS group showed a higher of hypoxaemia .
2,The MS group showed higher incidence of hypoxaemia .
2,The MS showed a higher incidence of hypoxaemia .
0,To investigate effects of intra-abdominal pressure in pregnancy on the development of spinal blockade and incidence of hypotension during cesarean section .
0,To investigate effects of intra-abdominal in pregnancy on the development of spinal blockade and incidence of hypotension cesarean section .
0,To investigate effects of intra-abdominal pressure pregnancy on the development of spinal blockade and incidence of during cesarean section .
0,To investigate effects of intra-abdominal pressure pregnancy on the development of spinal blockade and incidence of hypotension during cesarean .
0,To investigate effects of intra-abdominal pressure pregnancy on the development spinal blockade and incidence of hypotension during cesarean section .
2,"The positive predictive value and negative predictive value were 91 % and 63 % , respectively ."
2,"The positive predictive and negative predictive value were 91 % and 63 % , respectively ."
2,"The positive predictive value and negative predictive were 91 % and 63 % , respectively ."
2,"The positive value and negative predictive value were 91 % and 63 % , respectively ."
2,"positive predictive value and negative predictive value were 91 % and 63 % , respectively ."
3,"PUFA requirements of children with SAM are not met by current formulations of RUTF , or by an RUTF with elevated short-chain n-3 PUFA without additional preformed long-chain n-3 PUFA ."
3,"PUFA requirements of children with SAM are not met by current formulations RUTF , or by an RUTF with elevated short-chain n-3 without additional preformed long-chain n-3 PUFA ."
3,"PUFA requirements of children with SAM are not met by current formulations of RUTF , or by with elevated short-chain n-3 PUFA without additional preformed long-chain n-3 PUFA ."
3,"PUFA requirements of children with SAM are not met current formulations of RUTF , or by an RUTF with elevated short-chain PUFA without additional preformed long-chain n-3 PUFA ."
3,"PUFA requirements of with SAM are met by current formulations of RUTF , or by an RUTF with elevated short-chain n-3 PUFA without additional preformed long-chain n-3 PUFA ."
1,We analyzed the changes using the 12 subscale score of frequency scale for the symptoms of GERD ( FSSG ) and 15 items of the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compared the therapeutic efficacy between the 2 groups .
1,We analyzed changes using the 12 subscale score frequency scale for the symptoms of GERD ( FSSG ) and items of the Gastrointestinal Rating Scale at 4 and 8 weeks and compared the therapeutic efficacy between the 2 groups .
1,We analyzed the changes the 12 subscale score of frequency scale for the symptoms of GERD ( FSSG ) and 15 items of the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compared efficacy between 2 groups .
1,We analyzed the changes using 12 subscale score frequency scale for the symptoms of GERD ( FSSG ) and 15 items the Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compared the therapeutic efficacy between 2 groups .
1,We the changes using the 12 score of frequency scale for the symptoms of GERD ( FSSG ) and 15 items of Gastrointestinal Symptom Rating Scale at 4 and 8 weeks and compared the therapeutic efficacy the 2 groups .
1,This was a prospective randomized controlled trial performed between September 2009 and August 2011 .
1,This was a prospective controlled trial performed between September 2009 and August 2011 .
1,This was a prospective randomized controlled trial performed September 2009 and August 2011 .
1,This was a prospective randomized controlled trial performed between 2009 and August 2011 .
1,This was a prospective randomized controlled trial performed between September 2009 August 2011 .
0,To compare regimen-specific early virologic response .
0,To compare early virologic response .
0,To compare regimen-specific early response .
0,To compare regimen-specific early virologic .
0,To compare regimen-specific virologic response .
3,Clinical benefit was lower in patients with de-novo Thr790Met and exon 20 insertion mutations .
3,Clinical benefit was lower in patients with de-novo Thr790Met and exon 20 mutations .
3,Clinical benefit was lower in patients with de-novo Thr790Met and exon insertion mutations .
3,Clinical benefit was lower in patients with de-novo Thr790Met exon 20 insertion mutations .
3,Clinical benefit was lower patients with de-novo Thr790Met and exon 20 insertion mutations .
2,PR severity and RV mass/volume ratio were similar between these 2 groups .
2,PR severity and RV mass/volume ratio were similar these 2 groups .
2,PR severity and RV mass/volume were similar between these 2 groups .
2,PR severity and RV/volume ratio were similar between these 2 groups .
2,PR severity and mass/volume ratio were similar between these 2 groups .
1,"The research design was a prospective , randomized study ."
1,"The design was a prospective , randomized study ."
1,"The research design was a prospective , study ."
1,"The research design was prospective , randomized study ."
1,"research design was a prospective , randomized study ."
3,"Propofol and isoflurane exert similar adverse effects on RT , psychomotor coordination , and visual memory ."
3,"Propofol and isoflurane exert similar adverse effects RT , psychomotor coordination , and visual memory ."
3,"Propofol and isoflurane exert similar adverse effects on RT , psychomotor coordination , and visual ."
3,"Propofol and isoflurane exert similar effects on RT , psychomotor coordination , and visual memory ."
3,"and isoflurane exert similar adverse effects on RT , psychomotor coordination , and visual memory ."
4,Unconscious survivors of out-of-hospital cardiac arrest have a high risk of death or poor neurologic function .
4,Unconscious survivors of cardiac arrest have a high risk of death or poor neurologic function .
4,Unconscious survivors of out-of-hospital cardiac arrest have a high of death or poor neurologic function .
4,Unconscious survivors of out-of-hospital cardiac arrest have a high risk of death poor neurologic function .
4,Unconscious survivors of out-of-hospital cardiac arrest have a risk of death or poor neurologic function .
2,Similar numbers of subjects in the cinacalcet and placebo groups reported adverse events ( AEs ) ( 27 vs 20 ) and serious AEs ( three vs four ) .
2,Similar numbers of subjects in the cinacalcet and groups adverse events ( AEs ) ( 27 vs 20 ) and serious AEs ( three vs four ) .
2,Similar numbers of subjects in the cinacalcet and placebo groups reported adverse events ( AEs ) ( 27 vs ) and serious AEs ( three four ) .
2,Similar numbers of subjects in the cinacalcet and placebo groups reported adverse events ( AEs ) ( 27 vs 20 ) serious AEs ( three vs ) .
2,Similar numbers subjects in the cinacalcet and placebo groups reported adverse events ( AEs ) ( 27 vs 20 ) serious AEs ( three vs four ) .
1,"Participants will be randomized ( in a 1:1 ratio ) to receive oral granulated Chinese herbal medicine YXBCM01 plus topical calcipotriol 0.005 % or oral YXBCM01 placebo plus topical calcipotriol 0.005 % treatment for 12 weeks , with a 12-week follow-up phase ."
1,"Participants will be randomized ( in a 1:1 ratio ) to receive oral granulated Chinese herbal YXBCM01 plus calcipotriol 0.005 % or YXBCM01 placebo plus topical calcipotriol 0.005 % treatment for 12 weeks , with a follow-up phase ."
1,"Participants will be randomized ( in a 1:1 ratio ) to receive oral granulated Chinese herbal YXBCM01 plus topical calcipotriol 0.005 % or oral YXBCM01 placebo plus topical calcipotriol 0. % for 12 weeks , with 12-week follow-up phase ."
1,"Participants will be randomized ( in a 1:1 ratio ) to receive oral granulated Chinese herbal medicine YXBCM01 plus calcipotriol 0.005 % or YXBCM01 placebo plus calcipotriol 0.005 % treatment for 12 weeks , with a 12-week follow-up ."
1,"Participants will be randomized ( in a 1:1 ratio ) to receive oral granulated Chinese medicine YXBCM01 topical 0.005 % or oral YXBCM01 placebo plus topical calcipotriol 0. % treatment for 12 weeks , with a 12-week follow-up phase ."
1,"In six left-sided patients , IMN-RT was simulated , and OAR doses were compared to those in the original plan ."
1,"In six left-sided , IMN-RT was simulated , and OAR doses were compared to those in the original plan ."
1,"In six left-sided patients , IMN-RT simulated , and OAR doses were compared to those in the original plan ."
1,"In six left-sided patients , IMN-RT was simulated , and OAR doses were compared to in the original plan ."
1,"In six left-sided patients , IMN-RT was simulated , and OAR doses were compared to those in the plan ."
0,To assess the efficacy of trabeculectomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) in patients in a prospective randomized clinical trial .
0,To assess efficacy of trabeculectomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) in patients in a prospective randomized clinical .
0,To assess the efficacy of trabeculectomy with biodegradable Ologen implant ( ) versus mitomycin C ( MMC ) in patients in a prospective randomized clinical trial .
0,To assess the efficacy of trabeculectomy with biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) in in a prospective randomized clinical trial .
0,To assess the of trabeculectomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) patients in a prospective randomized clinical trial .
3,"These results are exploratory and are not intended to guide clinical decision-making , but rather offer a potentially useful strategy in the design of larger trials of IPS ."
3,"These results are and are not intended to guide clinical decision-making , but rather offer a potentially useful strategy in the design of larger trials of ."
3,"These results are exploratory and are not intended guide clinical decision-making , rather offer a potentially useful strategy in the design of larger trials of IPS ."
3,"These results are exploratory and are not intended to guide clinical , but offer a potentially useful strategy in the design of larger trials of IPS ."
3,"These results are exploratory and are not intended to guide clinical decision-making , but offer a potentially useful strategy the design of larger trials of IPS ."
0,"To determine whether the method of specimen preparation after transrectal ultrasound-guided biopsy of the prostate affected core fragmentation , and secondly to determine whether such fragmentation was influenced by the presence of malignancy in the biopsy specimen ."
0,"To determine the method of specimen preparation after transrectal ultrasound-guided biopsy of prostate affected core fragmentation , and secondly to determine whether such fragmentation was influenced by the presence of malignancy in the specimen ."
0,"To determine the method of specimen preparation after transrectal ultrasound-guided biopsy of the prostate affected core fragmentation , and secondly to determine whether such was influenced by the of malignancy in the biopsy specimen ."
0,"To determine whether the method of specimen after transrectal ultrasound-guided biopsy of the affected fragmentation , and secondly to determine whether such fragmentation was influenced by the presence of malignancy in the biopsy specimen ."
0,"To determine whether the method of specimen preparation transrectal biopsy of the prostate affected core fragmentation , and secondly to determine such fragmentation was influenced by the presence of malignancy in the biopsy specimen ."
3,Weekly measurements of liver function tests may be necessary for early detection of adverse events .
3,Weekly measurements of function tests may be necessary for early detection of adverse events .
3,Weekly measurements of liver function tests may be necessary early detection of adverse events .
3,Weekly measurements of liver function tests may be necessary for early detection of adverse .
3,measurements of liver function tests may be necessary for early detection of adverse events .
1,123 older adults with chronic and primary insomnia .
1,123 older adults chronic and primary insomnia .
1,123 older adults with and primary insomnia .
1,123 older adults with chronic and primary .
1,older adults with chronic and primary insomnia .
0,The present study aimed to compare the postoperative contrast sensitivity functions between wavefront-guided LASIK eyes and their contralateral wavefront-guided PRK eyes .
0,The present study aimed compare the postoperative contrast sensitivity functions between wavefront-guided LASIK eyes and contralateral wavefront-guided PRK eyes .
0,The present study aimed to compare the postoperative contrast sensitivity functions wavefront-guided LASIK eyes and their wavefront-guided PRK eyes .
0,The present study aimed to the postoperative contrast sensitivity functions between wavefront-guided LASIK eyes and their wavefront-guided PRK eyes .
0,The present study to compare the postoperative contrast sensitivity functions between LASIK eyes and their contralateral wavefront-guided PRK eyes .
0,To determine the prevalence of impaired olfaction in individuals presenting for cardiac surgery and the independent association between impaired olfaction and postoperative delirium and cognitive decline .
0,To determine prevalence of impaired olfaction in individuals presenting for cardiac surgery and the independent association between impaired olfaction and postoperative delirium and decline .
0,To determine the prevalence of impaired olfaction in individuals presenting for cardiac surgery and the between impaired olfaction and postoperative delirium and cognitive decline .
0,To determine the prevalence of impaired olfaction in individuals presenting for surgery and the independent association between impaired olfaction and postoperative delirium and cognitive .
0,To determine the prevalence of impaired olfaction individuals presenting for cardiac surgery and the independent association between impaired olfaction and postoperative and cognitive decline .
4,"Adverse events ( AEs ) , defined as unintended patient harm related to healthcare provided rather than an underlying medical condition , represent a significant threat to patient safety and public health ."
4,"Adverse events ( AEs ) , defined as unintended harm related to healthcare provided rather than an underlying condition , represent a significant threat to patient safety and public health ."
4,"Adverse events ( AEs ) , defined as unintended patient harm related to healthcare provided rather than an medical condition , represent a significant threat to patient safety and health ."
4,"Adverse events ( AEs ) , defined as unintended patient harm related to healthcare provided rather than an underlying medical condition , represent a significant to patient safety and health ."
4,"Adverse events ( AEs ) , defined as unintended patient harm related to provided rather an underlying medical condition , represent a significant threat to patient safety and public health ."
3,"Participants preferred to sleep with their arms beside their bodies , not with their arms in a crucifix position as commonly advocated ."
3,"Participants preferred sleep with arms beside their bodies , not with their arms in a crucifix position as commonly advocated ."
3,"Participants preferred sleep with their arms beside their bodies , not with their arms in a crucifix position commonly advocated ."
3,"Participants preferred to sleep with arms beside their bodies , not with arms in a crucifix position as commonly advocated ."
3,"Participants preferred with their arms beside their bodies , not with their arms in a crucifix position as commonly advocated ."
2,The average ( AV ) pain scores per infant after receiving injections were significantly lower when Pentavac was administered in a second place in A Group .
2,The average ( AV ) pain scores infant after receiving injections were significantly lower when Pentavac was administered in a second in A Group .
2,The average ( AV ) pain scores per infant after receiving injections were lower when Pentavac was administered in a second place A Group .
2,The average ( AV ) pain scores per infant after receiving injections were significantly lower when Pentavac was administered in a second in A .
2,The average ( AV ) pain scores per infant after receiving were significantly lower when Pentavac was administered in a second place A Group .
4,Disposable electrocardiographic lead wires ( ECG-LWs ) may not be as durable as reusable ones .
4,Disposable electrocardiographic lead wires ( ECG-LWs ) may be as durable as reusable ones .
4,Disposable electrocardiographic lead wires ( ECG-LWs ) may not be as durable as ones .
4,Disposable electrocardiographic lead wires ( ECG-LWs ) not be as durable as reusable ones .
4,electrocardiographic lead wires ( ECG-LWs ) may not be as durable as reusable ones .
2,"At baseline , the greater the desire to quit and one 's expectations of success , and the lesser the educational level , the more likely participants were to have a quit forever goal ."
2,"At , the the desire to quit and one 's expectations of success , and the lesser the educational , the more likely participants were to have a quit forever goal ."
2,"At baseline , the desire to quit and one 's expectations of success , and the the educational level , the more likely participants were to have a quit forever goal ."
2,"At baseline , the greater the desire quit and one 's expectations success , and the lesser the educational level , the more likely participants to have a quit forever goal ."
2,"At baseline , the greater the to quit and one 's expectations of success , and the lesser educational level , the more likely participants were to have a quit forever ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained activity of DNA-damaging agents ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease DFS events suggesting a better prognosis and potentially retained activity of DNA-damaging ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially of DNA-damaging agents ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained DNA-damaging agents ."
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DFS events suggesting better prognosis and potentially activity of DNA-damaging agents ."
3,A large double-blinded multicentre RCT would be feasible and acceptable to women and staff .
3,A large double-blinded RCT would be feasible and acceptable to women and staff .
3,A large double-blinded multicentre RCT would be and acceptable to women and staff .
3,A large double-blinded multicentre RCT would be feasible and to women and staff .
3,large double-blinded multicentre RCT would be feasible and acceptable to women and staff .
1,"We randomly allocated 80 clusters ( LHW catchments ) of children to receive routine health and nutrition services ( controls ; n = 368 ) , nutrition education and multiple micronutrient powders ( enhanced nutrition ; n = 364 ) , responsive stimulation ( responsive stimulation ; n = 383 ) , or a combination of both enriched interventions ( n = 374 ) ."
1,"We allocated 80 clusters ( LHW catchments ) of children to receive routine health and ( controls ; n = 368 ) , nutrition education and multiple micronutrient powders ( enhanced nutrition ; n = 364 ) , responsive stimulation ( responsive stimulation ; n = 383 ) , or a combination of both interventions ( n = 374 ) ."
1,"We randomly allocated 80 clusters ( LHW catchments ) of children to receive routine health and nutrition ( controls ; n = 368 ) , nutrition education and multiple micronutrient powders ( enhanced nutrition ; n = 364 ) , responsive ( responsive stimulation ; = 383 ) , or a combination of both enriched ( n = 374 ) ."
1,"We randomly allocated 80 clusters ( LHW catchments ) of to receive routine health and nutrition services ( controls ; n = 368 ) , nutrition education and micronutrient powders ( enhanced nutrition ; n = 364 ) , responsive stimulation ( responsive stimulation ; = 383 ) , or a combination of both interventions ( n = 374 ) ."
1,"randomly allocated 80 clusters ( LHW catchments ) of children receive routine health nutrition services ( controls ; n = 368 ) , nutrition education and multiple micronutrient powders ( enhanced nutrition ; n = 364 ) , responsive stimulation ( responsive stimulation ; n = 383 ) , or a combination of both interventions ( n = 374 ) ."
1,"Participants were evaluated before treatment , 3 weeks after completion , and at 2-month follow-up ."
1,"Participants evaluated before treatment , 3 weeks after completion , and at 2-month follow-up ."
1,"Participants were before treatment , 3 weeks after completion , and at 2-month follow-up ."
1,"Participants were evaluated before treatment , 3 weeks after completion , and at follow-up ."
1,"Participants were evaluated before treatment , 3 weeks completion , and at 2-month follow-up ."
4,"Additionally , it was investigated if cheek cell FA composition correlates with the FA composition of plasma , red blood cells ( RBC ) and peripheral blood mononuclear cells ( PBMC ) before and during both interventions ."
4,"Additionally , it was investigated if cheek FA composition correlates with FA composition of plasma , red blood cells ( RBC ) and peripheral blood mononuclear cells ( PBMC ) and during both interventions ."
4,"Additionally , it was investigated if cheek cell FA composition correlates with the FA composition of , red cells ( RBC ) and peripheral blood mononuclear ( PBMC ) before and during both interventions ."
4,"Additionally , it was investigated if cheek cell FA composition correlates with the composition of , red blood cells ( RBC ) and peripheral mononuclear cells ( PBMC ) before and during both interventions ."
4,"Additionally , it was investigated if cheek cell composition correlates with the FA composition of plasma , red blood cells ( RBC ) peripheral blood mononuclear cells ( PBMC ) before and during both ."
2,"Lactobacillus reuteri reduced mean hospital stays ( 4.31 1.3 days versus 5.46 1.77 days , p < 0.001 ) ."
2,"Lactobacillus reuteri reduced mean hospital stays ( 4. 1.3 versus 5.46 1.77 days , p < 0.001 ) ."
2,"Lactobacillus reuteri reduced mean hospital stays ( 4.31 1. days versus 5.46 1.77 , p < 0.001 ) ."
2,"Lactobacillus reuteri reduced mean hospital stays ( 4.31. days versus 5.46 1.77 days , p < 0.001 ) ."
2,"reuteri reduced mean hospital stays ( 4. 1.3 days versus 5.46 1.77 days , p < 0.001 ) ."
4,"Patellofemoral pain syndrome ( PFPS ) is a common musculoskeletal condition , particularly among women ."
4,"Patellofemoral pain syndrome ( ) is a common musculoskeletal condition , particularly among women ."
4,"Patellofemoral pain syndrome ( PFPS ) is a common musculoskeletal condition , particularly among ."
4,"Patellofemoral pain syndrome ( PFPS ) is a common musculoskeletal condition , particularly women ."
4,"pain syndrome ( PFPS ) is a common musculoskeletal condition , particularly among women ."
4,Cystic fibrosis is a life-limiting disease that is caused by defective or deficient cystic fibrosis transmembrane conductance regulator ( CFTR ) protein activity .
4,Cystic fibrosis is a disease that is caused by defective or cystic fibrosis transmembrane conductance regulator ( CFTR ) protein activity .
4,Cystic fibrosis is a life-limiting disease is caused by defective or deficient cystic fibrosis conductance regulator ( CFTR ) protein activity .
4,Cystic fibrosis is a life-limiting disease that is caused by or deficient cystic transmembrane conductance regulator ( CFTR ) protein activity .
4,Cystic fibrosis is a life-limiting is caused by defective or deficient cystic fibrosis transmembrane conductance regulator ( CFTR ) protein activity .
0,To compare the efficacy of two surgical techniques for controllong nasal width after Le Fort I osteotomy .
0,To compare the efficacy of two surgical techniques for controllong nasal after Le Fort I osteotomy .
0,To compare the efficacy of two surgical techniques for controllong nasal width after Le Fort I .
0,To compare the efficacy of two surgical techniques for controllong nasal width after Le I osteotomy .
0,To the efficacy of two surgical techniques for controllong nasal width after Le Fort I osteotomy .
0,"The aim of this study is to compare preoperative and postoperative conditions of GMP-140 concentration , the aggregation and activation of platelets in congenital heart disease patients undergoing transcatheter closure of atrial septal defects ( ASDs ) or ventricular septal defects ( VSDs ) , and the appropriate dose of aspirin of patients after transcatheter closure ."
0,"The aim of this study is to compare and postoperative conditions of GMP-140 concentration , the aggregation and activation of platelets congenital heart disease undergoing transcatheter closure of atrial septal defects ( ASDs ) or ventricular septal defects ( VSDs ) , and the dose aspirin of patients after transcatheter closure ."
0,"The of this study is compare preoperative and postoperative conditions of GMP-140 concentration , the and activation of platelets in congenital heart disease patients undergoing transcatheter closure of atrial defects ( ASDs ) or ventricular defects ( VSDs ) , and the appropriate dose of aspirin of patients after transcatheter closure ."
0,"The of this study is to compare preoperative and postoperative conditions of GMP-140 concentration , the and activation of platelets in heart disease patients undergoing transcatheter closure of atrial septal defects ( ) or ventricular septal defects ( VSDs ) , and the appropriate dose of aspirin patients after transcatheter closure ."
0,"aim of study is to compare preoperative and postoperative conditions of GMP-140 concentration , the aggregation and activation of platelets in congenital heart patients undergoing transcatheter closure of atrial septal defects ( ) or ventricular septal defects ( VSDs ) , and the appropriate dose of aspirin of patients after transcatheter ."
1,Placebo ( syrup base ) or zinc ( 20 mg/5 mL elemental zinc as zinc sulfate ) orally given for a period of 2 weeks .
1,( syrup base ) or zinc ( 20 mg/5 mL elemental zinc as zinc ) orally given for a period of 2 weeks .
1,Placebo ( base ) or zinc ( 20 mg/5 mL elemental zinc as zinc sulfate ) orally given a period of 2 weeks .
1,Placebo ( syrup base ) or zinc ( 20 mg/5 mL elemental zinc as zinc ) orally given for a period 2 weeks .
1,Placebo ( syrup base ) zinc ( 20 mg/5 mL elemental zinc as zinc sulfate ) orally given a period of 2 weeks .
2,"Following 12 weeks of training , there were no significant differences in the main measured outcome variables between RT and RTS ."
2,"12 weeks of training , were no significant differences in the main measured outcome variables between RT and RTS ."
2,"Following 12 weeks of training , there were differences in the main measured outcome variables between RT and RTS ."
2,"Following 12 weeks of training , there were no significant differences in the main measured outcome between RT and ."
2,"Following 12 weeks of training , there were no significant differences in the measured outcome variables between RT RTS ."
2,"Oral-health-related fatalism was apparent , with 74.2 % believing that most people usually get dental problems , 58.6 % believing that most people will need extractions at some stage , and that most children eventually get dental caries ."
2,"Oral-health-related fatalism apparent , with 74.2 % believing that most people usually get dental problems , 58.6 % believing that most people will need extractions at some stage , and most children get dental caries ."
2,"Oral-health-related fatalism was , with 74.2 % believing that most people usually get dental problems , 58.6 % believing that most people will need extractions some stage , and that most eventually get dental caries ."
2,"Oral-health-related fatalism was apparent , 74.2 % believing that most people get dental problems , 58.6 % believing that most people will extractions at some stage , and that most children eventually get dental caries ."
2,"Oral-health-related fatalism was apparent , with 74.2 % believing that most get dental problems , 58.6 % believing that most people need extractions at some stage , and that most children eventually get dental caries ."
2,This was significantly associated with the total monthly income of a household and the educational level of the respondent .
2,This significantly associated with the total monthly income of a household and the educational level of the respondent .
2,This was significantly associated the total monthly income of a household and the educational level of the respondent .
2,This was significantly associated with the total monthly income of a household and the educational level the respondent .
2,This was significantly associated with the total monthly income of a household and the level of the respondent .
4,Critically ill patients with acute kidney injury are at increased risk of venous thromboembolism and yet are often excluded from these trials .
4,Critically ill patients with acute kidney are increased risk of venous thromboembolism and yet are often excluded from these trials .
4,Critically ill patients with acute kidney at increased risk of venous thromboembolism and yet are often excluded from these trials .
4,Critically ill patients with acute kidney injury are at increased of venous thromboembolism and yet are often from these trials .
4,Critically ill patients with acute kidney injury are at increased risk thromboembolism and yet are often excluded from these trials .
2,Absence of PDGFR expression correlated with longer PFS .
2,Absence PDGFR expression correlated with longer PFS .
2,Absence of PDGFR correlated with longer PFS .
2,Absence of PDGFR expression correlated with longer .
2,Absence of PDGFR expression with longer PFS .
2,"After adjustment for known confounders , including the frequency of intermittent self-catheterization in the postoperative period , the protective effects of cranberry remained ( odds ratio , 0.42 ; 95 % confidence interval , 0.18-0 .94 ) ."
2,"After adjustment for known confounders , including the frequency of intermittent self-catheterization in the postoperative period , the protective effects of cranberry remained ( odds ratio ,.42 ; 95 % confidence , 0. .94 ) ."
2,"After adjustment known confounders , including the frequency of intermittent self-catheterization in the postoperative , protective effects of cranberry remained ( odds ratio , 0.42 ; 95 % confidence interval , 0.18-0 .94 ) ."
2,"After for known confounders , including the frequency of intermittent in the postoperative period , the protective effects of cranberry remained ( odds , 0.42 ; 95 % confidence interval , 0.18-0 .94 ) ."
2,"adjustment for known confounders , including the frequency of intermittent self-catheterization in the postoperative period , the protective effects of cranberry remained ( odds ratio , 0. ; 95 % confidence interval ,.18-0 .94 ) ."
4,"The primary objective of this study was to assess the effect of teduglutide on gastric emptying of liquids in healthy subjects , as measured by the pharmacokinetics of acetaminophen ."
4,"The primary objective of study was to assess the effect teduglutide on gastric emptying of liquids in healthy subjects , as measured by the pharmacokinetics of acetaminophen ."
4,"The primary objective of this study was to assess the effect of teduglutide on gastric emptying liquids in healthy subjects , as by the pharmacokinetics of acetaminophen ."
4,"The primary objective of this study was to assess the effect of teduglutide on gastric emptying of liquids in healthy subjects , as the pharmacokinetics of acetaminophen ."
4,"The primary objective of this was to assess the effect of teduglutide on gastric emptying of liquids in healthy subjects , as by the pharmacokinetics of acetaminophen ."
3,"Although oral midazolam reduces preprocedural anxiety , it does not reduce pain or anxiety with uterine aspiration during first-trimester surgical abortions ."
3,"Although oral midazolam preprocedural anxiety , it does not reduce pain or anxiety with uterine aspiration during first-trimester abortions ."
3,"Although oral midazolam reduces anxiety , it does not reduce pain or anxiety with uterine aspiration during first-trimester surgical ."
3,"Although oral midazolam reduces preprocedural anxiety , it does not pain or anxiety uterine aspiration during first-trimester surgical abortions ."
3,"Although oral midazolam reduces preprocedural anxiety , it not reduce pain or anxiety with aspiration during first-trimester surgical abortions ."
0,"To explore the outcomes of an Xbox Kinect intervention on balance ability , enjoyment and compliance for previously injured young competitive male athletes ."
0,"To explore the outcomes of Kinect intervention on balance ability , enjoyment and compliance for previously injured young competitive male athletes ."
0,"To explore the outcomes of an Xbox Kinect on ability , enjoyment and compliance for previously injured young competitive male athletes ."
0,"To explore the outcomes of an Xbox Kinect on balance ability , enjoyment and compliance for previously young competitive male athletes ."
0,"explore the outcomes of an Xbox intervention on balance ability , enjoyment and compliance for previously injured young competitive male athletes ."
1,"HIV-uninfected men ( HIV - ; n = 60 ) , HIV-infected men using HAART ( HIV + / HAART + ; n = 58 ) , and HIV-infected men not using HAART ( HIV + / HAART - ; n = 41 ) recruited from two sites of the Multicenter AIDS cohort study ( MACS ) underwent a nocturnal sleep study , anthropometric assessment , and questionnaires for fatigue and the Epworth Sleepiness Scale ."
1,"HIV-uninfected ( - ; n = 60 ) , HIV-infected men using HAART ( HIV + / HAART + ; n = 58 ) , and HIV-infected men not using HAART ( HIV + / HAART - ; n = 41 ) recruited from two of the Multicenter AIDS cohort study ( MACS ) underwent a nocturnal sleep study , anthropometric assessment , and questionnaires for fatigue Epworth Sleepiness Scale ."
1,"HIV-uninfected men ( - ; n = 60 ) , HIV-infected men using HAART ( HIV + / HAART + ; n = ) , and HIV-infected not using HAART ( HIV + / HAART - ; n = 41 ) recruited from two sites of the Multicenter AIDS study ( MACS ) underwent a nocturnal sleep study , anthropometric assessment , questionnaires for fatigue and the Epworth Sleepiness Scale ."
1,"HIV-uninfected men ( - ; n = 60 ) , HIV-infected men using HAART ( HIV + / HAART + ; n = 58 ) , and HIV-infected men not using HAART ( HIV + / - ; n = 41 ) recruited from two sites the Multicenter AIDS cohort study ( MACS ) underwent a nocturnal sleep study , anthropometric assessment , and questionnaires for fatigue and Epworth Sleepiness ."
1,"HIV-uninfected men ( HIV - ; n = 60 ) , HIV-infected men using HAART ( HIV + / HAART + ; n = 58 ) , and men not HAART ( HIV + / HAART - ; n = 41 ) recruited from two sites of Multicenter AIDS cohort study ( MACS ) underwent a sleep study , anthropometric , and questionnaires for fatigue and the Epworth Sleepiness Scale ."
1,"Secondary outcomes include ( i ) ulcer-related outcomes : time to healing , change in ulcer area , minor and major amputation , secondary infection and ( ii ) patient-related outcomes : local pain , mood and function ( EQ-5D ) , impact of the ulcer ( Cardiff Wound Impact Schedule ) and survival ."
1,"Secondary outcomes include ( ) ulcer-related outcomes : time to healing , change in ulcer area , minor and major amputation , secondary infection and ( ) patient-related outcomes : local pain , mood function ( EQ-5D ) , impact of the ulcer ( Cardiff Wound Impact Schedule ) and survival ."
1,"Secondary outcomes include ( i ) ulcer-related outcomes : time healing , change in ulcer area , minor and major amputation , secondary and ( ii ) patient-related outcomes : local pain , mood function ( EQ-5D ) , impact of the ulcer ( Cardiff Wound Impact Schedule ) and survival ."
1,"Secondary outcomes include ( i ) ulcer-related outcomes : time to healing , change in ulcer area , minor and major , secondary and ( ii ) patient-related outcomes : local pain , mood and function ( EQ-5D ) , impact of ulcer ( Cardiff Wound Impact Schedule ) and survival ."
1,"Secondary outcomes include ( i ) ulcer-related outcomes : time to healing , change in ulcer area , minor and major amputation , secondary and ( ii ) patient-related outcomes : local , and function ( EQ-5D ) , impact of the ulcer ( Cardiff Wound Impact Schedule ) and survival ."
4,Several randomized controlled clinical trials of PTA balloons coated with different formulations of paclitaxel have been conducted in Europe ( N Engl J Med 2008 ; 358:689 -699 ) ( Circulation 2008 ; 118:1358 -1365 ) ( Circ Cardiovasc Interv 2012 ; 5:831 -840 ) ( JACC Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more durable efficacy than PTA with comparable safety .
4,Several controlled clinical trials of PTA balloons coated with different formulations of paclitaxel have been conducted in Europe ( Engl J Med 2008 ; 358:689 -699 ) ( Circulation 2008 ; 118:1358 - ) ( Circ Cardiovasc Interv ;:831 -840 ) ( JACC Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more durable efficacy than PTA with comparable safety .
4,Several randomized clinical trials of PTA balloons with different formulations of paclitaxel have been conducted in Europe ( N Engl J 2008 ; 358:689 -699 ) ( Circulation ; 118:1358 -1365 ) ( Circ Interv 2012 ; 5:831 -840 ) ( JACC Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more durable efficacy than PTA with comparable safety .
4,Several randomized controlled clinical trials of PTA balloons coated with different formulations of have been conducted in Europe ( N Engl Med 2008 ; 358:689 -699 ) ( Circulation ; 118:1358 -1365 ) ( Circ Cardiovasc Interv 2012 ; 5:831 -840 ) ( JACC Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more efficacy than PTA with comparable .
4,Several randomized controlled clinical trials of PTA balloons coated with different of paclitaxel have been conducted Europe ( N Engl J Med 2008 ; 358:689 -699 ) ( Circulation 2008 ; 118:1358 - ) ( Circ Cardiovasc Interv 2012 ; 5:831 -840 ) ( Cardiovas Interv 2014 ; 7:10 -19 ) and demonstrated more durable efficacy than with comparable safety .
4,NCT01303614 .
4,NCT01303614 .
3,"Preoperative targeted therapy of advanced BRAF-mutant melanoma is feasible , well tolerated , induces brisk tumor responses , and facilitates correlative science ."
3,"Preoperative targeted therapy of BRAF-mutant melanoma is feasible , well tolerated , induces brisk tumor responses , and facilitates correlative science ."
3,"Preoperative targeted therapy of advanced BRAF-mutant melanoma is feasible , well tolerated , induces brisk tumor responses , and correlative science ."
3,"Preoperative targeted therapy of advanced BRAF-mutant melanoma is feasible , well tolerated , induces brisk tumor responses , facilitates correlative science ."
3,"Preoperative therapy of advanced BRAF-mutant melanoma is feasible , well tolerated , induces brisk tumor responses , and facilitates correlative science ."
3,High SOC scores were good predictors of successful lifestyle change in subjects at risk of type 2 diabetes .
3,High SOC scores were good predictors of successful lifestyle change in subjects at risk of 2 diabetes .
3,High SOC scores were good predictors of successful lifestyle change in subjects at risk of type 2 .
3,High SOC scores were good predictors of successful lifestyle change in subjects at risk type 2 diabetes .
3,High SOC scores were good predictors of successful lifestyle change in subjects risk of type 2 diabetes .
3,( Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes ; NCT00099788 ) .
3,( Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes ; NCT00099788 ) .
3,( Metabolic Efficiency Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes ; NCT00099788 ) .
3,( Metabolic Efficiency With Ranolazine for Ischemia in Non-ST Elevation Acute Coronary Syndromes ; NCT00099788 ) .
3,( Metabolic Efficiency With Ranolazine for Less Ischemia Non-ST Elevation Acute Coronary Syndromes ; NCT00099788 ) .
4,The results of low-tube-voltage coronary CT angiography ( CCTA ) performed on 320-row scanners have not been adequately assessed .
4,The results of low-tube-voltage coronary CT ( CCTA ) performed on 320-row scanners have not been adequately assessed .
4,The results of low-tube-voltage coronary CT angiography ( CCTA ) performed 320-row scanners have not been adequately assessed .
4,The results of low-tube-voltage coronary CT angiography ( CCTA ) performed on 320-row scanners have not been adequately .
4,results of low-tube-voltage coronary CT angiography ( CCTA ) performed on 320-row scanners have not been adequately assessed .
0,To determine whether daily irrigation with sterile saline solution during silicone hydrogel ( SiH ) contact lens continuous wear ( CW ) can mitigate increases in corneal epithelial permeability ( Pdc ) and reduce the risk of adverse events .
0,To determine daily irrigation with sterile saline solution during silicone hydrogel ( ) contact lens continuous wear ( CW ) can mitigate increases in corneal epithelial permeability ( Pdc ) and the risk of adverse events .
0,To determine daily irrigation with sterile saline solution during silicone hydrogel ( SiH ) contact lens continuous wear ( ) can mitigate increases in corneal epithelial permeability ( Pdc ) and the risk of adverse events .
0,To determine whether daily irrigation with sterile saline solution during silicone hydrogel ( SiH ) contact lens continuous wear ( CW ) mitigate increases in corneal epithelial permeability ( Pdc ) and the risk adverse events .
0,To determine whether with saline solution during silicone hydrogel ( SiH ) contact lens continuous wear ( CW ) can mitigate increases in corneal epithelial permeability ( Pdc ) and reduce the risk of adverse events .
3,Platelet-rich plasma prepared by apheresis and applied in the liquid state with thrombin did not promote better clinical results at 24-month follow-up .
3,Platelet-rich plasma prepared apheresis and applied in the liquid state with thrombin did promote better clinical results at 24-month follow-up .
3,Platelet-rich plasma prepared by apheresis and applied in the state with thrombin did not promote better clinical at 24-month follow-up .
3,Platelet-rich plasma prepared by apheresis applied in the liquid state with did not promote better clinical results at 24-month follow-up .
3,Platelet-rich prepared by apheresis and applied in the liquid state with thrombin did not promote better clinical at 24-month follow-up .
0,Hirsutism has negative impact on adolescent psychosocial development for both cosmetic and endocrine reasons .
0,Hirsutism has negative impact on adolescent development for both cosmetic and endocrine reasons .
0,Hirsutism has negative impact on adolescent psychosocial development for cosmetic and endocrine reasons .
0,Hirsutism has negative impact on adolescent psychosocial for both cosmetic and endocrine reasons .
0,has negative impact on adolescent psychosocial development for both cosmetic and endocrine reasons .
